Pre Clinical study of Herbo Mineral Drug KARPOORA SINTHAMANI MATHIRAI for its Anti-inflammatory, Analgesic, Anti-spasmodic and Laxative activities by Mahalaksmi, K
 PRECLINICAL STUDY OF SIDDHA DRUG 
KARPOORA SINTHAMANI MATHIRAI’S 
ANTI-INFLAMMATORY, ANALGESIC, ANTI-SPASMODIC                 
AND LAXATIVE ACTIVITIES 
 
Dissertation submitted to 
THE TAMILNADU DR. MGR MEDICAL UNIVERSITY 
CHENNAI-600032 
 
In partial fulfilment of the requirements 
for the award of the degree of 
 
DOCTOR OF MEDICINE (SIDDHA) 
BRANCH-II-GUNAPADAM 
 
POST GRADUATE DEPARTMENT OF GUNAPADAM 
THE GOVERNMENT SIDDHA MEDICAL COLLEGE 
TIRUNELVELI-627002 
OCTOBER 2019
  
GOVT. SIDDHA MEDICAL COLLEGE 
PALAYAMKOTTAI 
 
DECLARATION BY THE CANDIDATE 
 
I hereby declare that this dissertation entitled “Pre clinical study of herbo 
mineral drug KARPOORA SINTHAMANI MATHIRAI for its anti-inflammatory, 
analgesic, anti-spasmodic and laxative activities” is a bonafide and genuine research 
work carried out by me under the guidance of Dr. A. Kingsly M.D(s)., Reader, Head of 
the Department, Post Graduate Department of Gunapadam, Govt. Siddha Medical 
College, Palayamkottai and the dissertation has not formed the basis for the award of any 
Degree, Diploma, Fellowship or other similar title. 
 
 
 
 
Date:               Signature of the Candidate 
Place: Palayamkottai        Dr.K.Mahalakshmi 
  
GOVT. SIDDHA MEDICAL COLLEGE 
PALAYAMKOTTAI 
 
CERTIFICATE BY THE GUIDE 
 
This is to certify that the dissertation entitled “Pre clinical study of herbo 
mineral drug KARPOORA SINTHAMANI MATHIRAI for its anti-inflammatory, 
analgesic, anti-spasmodic and laxative activities”  is submitted to The Tamilnadu 
Dr.M.G.R.Medical University, Chennai-32 is a partial fulfilment of the requirements for 
the award of degree of  M.D (siddha) is the bonafide and genuine research work done by  
Dr. K. Mahalakshmi  under my supervision and guidance and the dissertation has not 
formed the basis for the award of any Degree, Diploma, Associateship, Fellowship or 
other similar title. 
 
 
 
Date:                         Signature of the Guide   
Place: Palayamkottai                                         Dr. A. Kingsly, M.D. (s)., 
Reader & HOD 
Department of PG Gunapadam, 
Govt. Siddha Medical College, 
Palayamkottai. 
  
GOVT. SIDDHA MEDICAL COLLEGE 
 PALAYAMKOTTAI 
 
BONAFIDE  CERTIFICATE 
 
This is to certify that the dissertation entitled “Pre clinical study of herbo 
mineral drug KARPOORA SINTHAMANI MATHIRAI for its anti-inflammatory, 
analgesic, anti-spasmodic and laxative activities” is a bonafide work done by                 
Dr. K. Mahalakshmi, a candidate of Government siddha medical college, palayamkottai 
in partial fulfilment of the University rules and regulations for award of M.D(siddha) - 
Gunapadam under my guidance and supervision during the academic year of 2019.  
 
 
 
 
 
 
 
 
 
 
Prof. Dr.S. Victoria M.D(s), 
Principal, 
Govt.Siddha Medical College, 
Palayamkottai. 
Dr. A. Kingsly, M.D(s), 
Reader  & HOD 
Department of PG Gunapadam 
Govt.Siddha Medical College, 
Palayamkottai. 
ACKNOWLEDGEMENT 
 
            I feel immense pleasure and gratitude in my heart to Siddhars for making this 
dissertation. 
  I wish to thank the esteemed authorities of the Tamil Nadu Dr. M.G.R. Medical 
University, Chennai for permitting me to undertake of Indian Medicine and 
Homeopathy, Chennai who flagged my dissertation with cheer. 
 I also wish to convey my deep gratitude to the former Principal,                                                           
Prof. Dr. R. Neelavathy, M.D.(s), Ph.D., and  Principal Prof. Dr. S. Victoria, M.D.(s), 
of Government Siddha Medical College, Palayamkottai.  
 I would like to express my deep and sincere gratitude to my guide                                               
Dr.A.Kingsly, M.D(s)., Reader, Head of the Department, PG Gunapadam Government 
Siddha Medical College, Palayamkottai, for providing much needed attentions helpful 
suggestions for dissertation. 
  I would like to give special thanks to Dr.G.Essakky pandiyan, M.D(s)., Lecturer, 
Government siddha medical college, Palayamkottai, for his valuable guidance, helpful 
suggestions and encouragement for preclinical studies. 
  I would like to give special thanks to Dr. R. Antony Duraichi, M.D(s)., Lecturer, 
Grade II Government siddha medical college, Palayamkottai, for her valuable guidance, 
helpful suggestions and encouragement for preclinical studies.  
The author is greedful to Mr.M.Kalaivanan, M.Sc., Head of the Department of 
Pharmacology, Govt. Siddha Medical College, Palayamkottai for his suggestions and 
opinions regarding to the pharmacological analysis of the study. 
  The author is grateful to Mrs.N.Nagaprema, M.Sc.,M.Phil., Head of the 
Department of Bio-chemistry, Govt. Siddha Medical College, Palayamkottai for her kind 
help and suggestion on biochemical aspect of this dissertation. 
The author is very happy to thank Dr. S. Sutha, M.Sc., Ph.D., Head of the 
Department of Herbal Botany and Herbal Pharmacognosy, Govt. Siddha Medical 
College,Palayamkottai for her kind help in botanical aspect of his study. 
The author wants to thank Dr. Murugesan Scientific Officer IIT, Chennai for ICP 
analysis, for helping me to do the test ICP-OES,GAS&FTIR. 
  I express my sincere thanks to Mr. Santhanakumar, M.Pharm., Assisant 
Lecturer Dept of Pharmacology, Arulmigu Kalasalingam college of pharmacy, 
Krishnankoil, for their excellent help in pharmacological study, toxicity study and other 
guidance to do the research work. 
  I acknowledge my thanks to Dr.K. Thanga mariappan, Ph.D., Microbiology, 
consultant Microbiologist, vivek institute of laboratory medicine, Nagercoil.  For his kind 
suggestion regarding with Antimicrobial studies and phyto-chemical studies of the work. 
  The author is greatful to the Mrs.Poongkodi, M.L.I.S., M.phil., Librarian Govt. 
Siddha Medical College,Palayamkottai and Library Assistants  for help in literary 
collections. 
I am also thankful to Mrs.Suganthi, DMLT, Pharmacist, and Post Graduate 
Department of Gunapadam for her kind co-operation to purification and preparation of 
the trail drug for my study and successful completion of dissertation. 
I am also thankful to all my college staffs for their kind co-operation for my study. 
I should express my gratefulness to All My Classmates and PG. Gunapadam students 
for leading their helping hands whenever needed during the course of the study.  
I express my sincere thanks to Dr. M. Elakkiya, M.D(s)., for leading her helping 
hands whenever needed during the course of the study. 
  The great walls to build my dissertation are my lovable family members they 
support me in all kinds to complete this work in a good way. I sincerely express                        
my love to my respectable father Mr. D. Kulasekaran, D.E.E.E., and my dearest mother                       
Mrs. Indrani Kulasekaran for their sincere encouragement and inspiration throughout 
my research work and lifting me uphill this phase of life. 
 Finally, I wishes my thanks to M.Maharaja & Mrs. Rajeswari (Maharaja DTP 
Services), Palayamkottai for their marvelous work in completing this dissertation.   
 
ABBREVIATIONS 
 
KSM  - KARPOORA SINTHAMANI MATHIRAI 
CPCSEA - Committee for the purpose of control and supervision of  
  experimental animals. 
DC -  Differential Count 
ESR - Erythrocyte Sedimentation Rate 
FTIR - Fourier transform infrared spectroscopy 
Hb  - Haemoglobin 
IAEC - Institutional Animal Ethical Committee. 
ICP-OES - Inductively coupled plasma optical emission spectrometry 
Ig E - Immunoglobulin E 
LDH -  Lactate Dehydrogenase 
MCV -  Mean Corpuscular Volume 
OECD -  Organisation for Economic Co-operation and Development 
PCV -  Packed Cell Volume. 
PGE -  Prostaglandin E 
RBC -  Red Blood Corpuscles 
SEM - Scanning electron microscope 
CCDS  - Charge coupled devices. 
SPME  - Solid phase micro extraction 
TCD  - Thermal conductivity detector  
FID  - Flame Ionization detector 
CCD  - Catalytic combustion detector 
LD  - Low dose  
Mg   Milligram 
Kg    Kilogram 
LD50   Lethal Dose 50 
p.o   peros 
ML   Milliliter 
%   percentage 
R&D    Research and Development 
 
 
 EDTA   Ethylene Diamine Tetra Acetic Acid 
M    Male 
g%    Gram percentage 
g   Gram 
NOAEL   No-Observed-Adverse-Effect-Level 
MLD    Minimum Lethal Dose 
MTD    Maximum Tolerated Dose 
CONTENTS 
S.No TITLE Page. No 
1. INTRODUCTION 1 
2. AIM AND OBJECTIVES OF THE STUDY 4 
3. REVIEW OF LITERATURE 5 
 3. 1. POORAM (HYDRAGYRUM SUB CHLORIDE) 5 
  3.1.1. Gunapadam Aspect 5 
  3.1.2. Geological Aspect 10 
  3.1.3. Lateral Research 12 
 3.2. MYRISTICA FRAGRANS  13 
  3.2.1. Gunapadam Aspect 13 
  3.2.2. Botanical Aspect 16 
  3.2.3. Lateral Research 19 
 3.3. CROTON TIGLIUM 20 
  3.3.1. Gunapadam Aspect 20 
  3.3.2. Botanical Aspect 23 
  3.3.3. Lateral Research 25 
 3.4.  ACACIA ARABICA 26 
  3.4.1. Gunapadam Aspect 26 
  3.4.2. Botanical Aspect 30 
  3.4.3. Lateral Research 33 
 3.5. ALOE BARBADENSIS 34 
  3.5.1. Gunapadam Aspect 34 
  3.5.2. Botanical Aspect 37 
  3.5.3. Lateral Research 40 
 3.6. DISEASE REVIEW 41 
  3.6.1. Siddha Aspect Of The Disease 41 
  3.6.2. Modern Aspect 47 
 3.7. PHARMACEUTICAL REVIEW 53 
  3.7.1. Siddha Aspect 53 
  3.7.2. Modern Aspect 54 
4. MATERIALS AND METHODS 56 
 4.1. Preparation of the drug 56 
 4.2. Standardization of the drug 61 
  4.2.1. Physical Analysis 61 
  4.2.2. Physio chemical Analysis 63 
  4.2.3. Bio Chemical Analysis 70 
  4.2.4. Phytochemical Analysis 72 
  4.2.5. Instrumental Analysis 76 
 4.3. Toxicological study 89 
  4.3.1. Acute Toxicity Study 89 
  4.3.2. Sub-Acute Toxicity Study 93 
 4.4. Pharmacological study 99 
  4.4.1. Anti- inflammatory Activity 99 
  4.4.2. Analgesic Activity 101 
  4.4.3. Anti-spasmodic Activity 102 
  4.4.4. Laxative Activity 103 
5. MICROBIOLOGICAL  ANALYSIS 104 
6. RESULTS AND DISCUSSION 105 
7. SUMMARY 149 
8. CONCLUSION 152 
9. FUTURE SCOPE 153 
10. BIBLIOGRAPHY 154 
 
 
TABLE CONTENTS 
 
Table
No. 
No 
Title of the Table Page. No. 
1. Weight variation limits of tablets 61 
2. Numbering and identification (Acute Toxicity Study) 90 
3. Numbering and identification (Sub-acute Toxicity Study) 94 
4. Physico chemical standardisation 105 
5. Preliminary test for basic and acidic radicles 108 
6. Phyto chemical test for KARPOORA SINTHAMANI MATHIRAI. 111 
7. Interpretation of FTIR spectrum 116 
8. Acute toxicity of KARPOORA SINTHAMANI MATHIRAI 121 
8.1 Physical and behavioural examinations. 121 
8.2 Home cage activity. 121 
8.3 Hand held observations 122 
8.4 Mortality 122 
9 Subacute toxicity of KARPOORA SINTHAMANI MATHIRAI 125 
9.1 Body wieght 125 
9.2 Organ weight 126 
9.3 Haematological parameter 127 
9.4 Biochemical parameter 130 
9.5 Food Intake 133 
9.6 Water Intake 134 
9.7 Electrolytes. 135 
10 
Anti Inflammatory activity of Karpoora Sinthamani Mathirai on 
Carrageenan Induced Hind Paw Oedema in rats 
139 
11 Analgesic activity of KARPOORA SINTHAMANI MATHIRAI by Hot Plate Method 
140 
12 Dose response relationship observations of Acetylcholine 142 
13 Dose response relationship observations of Atropine 142 
14 Dose response relationship observations of Acetylcholine and KSM 142 
15 Comparative dose response of Ach and Ach followed by KSM 143 
16 Laxative Activity of KSM in Rats 
 
145 
17 Antimicrobial activities of Drug by Agar well Diffusion method 147 
  
 
 
 
FIGURE CONTENTS  
 
Figure 
No. Title of the Figure 
Page. 
No. 
1. Scanning electron microscope 
 
76 
2. Fourier Transform Infra Red spectroscopy  
 
79 
3. Mechanism of FTIR analyzer 
 
82 
4. Inductively coupled plasma optical emission spectroscopy (ICP-OES) 
 
83 
5.  X-RAY Powder Diffraction Instrumentation 85 
6. Scanning electron microscope results 
 
113 
7. FTIR image of KARPOORA SINTHAMANI MATHIRAI 
 
115 
8. XRD Results of KARPOORA SINTHAMANI MATHIRAI 120 
9. Effect of KSM on Acute Inflammatory  139 
10. Analgesic Activity 140 
11. Comparative dose response of Ach and Ach followed by KSM 143 
12. Laxative Activity 145 
13. Microbiology Result 148 
 
 
 
 
 
 
 
 
 
 
 
  
                                                                                                                             
 
   1 PRE CLINICAL  STUDY OF  KARPOORA  SINTHAMANI  MATHIRAI 
 
1. INTRODUCTION 
  Siddha system of medicine, which has been prevalent in ancient tamil and is the 
foremost of all other medical system in the world. The unique nature of this system is its 
continuous services to humanity for more than 10,000years,in combating diseases and in 
maintaing the physical, mental and moral health.siddhar's are spritual scientist explored 
the nature . They educated this disiple and propagated siddha concepts. 
  The siddha system grew through the work of agathiyar,Bogar,Thirimoolar and 
others. Siddha's knowledge of iatrochemistry,minerals, metals and plants was stupendous. 
This was succesfully used system from immemorial. 
  The scientific evaluation is needed to validate its preciousness. The siddha system 
has not only the curative and preventive effects on different diseases but also paves the 
way for longevity and immortality. WHO has also recogonised indian system of medicine 
has an effective alternative medicine in the place of conventional allopathic system of 
medicine 
  According to Siddha the five basic elements (panchapootham) are present in all 
living and non-living things of the universe in various proportions. 
        Siddhars in their attempt to elevate themselves to a perfected earthly immortal 
(attain siddhi) developed techniques, which included controlled breathing (Vaasi), 
concentration of mind, intense meditation (Dhyanam), besides dietary regimen and 
certain postures (Yoga) for psychosomatic harmony. 
     They also explained five systems (Annamaya kosham, Manomaya kosham, 
Pranamaya kosham, Vignagnnanamaya kosham and Anandamaya kosham). This 
establishes the fact that human body is not merely a machine. But human being is 
composed of different dimensions namely physical, mental, supra-mental and spiritual 
which all should work in harmony. So that perfect health is maintained. In short, the 
Siddhar’s thoroughness and extraordinary knowledge that proceeded from the 
metaphysics of ancient India which is eternal. 
 
   This led to the understanding of the position of man in this universe and his 
relationship with it. 
       All the things in the universe and also man are made up of pancha-boothas in 
their gross state as well as in the subtle state. In the Siddha system of medicine, all vital 
processes (physiological, biochemical-metabolic) have been classified under three 
functional heads namely Vali, Azhal, Iyyam (vaatham, pitham, kabam) these are called 
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three Uyir-thaathukal. It is interesting to note that one and the same basic uyir-thaathu 
differentiates itself into three functional divisions. The meaning of Uyir-thaathu is the 
route cause and basis of life. 
     The basic principles of the Siddha system consist of panchapootham theory, tri-
humours pathology and 96 basic factors. In Siddha system of medicine, the understanding 
of the tri-humours status is very essential. The humours vadha, pitha and kabha exist in 
the ratio of 1:1/2:1/4 in normal physiological states in man. Any imbalance or deviation 
from this state leads to diseases or death will be the result. 
       The pulse reading (Naadi) forms the main diagnostic mode of Siddha medicine. 
Again this Naadi characteristic is also based on Vali, Azhal, Iyyam. All the diseases are 
brought under the three major divisions of Vali, Azhal, Iyyam as well as combination and 
recombination types.
  
       The Siddha system is unique in that it recognizes disease condition individually as 
well as in strict reference to the three-doshas principle. All diagnostic modes are designed 
to take into serious consideration the symptoms, signs, characteristics of the diseased 
conditions and rationally evaluate them in strict accordance with the three-dhosha 
principle. 
 The treatment aspect involves the neutralization of affected humours. 
“uqOvsek<kiz<!uikl<!kiPl<”!
“ulek<kiz<!hqk<kl<!kiPl<”!
“fsqb!nR<sek<kiz<!ghl<!kiPl<”!
Ofib<!fimz<!Ofib<!Lkz<!fimz<!higl<!.!I!
By giving viresanam (Purgative), Vatha kutrum is neutralized. By giving 
vamanam (emetics) pitham is neutralized. By giving Anjanam and nasiyam (application 
of medicine in eyes and nose), kaba kutram is neutralized.  
  The same has been stated as  
“lqgqEl<!GjxbqEl<!Ofib<!osb<Bl<!F~OziI!
utq!Lkzi!w{<{qb!&e<X”!
- kqVg<Gxt<!
                By calculating the imbalance of the three humors siddhars used to diagnose the 
root cause of the disease and the treatment also based on the way of diagnosis. Siddha 
medicines cure the root cause of the disease. So that it could be a successful medical 
system in the world.  
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The more scientific approach to the all aspects of life even before thousands of 
years should be appreciated and bring it to our day today life. 
            Herbal, medicines are being used by nearly about 80% of world populations, 
primarily in developing countries for primary healthcare. The herbal drugs described in 
Siddha system have been the basis of treatment of various human diseases. Selection of 
scientific and systematic approach for the biological evaluation of herbo mineral drug 
formulations based on their view in the traditional systems of medicine forms the basis 
for an ideal approach in the development of new drug from natural things.  
  According to the CDC (Council of  Disease prevention and Control), more than 
52.5 million peoples suffer with Arthritis today. Today number of synthetic anti-
inflammatory, anti-spasmodic, analgesic drugs are available for symptomatic control of 
arthritis. This synthetic  drug may cause side effects. Therefore the modern world is 
searching for suitable traditional remedies because of without any adverse effect.              
  In Siddha system, the symptoms of Keel Vayu can be correlated with Arthritis 
(Musculo Skeletal Disorder). In the literature of Anuboga vaithiya navaneetham, there is 
a preparation called, KARPOORA SINTHAMANI  MATHIRAI, which is exclusively 
indicated for Keel Vayu in which its efficacy has to be scientifically evaluated.  
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2. AIM AND OBJECTIVES 
AIM 
 The aim of this study is to do a scientific review to validate the safety and efficacy 
of “Karpoora Sinthamani Mathirai ” for Anti-inflammatory, Analgeisc, Anti-spasmodic 
and laxative activities. 
 
OBJECTIVES 
 The main objective of the present study is to high light the safety and efficacy 
of Karpoora Sinthamani Mathirai  in the treatment of Keel Vayu, the 
following methodology was adopted to evaluate the drug and its 
standardization studies. 
 To collect the literature systematically from siddha texts as well as modern 
science. 
 To standardize the preparation of drug according to classical siddha literature. 
 To subject the drug to physico chemical and chemical analysis. 
 To detect the elements present in the drug by instrumental analysis. 
 To study the acute and subacute toxicity profile of Karpoora Sinthamani 
Mathirai  according to OECD 423 and 407 guidelines. 
 Evaluation of Anti-inflammatory activity of test drug. 
 Evaluation of Analgesic activity of test drug 
 Evaluation of Anti-spasmodic activity of test drug 
 Evaluation of Laxative activity of test drug 
 To analyse all the above study results to validate the advantage of Karpoora 
Sinthamani Mathirai  
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3.REVIEW OF THE LITERATURE 
 
3.1. POORAM – H,vl<<<<!
(Hydrargyrum Subchloride) 
3.1.1 GUNAPADAM ASPECT 
Pooram does not find a place in the list of 64 padanas but is considered as one 
among them by the medical practitioners. It is prepared by the combination of rasam and 
salt. 
SYNONYMS: 
“Kv<g<jggjtobzqbqjms<seqH,vf<!kQm<Muqmkizqfg<gqH,clkif<”!!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! .filkQhfqg{<M/Q <Q <Q < !
Durgai, Kalai, Aellidai, Sani, Pooram, Thettu, Vidathaali, Nacki, Buddimaatham. 
METHOD OF SYNTHETIC PREPARATIONS (VAIPPU) 
“kioee<xgx<H,volie<Xosiz<Oue<!sikglib<S,kl<ov{<MK~g<gq!
uioee<xsm<cg<Gt<&e<XhcBh<jh!utligohick<kqm<MfMOuOgT!
Okoee<xosr<gz<K~t<giz<hckieqm<M!kqvligg<Gtqk<kkqOzS,kl<uqm<M!
Woee<xlXsm<cguqp<k<K&c!?bz<higouPsQjzl{<[l<osb<Ob!
l{<osb<Koki{<[~Xgcjgbh<hi!uigig&k<kQBolvqk<Kjlf<ki!
l{<osb<kOlz<sm<cg<Gt<OtOgT!uigigdjvk<kqVg<Gl<out<jtolkk<!
l{<osb<kfx<H,vr<Gpibqz<juk<K!uigigh{uqjmkie<K~g<gqg<ogi{<M”!
- Agasthiyar paripooranam 400. 
2 palam sootham placed in the mud pot in between 3 padi culinary salt(Nacl) 
and brick stone powder.Close the pot with another mud pot and seal with 7 mud seelai . It 
is burnt for 90 kadikai after it is cooled pooram is found deposited on the upper pot and 
the same is collected. 
lbg<gLXlqvkgx<H,vR<osiz<Ouil<uqbikqobz<zif<kQv<f<KOhil<uvqjsOgT!
lbg<gLxdh<HTg<Gs<osr<gz<K~Tl<!uvqjsohxupqk<okMk<Kjuk<kqmiOb!
juk<kOkiv<-VujgBf<K~tibim<c!jlf<kOesm<cg<Gt<hikqfQBl<!
juk<kqMuib<nkqx<Gjgjbs<S,klh<hi!uivimigpR<Shk<Klix<xle<xq!
juk<kr<OgGjguibqz<ohicBlqm<M!lXsm<cogi{<cm<Muijb&c!
juk<KfQObPsQjzl{<[l<H,sq!libqhkl<H,sqk<KnMh<hqOzx<xq!
nMh<Ohx<xqglzue<eqkqef<kioeie<X!nke<hqxGgmig<gqeqBf<kie<&e<X!
wvqk<kixqobMk<Kh<hiv<sm<cOlOz!Wxqfqx<Gl<gx<H,vl<wMk<Kjuk<K/!
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10 kalanju of sootham placed it mud pot in between the well powdered culinary 
salt and brick stone powder close the mud pot with 7mud seelai. Then burnt it as 
deepackini kamalackini and kaadackini for 3 days respectively after it is cooled the 
pooram is found deposited on the upper pot and and the same is collected. 
3. Sulfur 67.2gm is melted in mud pot and mercuery 336gm is added to it and kinded 
well and there forms a black colored powder (kajali). Brick stone powder is placed up to 
half of the level of a pot culinary salt (NaCl) 650 gm is placed over it . Mercury sulfur 
camphor is placed over the salt and sealed with mud paste cloth . It burnt for 12 hour with 
kadackini after it is cooled the mercurous chloride is found deposited on the upper pot 
and the same is collected. 
ORGANOLEPTIC CHARACTORS : 
Colour  - White 
Appearance - Hard 
Potency - Hot 
Taste  - Salty, Pungent 
ACTION: 
Laxative 
Tonic 
Antiseptic 
Diuretic 
  It is also an excessive bile producer. 
GENERAL PROPERTIES :  
“-jmuik!S,jz!obvqS,jzGe<lf<!okijmuijp!uikliR<!Osi{q!.!bqjmbik!
!ouig<Gvs!gv<h<H,v!olie<Ox!beouiVkz<!-g<Gouz<zk<OkPfitQ”/!
!
“ssque<egVh<H,vk<kqz<!sikqk<kgbR<Suisl<!
hsqgzqkihOsihl<!!hUk<kqvl<hqtjuG]<ml<!
usqkVgqvi{qObiM!utvkqsivOlgl<!
sqkVlqsqUS,jz!bqjuhzOvigl<OhiOl”/!
!
“kqv{<muikr<Gmz<uikl<!kQVR<sf<fqhkqe<&e<X!
lV{<OmGk<Kljvbih<H!! l{<jms<S,jzghizuqc!
hvr<gqs<S,jzhx<gqvf<kqhg<gS,jzbqjuLkz<Ohil<!
-V{<mOleqohie<eqxlil<!-KOugx<hl<-bl<hQOv”/!
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!
calomel is taken along with jaggery for seven days, 
It cures various types of throbbling pains,  
Throbbling pain in the lumbar region, 
Burning sensation, 
Ulcer due to disorders of vatha humours, 
Hepatomegaly,  
Pyrexia, 
Jaundice, 
Basillary dysentery, 
Dropsy, 
Chronic ulcer, 
Venereal diseases, 
Indigestion, 
Vomiting, 
Diarrhoea, 
Worm infestation, 
Rheumatism, 
Itching, 
Constipation, 
Scabies,etc., 
It is also effective in the treatment of head ache as explaind in the above tamil verses. 
In siddha system of medicine pooram is compared to sanjeevi because it cures hard 
disease like syphilis(kiranthi), uterine cancer(allgul putru), uterine ulcer(allgul ranam) 
and chronic non-healing ulcers. 
- Anuboga Vaithiya Navaneetham 4th vol  
PURIFICATION OF CALOMEL: 
1.The poultice made of betel leaf(piper betel) and pepper (piper nigram) each 
8.75gm,is taken and dissolved in 1.3 litre of water calomel 35gm and tied with a cloth and 
immersed in  the liquid from the cross bar and heated. After the water is reduced to  ¾  of 
its volume the calomel is taken out washed with water and dried to get it in purified form. 
2.Calomel 35 gm is consolidified in mother’s milk for 3 hours and again it is 
consolidified in garlic oil(thailam) for 9 hours.  It is taken out as purified. 
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3.Before mixing calomel in legium preparations, it is consolidified with the juice 
of mukia madraspatana (musumusukku) and washed. 
SIGNS AND SYMPTOMS OF CALOMEL POISONING: 
Multiple red boils may appear on the face, ache formation, ulcers in the chest, 
mouth and tongue diarrhoea and dysentery, scrotal swelling and ulcer in the uvula.   
ANTIDOTE FOR POISONING: 
Nilapanai kilangu (curculigo orchides)         -  8.75gm 
Vallarai ver (centella asiatica root)            -  8.75gm 
Ponnankanni ver (alternatheria sessiles)       -  8.75gm 
Kanduparangi ver (clerodendrumserratum)   -  8.75gm  
All the above ingredients are mixed and boiled to make a decoction.  This 
decoction is used twice a day for two or three weeks with suitable diet restrictions 
 
POORAM IN OTHER PREPARATIONS 
1. CHANDA MARUTHA SENTHOORAM 
Dose  : 50-100mg 
Adjuvant : Honey, ginger, juice, jaggery, thirikadugu chooranam,  
amukkara chooranam 
Indication : Arthritis, hemiplegia, parkinsonism, fever, ...etc 
       - Siddha vaithya thirattu 
2. LAVANGATHI MATHIRAI 
Dose  : Thuvarai alavu (0.202gms) 
Indication : Fever, pain, vatha diseases 
-Kannusamy parambarai vaithiyam 
3. VELLAI ENNAI 
Dose  : 15-30ml 
Indication : Constipation, arthritis, ulcer, swelling 
-Gunapadam (pagam-2) 
4. PRATHABA LINGA CHOORANAM 
Dose  : 1-2 kundri alavu (130-260mg) 
Adjuvant : Palm jaggery, Honey, ghee, butter, ginger juice 
Indication : Fever, pain, diarrhoea, wounds, arthritis and vatha diseases 
- Anuboga vaithya navaneetham 
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5.VAAYU MATHIRAI 
Dose  : ½ - 1 Kundri alavu (65-130mg) 
Adjuvant : Palm jaggery, dried ginger paste 
Indication : Arthritis, pain 
6. SOOLAI BEDHI MATHIRAI 
Dose  : Kadugu alavu (1-2 mathirai) 
Adjuvant : Jaggery , castor oil 
Indication : Deep wounds, Arthritis 
- Anuboga vaithya Navaneetham 
(part-9) 
7. SHANUMUGA MEZHUGU 
Dose  : ½ kundrimani alavu (130-195mg) 
Adjuvant : Palm jaggery, sugar, butter 
Indication : Arthritis, joint pain, vatha diseases 
- Anuboga vaithya navaneetham 
(part -9) 
8. KOOROSANAI MEZHUGU 
Dose  : ½  to 1 kundrimani alavu (65-130mg) 
Adjuvant : Palm jaggery, Butter 
Indication : Hemiplegia, arthritis, gonococcal arthritis 
- Anuboga vaithya navaneetham. 
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3.1.2.  GEOLOGICAL ASPECT: 
CALOMEL : 
 Calomel is a chemical compound with the formula Hg2Cl2. Also known as 
mercurous chloride  (a mineral form rarely found in nature) 
IUPAC name   :   Dimercury dichloride 
Other name    :   Mercurous chloride 
Calomel 
Horn mercury 
Mercury (I) chloride 
Chemical formula  :  Hg2Cl2 
Molar mass    :   472.09 g/mol 
Appearance    :   Heavy white rhombic crystals 
Density    :   7.150 g/cm3 
Melting point    :   525°c 
Boiling point    :   383 °c 
Solubility in water   :   0.2 mg/100ml 
Solubility    :   Insoluble in ethanol, ether 
Refractive index   :   1.973 
LD50 median dose   :   210 mg/kg (rat, oral) 
CHEMICAL ASPECT: 
Chemically pooram is a siddha drug has been identified as calomel the chief ore of 
mercury chemically pooram is known as mercury chloride or mercurous chloride. 
 
CRYSTAL SYSTEM : 
Tetragonal  
HABIT : 
  Crystal often tabular {001}; prismatic [001]; pyramidal; equant, especially in 
complex twins. Complex development often exhibited. Drusy crusts of minute crystals. 
Massive, earthy. 
TWINNING : 
  On {112}. as contact or interpenetrant twins often repeated and with irregular and 
concealed boundaries. 
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CLEAVAGE : 
Distinct / good  
{110} good but slightly uneven; {011} imperfect. 
HARDNESS : 
  1½ - 2 
TENACITY :  
  sectile 
COLOR :   
  colourless, white. 
OCCURRENCE: 
           Landsberg (moschellandsberg) 
Alsenz-Obermoschel 
Palatinate 
Rhineland-palatinate 
Germany   
ASSOCIATIONS : 
  It is commonly associated with calcite, clays, limonite, montroydite, cinnabar, 
eglestonite, mercury, terlinguaite. 
PREPARATION OF CALOMEL : 
1.When mercuric chloride is heated with mercury in an iron pot, calomel is obtained. 
HgCl2 ＋ Hg →  Hg2Cl2 
2.when mercuric chloride is treated with less amount of stannous chloride, calomel is 
obatained. 
HgCl2 + SnCl2  →  Hg2Cl2 + SnCl4    
It can also be prepared by grinding the mixture of mercury with concentrated H2SO4 
together with it, small amount of NaCl as well as mercury is added to get calomel. 
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3.1.3. LATERAL RESEARCH: 
In vivo Evaluation of Analgesic, Antipyretic and Anti-inflammatory potential 
of Siddha Formulation Natural and Synthetic Pooraparpam in selective 
Rodent Model - Journal of Chemical and Pharmaceutical Research,                                            
2016, 8(4):643-656 
ABSTRACT 
  Siddha system of medicine is one of the oldest medical systems of India existed 
separately in early times. Pooram is one among the Panchasootham (five mercurial 
compounds) which is widely used in Siddha preparation. The main component of the 
Pooram is Mercury. The mercurial compound has been in use in Siddha since many 
centuries and it is identified and indicated for the treatment of many diseases in ancient 
Siddha literature. The present study was 
undertaken to assess the in vivo evaluation of analgesic, antipyretic and anti-
inflammatory potential of Siddha formulation Natural and Synthetic Pooraparpamin 
rodents. The analgesic activity were evaluated through thermal (Eddy’s hot plate test) and 
mechanical method (Tail clip method) of pain induction in mice, whereas antipyretic 
activity by yeast induced pyrexia in rats. On the other hand, anti-inflammatory activity 
evaluated by carrageenan and cotton pellet induced inflammation in rats. Both the test 
drug was administered orally at the dose of 1.15 and 2.30 mg/kg, the activity was 
compared with a standard reference drug Indomethacin 20 mg/Kg and Paracetamol 
150mg/kg. The result obtained from the study clearly demonstrates that the Siddha 
formulations Natural and Synthetic Pooraparpam has promising analgesic, anti-
inflammatory and antipyretic activity in tested animals. Hence it was concluded that 
Pooraparpamis considered to be one of the safe medicine for the clinical managementof 
fever, pain and inflammation associates medical conditions. 
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3.2. SATHIKKAI – sikqg<gib<<< << <<!
(Myristica Fragrans) 
3.2.1. GUNAPADAM ASPECT 
Synonyms 
Kulakkai, Jathikkai 
- G{himl<!&zqjg!uGh<H 
sikqg<gibqe<!ohbi<gt<< < < << < < << < < <!
fz<zuikq!lzole<Xl<?!sQzqg<giobe<Xl<! !
fz<zlie!uikqOvikb!ole<Xl<!OhV!
osiz<zg<Ogt<?!squsqgqk!ole<Xl<!OhV{<mis<S!
! ! sQiqm!ole<xqkx<Gh<!Ohi<!osh<hqOeil<!fil<!
! osiz<z!sqk!ole<xqkx<Gh<!OhV!
! ! SOk!ueikq!kole<xqkx<Gh<!OhV!
! nz<zur<giv!ole<xqkx<Gh<!OhV!
! ! nVtqOtil<?!sikqg<gibkx<Gl<!OhOv!
! ! ! ! ! .!hR<s!giuqb!fqg{<M!!
Nalavathy malam, seelikkai, vathirothayam, sivasigitham, seeridam, sitham, 
sudevanathitham, allalangaram. 
Vernacular names 
Sanskrit  - Jati – Phalam 
Malathi  - Phalam 
English  - Nutmeg 
French   - Muscadier, Musque. 
Germany  - Achter muscatnussbaum 
Kash   - Zafal 
Bom.Punj.Gaj & mah - Jayiphal, Javantri 
Telungu  - Jejikaya 
Tamil   - Jadikkay, Jathikkai 
Malayalam  - Jathika 
Can   - Jajikai 
Kon   - Jaiphal 
Sinh   - Jadika 
Burm   - Zadu-phu 
Malay   - Bush-pala 
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Pers & Arab  - Sauz-ba-wawa, Zanza-ba-wawa 
Partused: 
  Unriped fruit 
Organoleptic Characters 
Taste (Suvai)   : Astringent, Pungent 
Potency (Thanmai)  : Hot(veppam) 
Bio Transformation (pirivu) : Pungent 
Action 
 Stimulant (Veppamundakki) 
 Carminative (Agattuvaivagatri) 
 Narcotic (Moorchaiundakki) 
 Aromatic (Manamooti) 
 Aphrodisiac (Kamam peruki) 
 Tonic (Uramakki) 
General properties 
kiKfm<ml<!Ohkq!sVuisq!bR<sqvOfib<!
YKSui!sr<gisl<!dm<gqv{q!–!OuOki!
czg<gib<!uVl<hq{qOhil<!Wx<xlbz<!hqk<kr<!
Gzg<gi!bVf<Kui<Gg<!%X!
- G{himl<!&zqjg!uGh<H!
Nut meg is useful in the cases of oligospermia, diarrhoea, headache, asthma, 
cough, stomachache, bloated abdomen. 
Traditional used 
 Dicoction of nutmeg is used for dehydration in the case of vomitting and 
diarrhoea 
 Nutmeg paste is applied around the eyes to promote eye sight. 
 Nut meg oil is used for tooth ache. 
 Nutmeg powder 130mg, dry ginger powder 130 mg and cumin seed powder 
130mg taken internally before meals for indigestion 
 For diarrhoea 2 grams of nutmeg powder is given with milk. 
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SATHIKKAI IN OTHER MEDICINES 
1.SATHIKKAI THAILAM 
Indication  : Arthritis, vatha disease, Diarrhoea 
- Gunapadam mooligai vagupu 
2. RAASA AMIRTHATHI CHOORANAM 
Dose   : 1-2 gram 
Adjuvant  : Hot water 
Indication  : Joint pain, Tuberculosis, Eczema and vatha diseases 
- Aathma Ratchamirtham ennum  
   vaithya sarasangiragam 
3. GARUDAN KIZHANGU ENNAI 
Dose   :  ¼ - ½ owunce 
Indication  : Hemiplegia, facial palsy, joint pain, joint swelling 
-   Kannusamy parambarai vaithyam 
4.NARASIMA ILAGAM 
Adjuvant  : Cow’s ghee 
Indication  : Vatha diseases, Nervine tonic 
-  Sikitcha Rathna Deepam 
5.THALISATHI CHOORANAM 
Dose   : 1-2 gram 
Adjuvant  : Honey 
Indication  : Arthritis, 80types of vatha diseases, 40 types of  
    pitha diseases 
-  Siddha vaithya thiratu 
6. MAHAVILVATHI LEGIYAM 
Dose   : 3 gram 
Indication  : Arthritis, Rheumatism 
-  Bogar vaidhyam -700 
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3.2.2. BOTANICAL ASPECT  
SATHIKKAI (MYRISTICA FRAGRANS) 
Classification 
Taxonomical Classification 
Kingdom  : Plant kingdom 
Division  : Flowering plant 
Class   : Dicotyledonae 
Subclass  : (YI!nMg<G!H,uqkp<!djmbju*!Monopetalae 
Series   : Microembryeae 
Family   : Myristicaceae 
Genus   : Myristica 
Species  : Fragrans 
Habitat 
 Nutmeg tree is indigenous to the Malay, Peninsula, Moluccas and Penang, now 
cultivated in many tropical countries of both hemispheres.  In India, it is grown in Madras 
state (Nilgiris, Coimbatore, Salem, Ramanathapuram, Tirunelveli,m Kanyakumari and 
Madurai Districts) a few trees are found invarious localities in kerala, Assam and other 
states.  Preliminary trials have shown that Araku Valley (Andrapradesh), wynaad 
(Madrasstate) are well suited for its cultivation. 
Description 
Habit 
 Moderate sized usually dioecious evergreen aromatic tree, upto 12mm tall. 
Leaves 
 Alternate, quite entire exstipulate, often pellucid-punctate. 
Flowers 
 Dioecious, small, regular fascicled umbelled or panicled.  Bracteoles persistent or 
caducoas. 
Male Flowers 
 Perianth-3 (2-4) lobed, valvate in bud.  Anthers 3 or more connate in a sessile or 
stropitate column head ring or disk, 2-celled. 
Female flowers: 
 Perianth of the male, staminodes, ovary superior, free sessile, 1-celled style short 
or a stigma capitate, discoid or lobed, ovale, basal, erect, anatropous. 
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Fruit 
 Fleshy at length 2 rarely 4 – Valved. 
Seed 
 Erect, enclosed in a thin or fleshy entire or lacerate often highly coloured aril, 
testa thin or crustaceous, albumen hard densely ruminate, embroyo basal, small, 
cotyledons rounded spreading often wrinkled, radicle short inferior. 
Macroscopic Description of seed 
 Seed ellipsoid, 20-30 mm long and about 20mm broad, externally greenish brown 
sometimes marked with small irregular, dark brown patches or minute dark points and 
line slightly furrcused reticulately, a small light coloured area at one end indicating the 
position of the radicle.  A grove running along the line of raphe to the darker chalza at the 
opposite end, surrounded by a thin layer of perisperm with infoldings appearing as dark 
ruminations in the abundant greyish brown endosperm, embryo in an irregular cavtiy, 
small with two widely spreading crumpled cotyledons and a small redicle, odour, strong 
and aromatic, taste, pungent and aromatic. 
Microscopic Description of seed 
 Transverse section of endosperm show peripheral perisperm, of several layers of 
strongly flattened polyhederal cells with brown contents or containing prismatic crystals, 
inner layer of perisperm of thin walled parenchyma about 40 µ thick, infolding into the 
tissue of the endosperm to form the raninations containing numerous very large oil cells 
with brown cell walls, vascular strands, in the peripheral, region numerous small spiral 
vessels, large called, endosperm parenchymatous with occasional tannin idioblasts, with 
the brown walls, containing numerous simple rounded and compound starch grains, with 
upto about 10 componenets usually 2-8, individual grains, upto 2 µ in diameter present 
most of the cells with crystalline fat and often a large aleurone grain in each cell, 
containing a rhombic protein crystal upto 12 µ and small aleurone grains with less regular 
crystalloids, embryo of shrivelled and collapsed parenchyma. 
Chemical constituents 
The main chemical compounds are 
• a-pinene, camphene, b-pinene 
• Sabinene, myrcene, a-phellandrene 
• a-terpinene, limonene, 1, 8 cinede, y-terpinene, linalool, terpinen-4-ol 
• Safrole, methyl eugenol and myristicin. 
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Therapeutic uses 
• Oil of nutmeg is employed for flavouring food products and liquorus 
• It is used for scenting, soaps, tobacco and dental cream. 
• It has been recommended for treatment of inflammation of bladder and urinary 
tract. 
• Alcoholic extract of nutmeg shows anti-bacterial activity against micrococcus 
pyogenes, aqueous decoctions are toxic to cockroaches. 
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3.2.3. LATERAL RESEARCH: 
 ANTI-INFLAMMATORY ACTIVITY OF MYRISTICA FRAGRANS (NUTMEG) 
USING HRBC MEMBRANE STABILISING METHOD INT. J. PHARM. SCI. REV. 
RES., 44(1), MAY - JUNE 2017; ARTICLE NO. 11, PAGES: 40-42 
 
ABSTRACT : The aim of the study is to determine the anti-inflammatory activity of 
Myristica fragrans (Nutmeg) using HRBC membrane stabilising method. Inflammation 
being a common symptom for various diseases has to be treated properly. The anti-
inflammatory drugs come into role here in decreasing the inflammation. Nutmeg spice is 
a good source of minerals like copper, potassium, calcium, manganese, iron, zinc and 
magnesium. Since it's a natural drug and has a lot of anti-inflammatory properties having 
no side effects, therefore it is better than synthetic drugs. Nutmeg being a natural drug 
with least side effects, in comparison with the other drugs can be used in the future to 
produce an efficient anti-inflammatory drug. 
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3.3. NERVALAM – Ofi<uitl<< << << <!
(Croton Tiglium.Linn) 
3.3.1. GUNAPADAM ASPECT 
Synonyms 
 Valam, Nepalam, Sobi, Sevalam, Sambari, Sithuruba, Sirukurinji, Thandi, Thendi, 
Nagathendhi, Nagakenthi, Naganam. 
- Gunapadam Mooligai Vaguppu 
Vernacular names 
Tamil  : Nervalam 
English : Purging croton 
Tel  : Napalam 
Mal  : Nervalam 
Kan  : Japala-beeja 
Sans  : Danthit 
Arab  : Hab-ul-salantin 
Pers  : Bed-anjir-e-khati 
Hind  : Jamalgotta 
Part used 
Seed 
Organoleptic character 
 Taste (Suvai)   : Bitter (Kaippu) 
 Potency (Thanmai)  : Hot (Veppam) 
 Bio transformation (Pirivu) : Pungent (Kaarpu) 
Action 
 Purgative (Neermalampoki) 
 Rubefacient (Dhadipundaki) 
General properties 
 wf<k!uqbikq!bqer<gjtBR<!siclz!
! hf<k!uqjejbh<!hiqhiqk<K!–!uf<kouh<jh!
! hihqobe!lim<Mkziz<!himi{!oul<jlbqEl<!
! Osihqlg!Osihqobe<X!osiz<!
. Okve<!ou{<hi 
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Purging croton has higher toxic effects because of its purgative action.  It is used to treat 
vadha disease, mupinni, kudaichal and other gastric disorders. 
 ykq!Zkuk<!KXlzl<he<!Oeib<!uqzGl<! !
! Ohkq!lVf<kqx<!ohiqkiGl<!.!uiklXr<!
! %Iuijt!obik<kuqpqg<!ogil<hjeOb"!h{<ckI!osiz<!
! Ofi<uitg<!ogim<jmkje!fQ!
!
! djvk<kqM!uik!Ofib<g<G!LjxogM!uqmR<se<!eqg<Gl<!
! fqjvk<kqM!$jz!Ge<l!fQ{<cM!lzg<gm<!cx<Gr<!
! gjvk<kqM!uitf<!ke<je!gkqk<kqM!Olgk<!kqx<Gl<!
! njvk<kqM!hqk<kk<!OkiIg<Gl<!ngx<xqM!nkjek<!kiOe!
Purification 
 Croton seeds are allowed to boiled in cow dung milk then remove the outer 
coating and leaf like cotyledones with sheath like substance from inside.  Then it is boiled 
in cow’s milk.  Then soaked in lime juice for 24 hours.  The croton embryo dried and 
roasted in cow’s ghee. 
Other purification process 
 Croton seeds 35 gram, Amla fruit juice, eclipta prostrata leaf juice, cow’s urine 
each 85 gram, totally 255 grams taken in a mud pot then it is closed with white cloth.  
Then place croton seed on it and it is boiled per 3 hours.  Repeat the procedure for 3 times 
then it is roasted with cow’s ghee. 
Toxicity of Croton tiglium: 
• It can cause severe diarrhoea and abdominal cramps along with burning sensation 
in the whole abdomen 
• Unpurified croton seeds cause severe irritational inflammation in the alimentary 
canal.  It results in Diarrhoea, Severe cramps, Severe abdominal tenderness, 
Ulceration in mouth, acid dyspepsia, vomitting, stupour, dizziness  
• Externally it cause Itching, Blisters and Burning sensation. 
Antidote 
 Cumin seeds roasted in honey and add sufficient amount of water to it make it 
dicoction.  
Traditional uses: 
• Croton seeds are made into paste with water mixed with honey and applied on 
tumours. 
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• Croton seeds are used with other raw drugs for anemia and constipation 
medicines. 
• Croton seeds should not be given separately. 
• Croton seeds should not be given to aged persons, younger children, diabetic 
patients and pregnant women. 
NERVALAM IN OTHER PREPARATION 
1.BALA VIRESANA KULIGAI 
Dosage : Kundrimani alavu (130mg) 
Adjuvant : Gulkanthu, sugar, jaggery, butter. 
Indication : Arthritis 
. Anuboga vaithya navaneetham 
2.SANJEEVI MATHIRAI 
Dose  : Kundri alavu (130mg) 
Adjuvant : urine 
Indication : Snake bite, Hemmorhoids, gastric ulcer tuberculosis 
. Bharathathil marunthu sei muraigal 
3. VIRESANA BHOOPATHI 
Dose  : 100mg 
Adjuvant : Water 
Indication : Vadha and kabha diseases, abdominal distension 
. Balavagadam 
4. LINGATHI SUGA KAZHICHAL KULIGAI 
Dose  : ½ -1 Kundrimani alavu (65-130mg) 
Adjuvant : Jaggery, sugar, butter 
Indication : Hemiplegia, arthritis, vadha fever, kabha diseases 
. Anuboga vaithya nevaneetham 
5. SOOLAI BEDHI MATHIRAI 
Dose  : 1-3 kadugu alavu (6mg-18mg) 
Adjuvant : Jaggery, castol oil. 
Indication : Arthritis, urinary tract infections, non-healing wounds. 
. Anuboga vaithiya navaneetham 
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3.3.2. BOTANICAL ASPECT  
NERVALAM (CROTON TIGLIUM) 
Taxonomical classification 
Kingdom : Plant 
Division : Magnoliphyta 
Class  : Magnoliopsida 
Subclass : Rosidae 
Order  : Euphorbiates 
Family  : Euphorbiaceae 
Genus  : Croton 
Species : Croton tiglium 
Habitat 
 It is native to India, Srilanka, South china, Philippines and the moluccan Islands. 
Description 
Habit  
 An erect (or) more (or) loss spreading shrub (or) small tree 
Leaves 
Croton tiglium is evergreen.  The simple leaves are alternate.  They are ovate, serrulate 
and petiolate 5-10cm long. 
Flower 
 It produces racemes of white five-stellate flower from January to July.  Flowers 
small unisexual nearly 2.5cm long. 
Fruit 
 The tree produce drupes 
Macroscopic character 
 The seed appear as oblong, oval, approximately 12-15mm length, 5-8mm width, 
ventrally shows longitudinally running centrally located ridge of raphe.  A small circular 
point located at the narrow end is the hilum.  It is brown and some seeds are black in 
colour. 
Microscopic character 
 The seed is spherical capsule, smooth, carunculate testa, crustaceous, albumin 
copious, cotyledon flat, ovary covered with stellate tomantum.  Further seed show wide 
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and thick broadly elliptical body.  It also consist of outer seed coat and inner pericarp.  
These two cotyledons which are flat, long, parellel to each other. 
Chemical constituents 
  Croten oil consist chiefly of the glycerides of steric, palmitic, myristic, lauric and 
oleic acids.  They are also present in the form of glycerin. ether the more volatile acids as 
formic, acetic,  Isobutyric and Isovalerianic acids.  The active principle is crotonic acid. 
Therapeutic uses 
• The seed oil and bark were widely used as a remedy for cancerous sores and 
tumours, carbuncles, colds, dysentery, fever, paralysis, scabies, schistosomiasis, 
snake bite, sore throat and toothache. 
• The powdered seeds mixed with dates are eaten as a purgative 
• The root is used as an abortifacient and purgative. 
• The leaves are used as a poultice to treat snake bite. 
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3.3.3. LATERAL RESEARCH: 
An Overview of the Biological and Chemical Perspectives of Croton tiglium Der 
Pharmacia Lettre, 2016, 8 (19):324-328 
ABSTRACT 
  Plants and their extract have the potential to cure the infirmity of mankind. From 
ancient times herbal plants are used for treatment. Croton tiglium Linn belongs to the 
family of Euphorbiaceae is widely distributed throughout the plain of India. The various 
part of Croton tiglium possess different biological and chemical perspectives such as anti- 
tumor, anti- HIV, anti- inflammatory, antidermatophytic, antioxidant activities in case of 
biological perspective and Toxicity, Phytochemistry, cytotoxic, detoxification activities in 
chemical perspectives. This plant has great prospects for development of Ayurvedic and 
modern medicines. 
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3.4. KARUVEL – gVOuz<<<<!
(Acacia Arabica (Linn) 
3.4.1. GUNAPADAM ASPECT 
SYNONYMS 
Karuvelam, Karuvel 
 gVOuzqe<!Ohi<kjeOb!gVkg<!OgT!
! ! gVlgi!OlOkiiq!Olks<s!liGr<!
! GVOuzir<!gqV]<{h<!hqxm<!OsikqbiGl<!
! ! GVuiGf<!kQLXgz<!H,Ug<Gt<Ot!
! sVOuziR<!sx<hiiq!hS!gs<jssgR<!
! ! sx<xqkh<!He<eigg<!gf<kliGR<!
! sqXOuziR<!sqOz]<l!hqk<k!sleqbiGR<!
! ! osh<hqbOkiI!gVOuzqe<!sQVliOl/!
. Ohigi<!fqg{<M!2311!
  As per the above verses the synonyms of vel are methori, methacham, krishna 
piratjodhi, theemurugal, poovukulae guruvahum, charpaari, pasukachaisagam, 
punnagakantham, sileshmapitha samani. 
VERNACULAR NAMES 
Eng name : Indian gum arabic tree, Babul, Black babool. 
Tel  : Nalla-tumma 
Sans  : Kala-burbura 
Mal  : Karuvolum 
Hind  : Kala-babul 
Kan  : Karijali 
Part used 
 Tender leaf, stem bark, root, gum, seed. 
Organoleptic character: 
Taste (Suvai)   : Astringent (Thuvarpi) 
Potency (Thanmai)  : Cool (Thatpam) 
Bio-transformation (Pirivu) :  Sweet (Inippu) 
Action 
 Leaf, bark, root, seed : Astringent 
Gum : Demulcent, Emollient, Nutrient, Aphrodisiac 
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General characters 
 hz<Zg<!gMk<k!hzOfi!bgx<xq!bjkg<!
! gz<Zg<G!Ofvigg<!gm<MOl!–!lz<Zg<G!
! f{<lqe<uje!gioteh<Ohib<!fiTl<!uqbikqgjts<!
! s{<lbqz<!ue<eiB!kl</!
. Okve<!ou{<hi!
  It cures all types of dental diseases and strengthen the gums. 
Bark 
 kf<kl<!-XGf<!keqs<$kh<!H{<{iXl<!
! uf<kSvl<!hqk<kl<!lcBr<gi{<!.!hf<k!
! lVOu!bgzi!lzvtg!liOk!
! gVOuzl<!hm<jmg<Gg<!gi{<!
. ngk<kqbi<!G{uigml<!
  It cures fever, gingivitis due to mercurial medicine, pitha diseases.  It strengths the 
teeth. 
Gum 
 fQIk<okiPGl<!uqf<K!fqjzg<gh<!HiqBoliq!
! H,k<okiPGl<!out<jtkjeh<!Ohig<Glql<!.!lik<kqvOli!
! OkS!kVLvR<!osb<Bl<!ohiqObivix<!
! OhSgV!Ouzl<!hqsqe<!
. ngk<kqbi<!G{uigml<!
 It cures spermatorrhoea purulent vaginal discharge with burning sensation. It 
improves complexion of skin and act as tonic. 
Root 
 gVOuzqe<!OuIg<Gg<!gMh<hqvk<kl<!lif<kl<!
! hVuikl<!DXgvh<!hiEl<!.!ohVG!
! ohVl<Ohkq!Bl<OhiGl<!Ohsuq!eqg<Gl<!
! gVl<Oh"!-kjeg<!gVK!
. ngk<kqbi<!G{uigml<!
  Decoction of the root cures vadha diseases, eczema, diarrhoea, dysentery with 
tenasmus, indigestion. 
Traditional Formulations 
1. Taking decoction of 3-4gm of tender leaves of Babla (prepared by 4gm leaves in 
125ml of water boiled down to 60ml), mixed with little sugar, twice daily for three 
days, cures diarrhoea characterized by discharge of mucous.  Some medicine may 
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recommend mixing 3-4 gm of bark of kuruchi (Holarrhena antidysenterica) 
preparing decoction. 
3/ Washing wound with decoction of leaves (prepared with 5-7 gm of tender Babla 
leaves in 3 cups of water boiled down to one cup on slow fire).  cures the wounds 
& controls further infection by pathogens. Sprinkling fine powder to Babla leaves 
on the wound helps it cure quickly.  sprinkling fine powder of Babla leaves on 
chilblain (sores in feel caused by excessive use of water) cures it.!
4/ Applying a hot paste of 10-12 gm of Babla leaves, 20-25gm of roasted sand and 2-
3 gm of khair (cutch), twice daily for 3 days.  Cures, both swelling and pain of 
mumps.!
5/ ‘Solid extract’ of Babla tree prepared and kept preserved, cures many diseases.  
Take bark of stem, bark of roots, leaves flowers and fruits, crush these and boil in 
water four times the quantity of the mixture.  Boil down the extract to one fourth 
of the initial volume.  Sieve and simmer the extract further, stirring all along to a 
consistency of molten bitumen.  While still hot, add 10gm of roasted sohaga 
(borax) for its preservation.  Keep this solid extract in airtight containers,  
Applying a little solid extract of Babla, diluted with water, through cotton doused 
in it, on gums cures their swelling.!
6/ Applying diluted solid extract of Babla on swelling, subsides it & removes pain.!
7/ Gurgling with a solution of 2-3 gm of ‘solid extract’ in half cup of hot water cures 
sores in  mouth.  Alternatively, boil 10-12 gm of bark of Babla in 500ml of water 
down to 120ml, decant the extract and gurgle, four times daily, for 3 days.  This 
gurgle cures obstinate oral ulcerations.!
8/ Giving vaginal douche with a solution of 2 gm of ‘solid extract’ in 250ml of wate, 
cures leucorrhea.!
9/ Washing wounds in nipples of lactating mothers (caused due to vigorous sucking 
by infants)  with decoction of bark of Babla cures it.!
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KARUVELAMPISIN IN OTHER PREPARATIONS!
1. OOZHI MATHIRAI 
 i.  Hydragyrum subchloride - 1 pangu 
 ii. Camphor   - 1 pangu 
 iii. Ferula asafoetetida - 1 pangu 
 iv.Phyllanthus emblica - 1 pangu 
 v. Myristica fragrans  - 1 pangu 
 vi.Piper nigrum  - 1 pangu 
 vii.Syzygium aromaticum - 1 pangu 
 viii.Trigonella foenum graecum -  1 pangu 
 ix.Acacia arabica  - 1 pangu 
 x. Papaver somniferum - 1 pangu 
 xi.Decoction of cannabis sativa- 1 pangu 
Preparation 
 Powder drugs from i to x then placed in stone morter grind it with decoction of 
cannabis sativa for 3 hours into fine pill rolling consistency make into 130 mg pills. 
Dose  : 130 mg 
Adjuvant : Hot water 
Indication : Cholera, diarrhoea, bacillary dysentry. 
-  Siddha vaithya thirattu 
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3.4.2. BOTANICAL ASPECT 
KARUVEL (ACACIA ARABICA (LINN) 
Taxonomical classification 
 According to Benthen and Hooker’s classification Acacia arabica is classified as 
follows 
Kingdom : plant kingdom 
Division : angiosperms 
Class  : dicotyledons 
Sub-class : polypetalae 
Series  : calyciflorae 
Order  : fabales 
Family  : leguminosae/fabaceae 
Sub-family : mimosoideae 
Genus  : acacia 
Species : nilotica 
Habitat 
 Indigenous to sind (Pakistan) Afghanistan and Nothern India.  Wild or cultivated 
and naturalized throughout India but not in the most humid regions on the western coast 
and in the extreme Northwest where frost is too severe in winter.  Also found in tropical 
Africa and Arabian countries. 
Habit 
 A moderate sized, thorny, almost evergreen, wild (or) cultivated xerophytic tree 
with a short trunk and a spreading crown of feathery foliage. 
Description 
Root 
 Tap much branched, deep. 
Stem 
 Erect, aerial, woody, solid, cylindrical, branched, bark dark brown, rough with 
deep narrow longitudinal fissures, heartwood pale red, when fresh cut nearly colourless, 
turning reddish brown on exposure to air 
Leaves 
 Stipulate, cauline and ramal stipules modified into spines that are straight, 1.5-
5cm long, turning white in the older branches, petiolate, alternate, 2.5-8cm long, 
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bipinnately compound, pinnaetly 3-6 pairs, subsessile, opposite, cup shaped glands at the 
base of lowest and uppermost pair, leaflets small, oblong, opposite, subsessile, entire, 
obtuse 1.5-4cm long, 10-20 pairs, venation unicostate reticulate. 
Inflorescence 
 Axillary cymose heads globose, on short or medium sized peduncles, heads about 
1.5cm in diameter, yellow. 
Flower 
 Ebracteate, subsessile, small complete, hermaphrodite, regualr, actinomorphic, 
hypogynous, cyclic, yellow, fragrant. 
Calyx 
 Sepals 5, gamosepalous, campanulate, 5-toothed, slightly petaloid, inferior. 
Androecium 
 Stamens indefinite, poly androus with long filaments and anthers, minute, yellow, 
dithecous, versatile. 
Gynoecium 
 Carpel, ovary superior, unilocular, sessile, green, hairy, oval with small white 
glands, style long, filiform, stigma minute, placentation marginal, ovules  numerous. 
Fruit 
 A lomantaceous pod, much constricted between seeds at both sutures, whitish, 
tomentose, 8-15cm long, stalked, fleshy, grey seeds non-endospermic, 8-12 in a single 
row. 
Flowering 
 Rainy season and cold season. (June- december) 
Sprouting 
 Never leafless but young foliage comes out in Feb-April, 
Microscopical characters 
Periderm 
 20-25 layered, cells thinwalled flattened, tanniniferous, mostly rectangular, 
measuring T-49-56-70 X 21-28-58µ, a few lenticels are formed by the rupturing of cork. 
pellogen: 8-12 layered, cells rectangular, phelloderm many layered, cells ovate to 
elongate, tanniniferous.  Stone cells present in patches.  Sclerenchyma is in the form of a 
ring next to secondary cortex, 2 to many layered cells polygonal, lamellated, some 
developing into stone cells with narrow lumen, tanniniferous, measuring T-21-28-42µ. 
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Macroscopical characters 
Gum 
 Gum is obtained by making incisions into the bark.  It occurs in irregular or 
broken tears of various sizes agglutinated masses and angular fragments or pieces.  The 
thick pieces are opaque, the thin ones are transparent.  Each tear is about 1.5cm in 
diameter.  The gum is brittle, the taste is bland mucilaginous.  Makalai gond is of the best 
quality, colourless, occurs in large round tears and twisted pieces of a white colour.  That 
of an inferior quality is known as mesarigond.  It is in angular pieces which are fissured, 
strong yellowish red or straw colour or brownish yellow with a tinge of white, soluble in 
water forming a sticky solution. 
Chemical constituents 
 Various constituents are Gum : galactose, L-arabinose, L-rhamnose, and 4 
aldobiocronic acids, a new arabinobinose 2-0-β-L-arabinofuranosyl L-arabinose along 
with 3-0-β-L-arabino pyranosyl –L-arabinose. 
 Bark-quercetin, gallic acid, catechin (-) epicatechin (+) dicatechin (+) 
leucocyanidin isolated, epigallocateatin, catechol, pyrogallol. 
 Seeds-glucose, galoctose, fructose, maltose, aspartic acid, glutamic acid, glycine, 
alanine, proline, leucine and theronine. 
 
Therapeutic uses 
 Bark is used for asthma, bronchitis, diabetes, dysentry, diarrhoea & skin diseases. 
 Stem is used for tooth brush & gum for burns 
 Leaves are useful for eye diseases, head ache, throat infection, urinary tract 
infections & gonorrhoea. 
 The flowers are used for ear diseases and as tonic. 
 Bark is used in haemorrhages, wounds, ulcers also used as a decoction in the 
treatment of diarrhoea and vaginal secretions. 
 Aphrodisiac, diuretic, used to treat leprosy, leucoderma, bronchitis, seminal 
weakness, utero-vesical disorders. 
 The bark in combination with the bark of the ficus bengalensis Linn are frequently 
used as a gargle in sore throat, in excessive bleeding from haemorrhoids. 
 The powder of the tender pods is astringent, demulcent and has a beneficial 
influence over diarrhoea and dysentry 
 Gum powder is used to stop bleeding from leach bites. 
 
                                                                                                                             
 
   33 PRE CLINICAL  STUDY OF  KARPOORA  SINTHAMANI  MATHIRAI 
 
3.4.3. LATERAL RESEARCH 
Gum Arabic Fibers Decreased Inflammatory Markers and Disease Severity Score 
among Rheumatoid Arthritis Patients, Phase II Trial International Journal of 
Rheumatology 
Volume 2018, Article ID 4197537, 6 pages 
Background. Rheumatoid arthritis (RA) is autoimmune inflammatory disease that attacks 
the synovium of the joints. Both TNF and interleukin-1 play crucial roles in the 
pathogenesis of RA. Gum Arabic (GA) is gummy exudates fromAcacia senegal tree. 
Gum Arabic fermentation by colonic bacteria increases serum butyrate concentrations, so 
it is considered as prebiotic agent. Gum Arabic (GA) has anti-inflammatory activity 
through its derivative butyrate. To the best of our knowledge, this is the first study 
conducted to investigate GA intake on inflammatory markers among RA patients. 
Patients andMethods. This is clinical trial phase II in which 40 
patients were enrolled aged 18 to 70 years. Patients received 30g/day GA for 12 weeks. 
TNF �, ESR, and complete blood count were measured and DAS-28 was calculated 
before and after regular GA consumption. Study was approved by the Ethical committee 
of NationalMedicines and Poisons Board. Results. This study showed significant decrease 
in level of serum TNF � (p value 0.05) [95% CI, 0.65 -16.5], ESR (p value 0.011) [95% 
CI, 2.6 -18.89], and number of swollen and tender joints in RA patients after 12 weeks of 
GA intake which reflected as significant decrease in disease severity score DAS 28 
P.V:0.00 [95% CI, 1.25 -1.99]. On the other hand, GA had trivial change in blood indices. 
Conclusion. Gum Arabic has favorable immunemodulator effect on rheumatoid arthritis. 
It can be utilized in clinical practice as adjuvant therapy. Trial Registration. This trial was 
registered with ClinicalTrials.gov Identifier: 
NCT02804581 Registered at 19 June 2016, prospective registration. 
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3.5. KATRAZHAI – gx<xijp<<< !
(Aloe Barbadensis) 
3.5.1. GUNAPADAM ASPECT 
Synonyms  :  Kanni, Kumari 
Vernacular names 
Eng : Indian aloe, curacao aloe 
Tel : Kalabanda 
Mal : Kattuvazha 
Kan : Kathalai gidsa, lolisara 
San : Kumari 
Hin : Ghikauvar 
Part used 
 Latex, juice, root 
Organoleptic character 
Taste (Suvai)   : Slightly bitter (Siru kaippu) 
Potency (Thanmai)  : Coolant (Thatpam) 
Bio-Transformation (pirivu) : Sweet (Inippu) 
Action 
Tonic (Uramakki) 
Alternative ( Udarthetri) 
Purgative (Neermalampooki) 
Emmenagogue (Ruthu-undaki) 
General character 
“ohiz<ziOl!gr<ghl<H!Ps<$jz!Gm<mvsl<!
nz<ziIlk<!gl<hgf<k!vr<Ge<ll<!wz<zil<uqm<!
OmG!liqg<G!oliqs<sx<!gqiqs<svL!
liG!liqg<G!lV{<M” 
. Okve<!G{uigml<!
It cures leprosy, fistula, hemmorhoides, gastric ulcer. 
Traditional uses 
 Aloevera leaf extract along with green cumin and sugar candy is used to treat 
bloody diarrhoea. 
 Aloevera leaf juice is given for dehydration due to cholera and also applied 
exernally for swelling. 
 Oil prepared from the leaf juice promotes hair growth and sleep. 
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KATRAZHAI IN OTHER PREPARATIONS 
1. ARUMUGA CHENDOORAM 
Dose  : 63-130mg 
Adjuvant : Thirikadugu chooranam, Honey 
Indication : Paraplegia, Hydrocele, gastric ulcer, Hemmorhoids, Chest  
pain, Anemia, diarrhoea, Headache, throat pain. 
-  Siddha Vaithya thirattu 
2. SUYAMAKINI CHENDOORAM 
Dose  : 130mg 
Adjuvant : Ginger juice 
Indication : Ascitis, Hemmorhoides, diarrhoea and vatha diseases 
- Siddha vaithya thirattu 
3. PATCHAI KARPOORA MATHIRAI 
Dose  : 100mg 
Adjuvant : Honey, Ginger, Juice 
Indicaiton : Fever, 80 types of vatha diseases, 40 types of  
pitha diseases, 96 types of kabha diseases 
- Siddha vaithya thirattu 
4. VENPOOSANI NEI (KOOZHPANDA KIRUTHAM) 
Dose  : 5-10ml 
Indication : Leuchorrea, Tongue diseases, leprosy, tuberculosis 
- Agathiyar vaithya rathna surukkam 
5. VELVANGA PARPAM 
Dose  : 65-135mg 
Adjuvant : Butter, ghee, honey 
Indication : Hemorrhoides and fistula 
- Hospital pharmacobia 
6. SHAYA KULANTHAGA CHENDOORAM 
Dose  : 30-130mg 
Adjuvant : Thirikadugu chooranam, Honey 
Indication : Tuberculosis, cough, Asthma 
- Agathiyar bin-80 
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7.MAGA VASANTHA KUSUMAGARAM 
Dosage : 130mg 
Adjuvant : Amukkara chooranam, vilam pazham, ghee 
Indication : Arthritis, Indigestion, swelling, fever. 
8. LINGA CHENDOORAM 
Dose  : ½ -1 kundri (65-130mg) 
Adjuvant : Milk Halwa, Butter, wheat halwa. 
Indication : Arthritis, Blood purifier and nervine tonic 
- Anuboga vaithya navaneetham  
9. VEERA CHENDOORAM 
Dosage : ½ kundri (65mg) 
Adjuvant : Palm jaggery, ginger juice, honey. 
Indication : Arthritis, gastric ulcer, indigestion. 
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3.5.2. BOTANICAL ASPECT  
KATRAZHAI  (ALOE BARBADENSIS) 
Toxonomical classification 
Kingdom : Plants 
Devision : Magnoliophyta 
Class  : Monocotyledeons 
Subclass : Lilidae 
Order  : Liliales 
Family  : Liliaceae 
Genus  : Aloe 
Species : Barbadensis 
Habitat 
 An evergreen perennial, it originate from the Arabian peninsula, but grows wild in 
tropical climates around the world and cultivated for agriculture and medicinal uses. 
Description 
Habit 
 Aloe vera is short stemed shrubby aloe, frequently suckering and forming dense 
clumps. 
Leaves 
 The leaves of the aloe vera are succulent, thick and fleshy.  The slightly curved, 
dagger shaped foliage grows as a rosette out of the plant’s base and each plant generally 
has 16 to 20 leaves.  Each leaf grows 18 to 36 inches long and 2 to 3 inches wide.  The 
gray-green (or) pale green upper leaf surface, sometimes variegated with small white dot, 
is mostly flat, while the lower leaf surface is convex.  Aloevera leaf margins are slightly 
pinkish and have plae, firm and triangular teeth. 
Flowers 
 Aloe vera flowers appear on spikes upto 3 feet tall.  The flowers are yellowish-
orange and tubular.  They are arranged in an arrow shaped cluster atop the stalk.  Tend to 
flower in spring but may bloom sporadically throughout the year. 
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Stems and Roots 
 Aloevera plants are stemless (or) have a short stem not more than about 12 inches 
tall.  The plants do produce shallow rhizomes and stolons that allow spreading and the 
formation of dense calories of plants. 
Root 
 Multiple tuberous roots store moisture while a fibrous system of small root 
anchors the plant and absorbs moisture and nutrients. 
Fruits and seed 
 The fruit of the plant is a capsule that open vertically.  The plant seed are ½ to 
3/10 inch long, dark brown and winged. 
Microscopic character 
 A strong cuticularized epidermis with numerous stomata on both side of surfaces 
which enclose a region of parenchyma containing chlorophyll, starch and occasional 
bundles of needle of calcium oxalate a centre region which frequently occupies about 
three-fifth of the diameter of the leaf, consist of large, mucilage containing 
parenchymatous cells which cover the doubble row of vascular bundles which lie at the 
junction of two previous zones and have a well marked pericycle and pericycle cells. 
Macroscopic character 
 Perennials, stem-1.5meter high, woody, rough from leaf-remnants, leaves 
glaucous green often with darker spots, thick, succulent, bayonet-shaped, margin with 
reddish spines (or) serratures flowers racemose (or) spicate, tubular, yellowish orange-
red, stamens 6, unequal, 3 longer than corolla. 
Chemical constituents 
 It contain 19 amino acids, 7 essential amino acid such as isoleucine, leucine, 
lysine, methionine phenylalanine, threonine, valin. 
• Anthroquinones 
• Enzymes (Alkaline phosphatase, cellulase, lipase etc) 
• Hormones (Auxin, Gibberiellin) 
• Ligiuns 
• Salicylic acid 
• Saponin 
• Sterols and vitamins 
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Theraputic uses 
1. 1.Extract of leaves is used for treating lymphatic obstruction, arthritis, 
myopathies. 
2. Juice of leaves is reported to be used for treating gonorrhoea and mensural 
problems. 
3. The pulp is also used as vermicide. 
4. The phenolic and non-phenolic fraction of the leaf extract showed anti-microbial 
activity comparable to standard antibiotics such as neomycin, tetracycline and co-
trimaezole. 
5. Crushed leaves are applied on forehead for headache. 
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3.5.3. LATERAL RESEARCH: 
 
EVALUATION OF ANTI-INFLAMMATORY ACTIVITY AND ANALGESIC 
EFFECT OF ALOE VERA LEAF EXTRACT IN RATS Thirunethiran Karpagam et 
al. IRJP 2 (3) 2011 103-110 
ABSTRACT: 
Clinical evaluation of analgesic and anti-inflammatory drugs envisages the development 
of side effects that makes efficacy of a drug arguable. Alternatively, indigenous drug with 
fewer side effects is the major thrust area of research in the management of pain and 
inflammation. In the present study aqueous extract of whole leaf of Aloe vera at various 
concentrations was investigated for its antiinflammatory and analgesic activities in albino 
wistar rats. Carrageenan and formaldehyde-induced rat paw oedema was used to evaluate 
the anti-inflammatory activity and tail flick, hot plate and acetic acid tests were used to 
assess the analgesic activity of A. vera leaf aqueous extracts. Whole leaf aqueous extracts 
at various concentrations (100, 200, 400, and 600 mg/kg of bw) significantly reduced 
formation of oedema induced by carrageenan and formaldehyde and granuloma formation 
in a dose dependent manner. Further, acetic acid-induced writhing model exhibited 
significant analgesic effect characterized by reduction in writhes. Whole leaf aqueous 
extract showed dose dependent increase in tolerance to thermal stimulus comparable to 
indomethacin. No mortality was observed during the acute toxicity test at 
a dosage of 600mg/kg. Thus whole leaf aqueous extract of Aloe vera can be exploited as 
non toxic drug for the treatment and clinical management of inflammation and pain. 
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3.6. DISEASE REVIEW 
KEEL VAYU 
3.6.1. SIDDHA ASPECT 
Definition: 
     Keel vayu is a Vadha disease characterized by pain and swelling of the joints, stiffness 
of the muscles and joints with tenderness frequently associated with fever, insomnia etc. 
it may be accompanied by emaciation, anemia and restriction of joint movements and in 
some cases even immobility can also occur.   
“utqB!jlBf<!ke<eqjz!!ogm<M!!
uzqBme<!uQg<gs<!SvLl<!gib<f<K!!
&m<Mg<!OmiXl<!LMg<gqOb!ofif<K!!
&m<Mg!me<eqe<!fQVl<!Svf<K!!
kir<ogi{i!uzqBme<!okif<kqM!ll<Ol”!!
! ! ! ! ! ! !!!)shihkq!jgObM*!
Etiology:!!
“utqkV!gib<gq!pr<G!!
! ! ujvuqzi!kbqzz<!Ogijp!!
Ltqkbqi<!Ohie<lq!Gg<G!!
! ! Ljxbqzi!U{<c!Ogimz<!!
Gtqi<kV!utqbx<!Oxgr<!!
! ! Geqh<Hx!Uzuz<!oh{<ci<!!
gtqk<kV!Lbg<gl<!ohx<Oxii<!
! ! gcosbz<!gVuqbiliz<” 
Classification of Keelvayu: 
       Classification of Keelvayu are described in different Siddha literature differently. 
In the text Siddha maruthuvam Keelvayu is classified and described according to 
Mukkutra theory.   
On the basis of Mukkutra theory it is classified into 10 varieties: 
1. Vali Keelvayu   6. Azhal vali Keelvayu 
2. Azhal Keelvayu  7. Azhal iya Keelvayu 
3. Iya Keelvayu   8. Iya vali Keelvayu 
4. Vali azhal Keelvayu  9. Iya azhal Keelvayu 
5. Vali iya Keelvayu          10. Mukkutra Keelvayu 
! !
                                                                                                                             
 
   42 PRE CLINICAL  STUDY OF  KARPOORA  SINTHAMANI  MATHIRAI 
 
utqg<gQz<uiB!;!< Q << Q << Q < !
“uzqg<Gk<kz<!uQg<gr<!gi[l<!
! ! uib<oki{<jm!uxm<sqgib<s<sz<!!
kjzuzq!lii<K!ch<Hk<!!
! ! kir<ogi{i!uzquQg<!gf<kie<!!
fqzUgix<!g[g<G!xr<G!!
! ! fQMOkit<!Lpr<jgg<!gix<gil<!!
lzg<Gmx<!gm<M!Oui<ju!!
! ! uikk<kqz<!uib<uq!kiOl/”!!
! ! ! ! ! !!!!!)shihkq!jgObM*!
       It is characterized by excruciating pain and swelling involved in toes, knee joints, 
hip joints, elbow joints, shoulder joints and associated with systemic disturbances like 
dryness of mouth, pyrexia, headache, palpitation, constipation and sweating. 
npz<!gQz<!uiB!;!< Q << Q << Q < !
! ! “hqk<kg<gQz<!uib<U!ke<eix<!!
! ! !!!!!bqxr<GgQe<!Lm<M!uQr<gqs<!!
! ! sqk<ki<osb<!lVk<K!uk<KR<!!
! ! !!!!!sQi<hmik<!ke<jlk<!kigqk<!!
! ! kk<kX!gib<s<sz<!g{<M!!
! ! !!!!!sizOu!kjekie<!kf<Ok!!
! ! olk<kX!sqgqs<js!ke<eiz<!!
! ! !!!!ole<Olz<!fQr<G!lh<hi/”!
 It is characterized by swelling of joints associated with severe pain and pyrexia. 
Since it is not quickly responding to medicine the prolonged medical care is said to be 
essential. As Pitha increases, kaba in the joint decrease and hence dryness occur. So 
during flexion of the joint crepitation sound “ kaluk kaluk” is produced. In advanced 
cases it produces ankylosis of the joints and hence restriction of joint movement results.  
Jbg<gQz<!uiB;!< Q << Q << Q < !
! ! “gVkVr<!ghg<gQz<!uiB!!
! ! ! g{<ce<!dmzq!jtg<Gl<!!
! ! dVolzq!uig<Gr<!ogit<Tl<!!
! ! ! d{<cjbg<!gVg<Gl<!-e<hf<!!
! ! kVKbqz<!fQr<G!Lm<cx<!!
! ! ! xir<ogi{i!uZju!big<Gl<!!
!
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! ! -VlOz!uqg<gz<!uif<kq!!
! ! ! Osijhhi{<!omPh<Hl<!hiOv!!
! ! ! ! ! ! ! )shihkq!jgObM*!
      It is characterized by severe pain in the joints associated with Emaciation of the 
body, anorexia, insomnia, cough, hiccup-cough, vomiting, anemia and dropsy. The 
common sites are spinal cord, hip joint and knee joint.  
utqnpz<!gQz<!uiB;!< Q << Q << Q < !
! ! “uikhqk<!kg<gQz<!uib<uqe<!!
! ! ! uVr<Gxq!six<xg<!Ogtib<!!
! ! Wklii<!lf<k!Olh<hl<!!
! ! ! -jvs<sZl<!ubqx<xqx<!gi[l<!!
! ! YkVr<!Gk<kz<!uQg<gl<!!
! ! ! Yb<kzqz<!wiqs<s!Z{<mil<!!
! ! gikX!Lxg<g!lqe<jl!!
! ! ! gib<s<sZl<!gi[r<!g{<mib<”!! !
       Vali azhal keelvayu have the symptom of indigestion i.e., mantham, aeppam 
(eructation), borborygmus of the abdomen. This disease occurs due to excessive intake of 
foods which increases Vadha and Pitha (ex. Mutton, egg, fish, potato) and frequent intake 
of liquors. Laziness may also be produces this disease.   
utq!Jbg<!gQz<uiB;< Q << Q << Q < !
! ! “Jbqje!uqjzg<G!L{<c!!
! ! ! bbqxOz!%kqi<g<!gix<X!!
! ! olb<bqje!bjzg<G!lir<g{<!!
! ! ! OluOzi!OmikR<!sii<f<k!!
! ! jubk<kqe<!dxr<ge<!liiq!!
! ! ! heqbqeie<!uim<m!olb<kz<!!
! ! olb<bbi<!UxU!jpk<kz<!!
! ! ! !
!!!!!!!!!!!!!!gujzbie<!OlU!lqf<Ofib<!!
! ! ubr<ui!kg<g!hg<gQz<!!
! ! ! uiBuie<!uzqlq!Gf<Ok!!
! ! dbr<GfQi<!Ogik<Kg<!gQz<gt<!!
! ! ! yiqbe<!kjzOhix<!gi[l<!!
! ! fbr<ogit<t!Lmg<gz<!fQm<mz<!!
! ! ! f{<{qmi!olb<Br<!giBl<!!
! ! lbr<GX!Lxg<g!lqe<eil<!!
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!
! ! ! le<eqb!ofiqg<gm<!miOl!!
! ! dmzK!ouKl<hqg<!jgbiz<!!
! ! ! dmzK!gMk<K!ofif<K!!
! ! gmZkir<!giz<g!vr<gt<!!
! ! ! gek<kix<Ohi!Zbi<f<K!gi[l<!!
! ! smlK!uqPf<k!kiGR<!!
! ! ! szr<ogm<M!Okim!L{<mil<!!
! ! Lmlkir<!jggiz<!kiE!!
! ! ! Lbr<gqe!uik!liOl”!
! ! ! ! ! ! )shihkq!jgObM*!
     It is characterized by pain in the joints associated with effusion of joint fluid 
and swelling, restricted joint movements, pyrexia, fainting, insomnia, lymphadenitis, 
generalized malaise, atrophy of affected limb etc. The affected joint looks like as “Fox’s 
head”.    
npz<utqg<gQz<!uiB;!< < Q << < Q << < Q < !
! ! ! “oubqzqjmk<!kqiqkz<!hqk<k!!
! ! ! ! lqGL{!uVf<k!Zt<tl<!!
! ! ! hbqZX!gujz!bikqh<!!
! ! ! ! h{<hqeiz<!hqk<k!uikl<!!
! ! ! gbqZX!uib<U!Okie<xqg<!!
! ! ! ! jgh<Hme<!lbg<gl<!uif<kq!
! ! ! -bZX!hz<zqx<!osf<fQi<!!
! ! ! ! -xr<gfiz<!Ofig<gr<ogit<Tl</”!!
! ! ! ! ! ! ! ! )shihkq!jgObM*!
      It is characterized by pain and swelling of the joint associated with bitter taste, 
vomiting, fainting, bleeding from the gums, malena, haematemesis. The common site is 
ankle joint pain, swelling, redness may also present.  
npz<<<<!Jbg<gQz<!uiB;!< Q << Q << Q < !
! ! “lqklqzig<!gzuq!jbjb!!
! ! ! lqGuqg<G!L{<c!hqk<kg<!!
! ! gkLX!osbzq!ux<xqx<!!
! ! ! gi{<hqk<kg<!ghg<gQz<!uiB!!
! ! -klX!lbg<gl<!uif<kq!!
! ! ! wiqSvf<!kjzOfib<!uQg<gl<!!
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! ! lkgiq!febqe<!lii<H!!
! ! ! Kch<Hme<!wiqUl<!osb<Bl<”!!
! ! ! ! ! !!!!!)shihkq!jgObM*!
      It is characterized by pain and swelling of the joints associated with fainting, 
vomiting, hyperpyrexia, headache and palpitation. Common sites are elbow and knee 
joints. 
Jb!utqg<gQz<!uiB;!< Q << Q << Q < !
“Jutqh<!ohVg<G!L{<c!!
! ! ! n{r<Gme<!gzuq!lx<X!!
Jutq!uqjeL!pg<Og!!
! ! ! ntuqzi!lKu!Vf<kz<!!
olb<BX!Olg!uikg<!!
! ! ! Ogijpbqe<!lqGkq!gi{z<!!
Jujg!ghui!kg<gQz<!!
! ! ! uiBue<!nxq%!xilz<!!
!
fiqk<kjz!uik!fvl<H!!
! ! ! gt<uiB!Ogihqk<!okie<xib<!!
niqf<kqMf<!kjzOlz<!jggiz<!!
! ! ! nr<goliM!ujtf<K!oul<hq!!
Liqk<kK!-xr<gq!uf<K!!
! ! ! Lpr<giz<!jg!giz<g!Mg<Gl<!!
fiqk<kjz!uik!ole<X!!
! ! ! fuqe<xei<!Lequi<!kiOl”!
! ! ! ! ! ! !!!!!!)shihkq!jgObM*!!
     It is otherwise called as Narithalai Vadham characterized by pain and swelling of the 
joints which looks like fox head and body pain. 
      This clinical entity mainly involves the knee joints were accumulation of blood in 
the joint which result in immobilization of the joint with stiffness of periarticular 
structures, the swelling which resembles to fox head and palpitation may occur.  
Jbk<!kQg<gQz<!uiB;< Q < Q << Q < Q << Q < Q < !
“Jbqjeh<!ohVg<G!L{<c!
!!!!!! !!!!!Bbqzzix<!GtqVr<!gix<xiz<!
olb<BX!Ogijp!lqg<G!
!!!!!! !!!!!lqGuzq!oki{<jm!gm<mz<!
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JBX!gib<s<sz<!uif<kq!
!!!!!! !!!!!!nbIUme<!-Vlz<!uQg<gl<!
osb<BgQz<!lmg<gz<!fQm<mz<!
!!!!!! !!!!!!osb<kqmik<!KbV{<miOl/”!
      It is characterized by excruciating pain in the joints associated with increased 
sputum, laryngitis, pyrexia, vomiting, drowsiness, cough, odema and restricted joint 
movements etc.   
Lg<Gx<xg<!gQz<!uiB;< < < Q << < < Q << < < Q < !
“lqg<Gx!uqbIk<kz<!&s<S!
!!!!!! !!!!!Olzqmz<!kjzgq!Xk<kz<!
lg<GX!lbg<gf<!Okie<xz<!
!!!!!! !!!!!uif<kqOb!uib<hq!kx<xz<!
ohig<GX!lzfQI!gm<mz<!
!!!!!! !!!!!ohiVlqb!uQg<gr<!gi{z<!
Lg<Gx<xg<!gQzqe<!uiB!
!!!!!! !!!!!Lgqp<k<kqMr<!Gxqg!tiOl/”!
      It is the chronic ailment characterized by pain and swelling of the joints which 
increased day by day, suppuration of the surrounding and adjacent structures associated 
with excessive sweating, dyspnoea, giddiness, syncope, vomiting, delirium, constipation, 
anuria, odema. If this is treat improperly can lead to fatal termination. 
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ARTHRITIS 
3.6.2. MODERN ASPECT 
Diseases of Joints 
A joint is where two or more bones come together, like the knee, hip, elbow, or 
shoulder. Joints can be damaged by many types of injuries or diseases, including 
 Arthritis - inflammation of a joint. It causes pain, stiffness, and swelling. Over 
time, the joint can become severely damaged. 
 Bursitis - inflammation of a fluid-filled sac that cushions the joint 
  Dislocations - injuries that force the ends of the bones out of position 
Diseases of Joints and their classifications: 
Joints are subjects to various types of diseases and disorders. Many lesions which 
are not strictly inflammatory are still loosely termed as arthritis.
 
Diseases of joints can be classified as follows: 
1. Infective Arthritis 
2. Rheumatoid Arthritis 
3. Degenerative Arthrosis (osteoarthritis) 
4. Neuropathic arthropathy 
5. Metabolic Arthritis 
6. Arthritis in systemic disorders 
7. Miscellaneous conditions 
8. Hysterical joints 
Degenerative Arthritis 
Osteoarthritis: 
Osteoarthritis is a chronic degenerative condition of the joints. It is not primarily 
an inflammatory disorder. 
Aetiology: 
The major factor leading to osteoarthritis is ;uneven distribution of load stress’ 
across the articulating surfaces in a joints. 
Osteoarthritis can be broadly grouped into 
• Primary Osteoarthritis 
• Secondary Osteoarthritis 
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Primary Osteoarthritis: 
Primary osteoarthritis is due to the wear and tear changes in old age in which 
weight bearing joints such as the hips and knees are commonly affected. It is uncommon 
in non-weight bearing joints such as the shoulder and elbow. Obesity is a predisposing 
factor. 
Osteoarthritis is a progressive process affecting the articular cartilage of ageing 
joints. It is characterised by focal degeneration of the articular cartilage. As the articular 
cartilage is cyclically loaded during movements of joints, it undergoes fatigue failure 
leading to fragmentation of the surface and fibrillation. In the later stage, the cartilage 
gets completely eroded, exposing the sclerosed (eburnated) bone and subchondral cysts 
are also found. 
The bone undergoes reactive hypertrophy forming peripheral osteophytes. The 
synovial membrane undergoes hyperaemia and reactive inflammatory thickening. As 
there is no distructive pathology, the joints does not get ankylosed. 
Secondary osteoarthritis: 
Secondary osteoarthritis refers to arthritis occurring in a joint secondary to a 
previously occurring disease or disorder of the joint. It may occur in any age and involve 
any joint. Factors associated with secondary osteoarthritis are as follows:  
1. Congenital malformation of joints 
2. Traumatic alteration of articular surfaces causing articular incongruence 
3. Loose bodies in the joint 
           4. Deformity of the joints, for example coxa vara, genu varum 
5. Hip  
Perthes disease 
Slipped epiphysis 
Avascular necrosis of the formal head  
6. Internal derangement of knee 
Pathology: 
The main factor associated with osteoarthritis is an abnormal increase in the 
mechanical stress in some part of the articulating surfaces. 
• Initial changes occur in the articular cartilage. There is an increase in the water 
contents and decrease in proteoglycans in the cartilage, leading to progressive 
cartilage destruction. 
                                                                                                                             
 
   49 PRE CLINICAL  STUDY OF  KARPOORA  SINTHAMANI  MATHIRAI 
 
• Articular cartilage destruction leads to its softening, fraying and fibrillation. 
• As soon as the articualr cartilage is destroyed, the underlying subchondral bone is 
exposed; it looks tough, sclerotic with ivory-like smoothness (eburnation) 
• Subchondral sclerosis and subchondral cysts are seen. 
• Bony projections and new bone formation (osteophytes) Occur within the joints 
• Thickening of the joint capsule and synovium leads to stiffness and 
deformity of the joint. 
Clinical Features 
Since the patients are usually elderly, weight- bearing joints are commonly 
involved. 
• The Patient presents with Pain that starts insidiously and increase over time, 
• Swelling- as a result of joint effusion, 
• Stiffness from the thickening of capsule and synovium, 
• Crepitus-while moving the joint,\ 
• limping-due to pain and deformity of the joint. 
On examination, the joint is 
• Tender and swollen, 
• Synovium-thickened, 
• Restricted movements, 
• Deformities such as genu varum/genu valgum may be present, 
• Joint instability may occur, 
• Muscle wasting around the involved joint is usually seen. 
 
Osteoarthritis Knee  
Primary osteoarthritis of the knee is a common clinical problem in our country. 
The patient is usually a male above 50 years presents with pain, swelling and restricted 
movements and inability to squat in the Indian toilet. The onset is insidious starting with a 
mild aching pain in the joint which is relieved by rest. The other main symptom is 
stiffness, which is maximum at the end of the long period of rest and loosens on activity 
for a few minutes. 
The cause of secondary osteoarthritis in the knee joint is alterations in the 
congruity of the articular surfaces due to various lesions, such as  
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• malunion of fractures involving the articular surfaces of tibia, femur or 
patella, 
• loose bodies in the joint, 
• malligament of the bone due to deformity such as genu valgum or genu 
varum  
Clinical features 
On examination, the joint is swollen and there may be an effusion into the  joints. 
The synovium is thickened and tender. There is a tenderness in the joint line and over the 
attachment of the medical collateral ligament. Movements are restricted. Crepitations are 
felt on movement. In late cases, there is often a genu varum deformity. 
Rheumatoid Arthritis: 
Collagen diseases are systemic diseases affecting all connective tissues in the 
body. 
Many of these disorders have joint manifestations. The most important of these is 
rheumatoid arthritis. Rheumatoid arthritis is a generalized chronic multi system disease 
affecting the connective tissues of the whole body with localized involvement of the 
musculoskeletal system. 
There is inflammatory synovitis of peripheral joints, leading to cartilage damage, 
bone erosions and subsequent joint changes. 
 
Aetiology: 
Aetiology remains unknown. The following are put forth as possible aetiology 
factors: 
Genetic predisposition: Rheumatoid arthritis runs in families. It is associated with 
Class II major histocompatability complex allele HLA-DR4 and HLA-DRBI. Genetic 
factors alone do not account for the disease. 
Abnormal Immune response: Rheumatoid arthritis may be a manifestation of an 
immune-mediated response to infections caused by mycoplasma, Epstein-Barr virus, 
cytomegalovirus, parvovirus in a genetically predisposed individual. 
Clinical Features: 
Rheumatoid arthritis is more common in women and occurs between 25 and 40 
years of age. It is a chronic disease with periodic acute exacerbations and remissions. 
Morning stiffness is very characteristic of rheumatoid arthritis. It is usually involves the 
small joints of the hands and feet and later on spread to the proximal joints such as the 
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knee, hips, elbow and shoulder. Bilateral symmetric polyarthritis is also  characteristic 
feature. 
Occasionally, it may start in the knee or hip and remain as a monoarticular lesion 
for some time, but soon it spread to other joints. The presenting joint is swollen and 
warm. There is joints line tenderness and the movement are painful and limited. There is 
effusion into the joint. The synovium could be felt thickened and tender. In the knee joint, 
the swelling cause a fusiform appearance with pericapsular swelling. In the stage, with 
progressive damage to the articular cartilage, there will be an increase in infection 
deformity, ultimately ending in ankylosis. 
If the hand, the small joints are swollen and the finger assume a position of ‘ulnar 
deviation’, clinically called ‘ulnar drift’. The fingers assume an’ intrinsic plus’ deformity 
which consists of flexion at the metacarpophalangeal joints and extension at the 
interphalangeal joints. The end stage of the disease is market by ankylosed joints. 
The ‘intrinsic plus’ position of the finger is due to the spasm of the intrinsic muscles 
of the hand which later become a contracture. The other deformities in the hand are as 
follows: 
• Boutonniere (buttonhole) deformity due to the rupture of the central slip of the 
extensor tendon resulting in flexion at the proximal interphalangeal joints with 
hyperextension at the distal interphalangeal joints. 
• Swan neck deformity, where there is hyperextension at the proximal 
interphalangeal joints and flexion at the distal interphalangeal joints. In the late 
stages, he capsular contractures become fixed, resulting in a permanent crippling 
derformity 
• Elbow- flexion deformity 
• Knee-flexion deformity followed by triple subluxation: flexion, posterior 
subluxation and external rotation. 
• Ankle-equinus deformity 
• In  the foot, patients develop hallux valgus of the great toe, claw toes, hammer 
toes and callosities. 
Other joints involved in order of frequency are as follows: 
• Foot 
• Wrist 
• Knees, elbow 
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• Ankle 
• Hip 
• Temporomandibular joints 
• Interspinous facet joint (rare) 
Juvenile Rheumatoid Arthritis 
Juvenile rheumatoid arthritis is a clinical variant of rheumatoid arthritis in 
children and adolescents.  
This is of the following three types: 
1.Systemic type, called still’s disease:  
The child is usually less than 3 years, presenting with pyrexia, malaise, rashes and 
polyarthritis. Other feature are as follows: 
Lymphadenitis 
Hepatosplenomegaly 
By puberty, stunting of growth occurs 
2. Polyarticular type:  
This involves the joints of the hands and feet. Temporomandibular joints and the 
cervical spine are typically involved. 
3. Pauciarticular type: 
This involves less than four joints, usually the large joints. This is the commonest 
type. Usually, medium-sized and large joints are involved. 
Clinically, the orthopaedic manifestation includes stiffening of joints, premature 
closure and deformities of the joints. Treatment is in the same line as for the adult type. 
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3.7.PHARMACEUTICAL REVIEW 
3.7.1. SIDDHA ASPECT OF THE FORMULATION 
 
PILL (MATHIRAI) 
DEFINITION OF PILL 
 The raw drugs are triturated with the juices of leaves or kudineer.  They are rolled 
into different sizes of pills, dried and stored. 
 
RULES OF TRITURATION 
 The ingredients should be first purified and  powdered into a find powder and then 
maserated with the prescribed juices or liquid one after the other in their order.  Each time 
it must be grinded till it becomes waxy in consistency does not adhere to the fingers or 
mortar and pestle, lastly it must be made into pills as prescribed and dried in shade. 
 
ADDITION OF AROMATIC INGREDIENTS 
 Aromatic ingredients were added just before 24mins (1 naazhigai) of pill rolled 
from finely grounded paste.  The aromatic ingredients added pills should allowed to dry 
in shade and keep them in a tightly closed container. 
 
SIZE AND SHAPE 
 Usually round in shape, there fore it also called as ‘Urundai’.  But it may differ in 
some preparations.   e.g. Urai mathirai.  The size, shape and weight of the pills should be 
made as said in the literature evidence. 
 
SHELF LIFE 
 1 year 
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3.7.2. MODERN ASPECT OF THE FORMULATION  
DEFINITION OF PILLS (MATHIRAI): 
 A tablet is a pharmaceutical dosage form it otherwise called as caplet.  Medicinal 
tablets are called as “pills”.   Originally “pills” referred specifically to a soft mass rolled 
into a ball shape, rather than a compressed powder. 
 As per Indian pharmacopeia 2007 defined the tablets are solid dosage forms each 
containing a unit dose of one or more medicaments.  They are anticipated for oral route.  
A tablet consists an active medicament with excipients which are in powder form are 
compressed or pressed into a solid  dosage form.  About two third drugs prescribed are in 
solid dosage form and tablets include half of them. 
Classification 
 As per IP 2007 tablets are majorly classified into following categories (Indian 
pharmacopoeia 2007). 
1. Uncoated Tablets 
This type of tablets contains single layer or more than one layer tablet consisting 
of active ingredient with  the excipients, no additional cover is applied onto it after the 
compression. 
2. Coated tablets 
 Coated types of tablets have an additional coating layer on it after the tablet was 
compressed, the coating layer of tablets formed with sugar, gums, resins, inactive or 
insoluble fillers, plasticisers, polyhydric alcohols, waxes. 
3. Dispersible tablets 
 These are the film coated or uncoated tablets because a uniform dispersion when 
suspended in water. 
4. Effervescent Tablets 
 These type of tablets which are uncoated and are planned to be dissolved and 
produce an dispersion before they are administered the dissolution is achieved by the 
reaction between an organic acid and bicarbonate which produce Co2, thus produced Co2 
will disintegrate the tablet so which dissolves in the solution to produce an suspension 
which was rapidly absorbed. 
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5. Modified-release tablets 
 These types of tablets are the coated or uncoated tablets which are designed in 
such a way that the rate or location of the active ingredient released is modified.  It 
includes enteric coated tablets, prolong release tablet or delay release tablet. 
A. Enteric- coated tablets 
 These are also called as gastro resistant tablets as they resistant to the gastric 
juices; these are formulated by coating the tablet with anionic polymer of methylacrylic 
acid and their esters or by coating with cellulose acetyl pthylate.  Ex. Erythromycin, 
NSAIDS. 
B. Prolonged –release tablets 
 These types are otherwise called as sustain release tablets or extended release 
tablets was formulated in such a way that the active ingredient is released for a prolong 
duration of time and is available in systemic circulation  after administration. 
C. Delayed –release tablets. 
 This dosage form was planned to release the drug after some time delay or after 
the tablet has passed one part of the GIT into another.  All enteric coated tablets are type 
of delayed action tablet but all delayed action of tablets was not enteric or not intended to 
produce enteric action. 
6. Soluble tablets 
 These are coated or uncoated tablets which are planned to dissolve in water before 
they are administered. 
7.  Tablets for use in the mouth: 
 These are the tablet formulations which are planned to be show local action in the 
buccal cavity.  These include buccal tablet, sublingual tablets and troche or lozenges.  
Buccal tablets are placed in between the cheek and gingival.  Sublingual tablets are 
placed below the tongue. 
Eg : glyceryl trinitrate 
8.  Tablets for other routes of administration 
 These include implantable tablets and vaginal tablet.  These are inserted into the 
rectum or vagina for their local or systemic action. 
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4. MATERIALS AND METHODS 
4.1. PREPARATION OF THE DRUG 
 Karpoora Sinthamani Mathirai  has been selected from classical siddha literature 
Anuboga Vaithiya Navaneetham, Part – IV Page No.106 
 Ingredients of the test drug are Rasa karpooram, Sathikkai, Nervalam, Karuvelam 
pisin, Katrazhai saru. 
 
COLLECTION OF THE DRUG 
 The raw drugs Rasa Karpooram, Sathikkai, Nervalam, Karuvelam pisin were 
purchased from authorized drug store in Nagercoil at Kanyakumari district. 
 
IDENTIFICATION AND AUTHENTICATION OF DRUGS : 
 The raw materials were identified and authenticated by the experts of PG 
Gunapadam Dept, Government Siddha Medical College, Tirunelveli. 
 The identified raw materials were conserved in the laboratory of PG Gunapadam, 
Government Siddha Medical College, Tirunelveli. 
 
INGREDIENTS: 
1. Purified Rasa Karpooram (Hydragyrum subchloride) - 17 1/2 gram (5 Varakan) 
2. Sathikkai (Myristica fragrans. Houtt)   - 17 1/2 gram (5 varakan) 
3. Nervalam (Croton tiglium. Linn)    - 35 gram (10 varakan) 
4. Karuvelam Pisin (Gum of Acacia arabica. Linn) - 3 1/2 gram (1 varakan)  
5. Aloe Vera Juice (Aloe barbadensis. Linn) - Quantity sufficient 
 
PURIFICATION OF DRUGS: 
1) Rasa Karpooram (Hg2cl2)  
 The Poultice made of betel leaf (piper betle) and pepper (piper nigrum) each 8.75 
gm is taken and dissolved in 1.3 litre of water, 35gm of calomel is tied with a cloth and 
immersed in the liquid from the cross bar and boiled. After the water is reduced to 3/4 of 
its volume. The calomel is taken out, washed with water and dried, to get it in purified 
form. 
 
2) Sathikkai: (Myristica fragrans) 
 Scrap the outer skin and roast it in ghee  
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3. Nervalam : (Croton tiglium) 
 Croton seeds are allowed to boiled in cow dung milk then remove the outer 
coating and leaf like cotyledones with sheath like substance from inside.  Then it is boiled 
in cow’s milk.  Then soaked in lime juice for 24 hours.  The croton embryo dried and 
roasted in cow’s ghee. 
4) Karuvelam Pisin: (Gum of Acacia arabica) 
 The gum is dissolved in water, filtered and then dried in sunlight. 
 
PROCESS OF PREPARATION: 
 All the above purified ingredients are powdered separately. Powder of Rasa 
Karpooram (Calomel), the powder of Myrstica fragrans and embryo of croton tiglium 
triturated well in a butter form. Then juice of aloe vera is added at small intervals grind it 
for a 6 hours. Finally add the gum of acacia Arabica powder and made in to pill upto size 
of Kundrimani and then stored in the air tight container. 
 
DOSAGE: 
 1/2 to 1 pill 
 
ADJUVENTS: 
 Sugar, Jaggery, Ghee 
 
INDICATION: 
 All type of Suram, Keel vaayu, Mudaku Vaayu, Soolai. 
 
SHELF LIFE : 
 1 Year  
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Ingredients of Karpoora Sinthamani Mathirai 
BEFORE PURIFICATION 
 
Nervalam 
 
Karuvelam pisin 
 
Pooram 
 
Sathikkai 
 
Katrazhai 
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 Ingredients of Karpoora Sinthamani Mathirai 
AFTER PURIFICATION 
 
 
Nervalam 
 
Karuvelam pisin 
 
Pooram 
 
Sathikkai 
 
Katrazhai Saru 
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Drug : KARPOORA SINTHAMANI MATHIRAI 
 
  
 KARPOORA SINTHAMANI MATHIRAI  
On Processing 
Prepared Drug  - Karpoora Sinthamani Mathirai 
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4.2. STANDARDIZATION OF THE DRUG: 
  The standardization of the drug is essential to exhibit the purity, quality and 
quantity of the drug. This is basically done by chemical, physico-chemical and 
instrumental analysis. 
 
4.2.1. PHYSICAL ANALYSIS 
TESTING PHYSICAL CHARACTERIZATION OF SAMPLE: 
 
Colour Examination:  
  Ten tablets were taken into watch glasses and positioned against white back 
ground in white tube light. Its colour was observed by naked eye and note in results. 
 
Odour examination: 
 Ten numbers of tablets were smelled individually. The time interval among two 
smelling was kept two minutes to overturn the effect of previous smelling. Odour of 
KARPOORA SINTHAMANI  MATHIRAI.  tablet was noted in results table.  
 
Size examination: 
 The diameter of ten tablets was measured by Vernier caliper. The mean value of 
diameter was noted. (Lohar DR-Protocol for testing ASU drugs) 
 
Weight Variation Test:  
 It was carried out to make sure that, each number of tablets contains the proper 
amount of drug. The test was carried out by weighing the 20 tablets individually using 
analytical balance, then the average weight was calculated, and comparing the individual 
tablet weights to the average. (Sukalyan Sengupta 1988) 
 
  The percentage of weight variation is calculated by using this formula.  
% of wt. variation =    Individual wt. – Average wt.  x 100 
   Average wt. 
 
Table. 1         Weight Variation limits  of Tablets (IP) 
Average weight   of tablets Maximum percentage of weight  difference  allowed 
80mg or less + 10.0 
Between 80mg and 250mg + 7.5 
250mg and more + 5.0 
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Accepted tablet:  
 Weight Variation limits of the sample not more than two tablets are outside the 
percentage limit and no tablet differs by more than two times the percentage limit 
according to the above table. 
 
Suspected tablet:  
 Suspected tablet variation was not more than six tablets are outside the percentage 
limit and no tablet differs by more than two times the percentage limit according to the 
table. 
 
Rejected tablets:  
 When a tablet weight variation test results showed rejected tablets mean in that 
test sample one tablet differs by more than two times the percentage limit according to the 
table or More than six tablets are outside the percentage limit. (Sukalyan Sengupta, 1988) 
 
Solubility:  
 A pinch of the sample was taken in a dry test tube and shaken well with distilled 
water.  A little amount of the sample is shaken well with con HCl and then Con.H2SO4. 
Test sample Solubility was observed.  
 
pH Value: 
 Potentiometrically pH value was determined by a glass electrode and a suitable 
pH meter. The pH of the KARPOORA SINTHAMANI  MATHIRAI tablet was written in 
results column. 
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4.2.2. PHYSICO CHEMICAL ANALYSIS 
1. LOSS ON DRYING (INDIAN PHARMOCOEPIA, 1996) 
               Loss on drying is the loss in percentage w/w resulting from water and volatile 
matter of any kind that can be driven off under a specified condition. A glass stopper, 
shallow weighing bottle was weighed accurately and the quantity of the sample as 
specified was transferred to the bottle was weighed accurately and the quantity of the 
sample as specified was transferred to the bottle covered and weighed. The sample was 
distributed evenly and the bottle was placed in the drying chamber. The sample was then 
dried for a specific period of time, and the bottle was removed from the chamber and 
allowed to cool at room temperature in a desiccators before weighing. 
 
2. TOTAL ASH: 
       Two grams of ground air dried powder of KARPOORA SINTHAMANI  MATHIRAI  
was accurately weighed in a previously ignited and tared silica crucible. The drug was 
gradually ignited by raising the temperature to 450oC until it was white. The sample was 
cooled in a desiccators and weighed. The percentage of total ash was calculated with 
reference to air-dried drug. 
a)Acid insoluble ash 
              The ash was boiled with 25ml of 2M hydrochloric acid for 5 minutes, the 
insoluble matter was collected on an ash less filter paper, washed with hot water, ignited 
cooled in a desiccators, and weighed. The percentage of acid insoluble ash calculated 
with reference to the air-dried drug. 
b)Water soluble extractive 
               Proceed as directed for the determination of Alcohol-soluble extractive , using 
chloroform water instead of ethanol. 
c)Alcohol soluble extractive 
                Macerate 5g of the air dried drug, coarsely powdered, with 100 ml of alcohol of 
the specified strength in a closed flask for 24 hrs, shaking frequently during six hours and 
allowing to stand for eighteen hours. Filter rapidly, taking precautions against loss of 
solvent, evaporate 25 ml of the filtrate to dryness in a tared flat bottomed shallow dish, 
and dry at 105o to constant weight. Calculate the percentage of alcohol-soluble extractive 
with reference to the air-dried drug. 
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3. TABLET DISINTEGRATION TEST:  
 Each KARPOORA SINTHAMANI  MATHIRAI tablet was placed in each of the six 
tubes of the basket present in the disintegration apparatus. The apparatus was operated by 
using water as the immersion fluid maintained at 35-39 °C. At the end of the 30 min, the 
basket is lifted from the fluid and the state of the tablet is observed. The disintegration 
time of Karpoora Sinthamani  Mathirai was recorded.(Loher Dr). 
 
MICROBIAL LIMIT TEST OF KARPOORA SINTHAMANI MATHIRAI  
Evaluation of Total Aerobic Bacterial Count 
1.1. Preparation of  Sample for Experimental Work 
  Weighed 10 gm of the homogenized drug sample aseptically and dissolved in 10 
ml of sterile water and made up to 100 ml with the sterile water. The insoluble drug 
product was suspended in 100 ml of buffered sodium chloride-peptone solution (pH 7.0).   
1.2. Serial dilution of Sample 
 A serial dilution is the dilution of a sample, in 10-fold dilutions. From the sample, 1 ml 
of the sample was added to 9 ml of sterile distilled water and mixed it well. This dilution 
was denoted as 10-1 dilution. From this dilution, 1ml was taken from that mixture is added 
to 9 ml, and designated as 10-2 dilution. The same procedure was repeated up to    10-4. 
1.3. Isolation of Total Viable Aerobic Microbial Count 
1.3.1. Isolation of Bacteria by Plate Count Method 
 In this test, the bacteria in sample were made to grow as colonies, by inoculating a 
known volume of sample into a solidifiable nutrient medium (Casein Soybean Digest agar 
or Nutrient agar medium) in petridish. The agar plate was prepared by mixing growth 
medium with agar and then sterilized by autoclaving. Once the agar was cooled to 45oC, 
approximately 15 to 20 ml of medium was poured into a sterile Petri dish under aseptic 
condition and left to solidify for 15 minutes. After solidification, each plate was smear 
with 0.1 ml of sample from the dilution of 10-1 and 10-2. After inoculations, all the plates 
were incubated at 37oC for 24 hours. After incubation, the bacterial colonies were 
developed as visible to the naked eye and the number of colonies on a plate was counted 
using Quebec Colony Counter. Plates with an average of from 30 to 300 colonies of the 
target bacterium were selected for colony count. Because of the statistical problems, 
plates with lower than 30 colonies greater than 300 colonies were rejected     
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1.3.1.1. Composition of Nutrient Agar Media 
Peptone   : 5.0 gm  
Sodium chloride  : 5.0 gm  
Beef extract   : 1.5 gm 
 Yeast extract   : 1.5 gm 
Agar    : 15.0 gm 
Distilled water   : 1000 ml  
 pH ( at 25°C)   : 7.4±0.2 
 
1.3.2. Isolation of Fungi 
  From each of the above prepared samples, 0.1 ml of sample was transferred to 
Sabouraud Dextrose agar (SDA) prepared with Chloramphenicol. The plates were then 
incubated for 5 days at room temperature (20 to 25°C). After incubation, the fungal 
colonies were observed and calculated.   
 
1.3.2.1. Composition of SDA 
Dextrose   ; 40 gm 
Peptone   : 10 gm 
Agar   : 15 gm 
Distilled water : 1000 ml 
 
1.4. Evaluation of Antimicrobial Activity of Drug 
  Antimicrobial activity was performed by agar well diffusion method on agar. 
 
1.4.1 Preparation of drug extracts solutions for the experiment  
  The dried drugs were weighed and dissolved in sterile distilled water to prepare 
appropriate dilution to get required concentrations of about 10, 20 and 30µg/ml. They 
were kept under refrigerated condition unless they were used for the experiment. 
 
1.4.2. Procedure for the Agar Well Diffusion Test 
   The antibacterial screening of the drugs were carried out by determining the zone 
of inhibition using agar well diffusion method. All the drug extracts were tested against 
four pathogenic bacterial strains of gram positive and gram negative organism by agar 
well diffusion method. 
 
                                                                                                                             
 
   66 PRE CLINICAL  STUDY OF  KARPOORA  SINTHAMANI  MATHIRAI 
 
1.4.3. Bacterial Inoculums Preparation 
 Inoculums of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus 
vulgaris, and Bacillus substilis were prepared in nutrient broth medium and kept for 
incubation at 37°C for 8 hrs. 
 
1.4.4. Agar well-diffusion method  
  This method was followed to determine the antimicrobial activity. Muller-Hinton 
Agar media plates were swabbed (sterile cotton swabs) with 8 hour old - broth culture of 
respective bacteria. After inoculation, wells with the size of 10 mm diameter and about 2 
cm a part were made in each of these plates using sterile cork borer. Stock solution of 
each drug extract was prepared at a concentration of 1 mg/ml in water. About 100 µl of 
different concentrations of drug solvent extracts were added into the wells and allowed to 
diffuse at room temperature for 2 hrs. The plates were incubated at 37°C for 24 hrs. After 
incubation, the diameter of the inhibition zone (mm) was measured and the activity index 
was also calculated.  
 
1.4.4.1. Composition of Muller Hinton Agar Media 
 Beef Extract     : 02.00 gm 
 Acid Hydrolysate of Casein   : 17.50 gm 
 Starch      : 01.50 gm 
 Agar     : 17.00 gm 
 
1.5. Evaluation of Specified Microorganisms  
1.5.1. Isolation & Identification of Escherichia coli 
  One ml of the prepared sample was added in a sterile screw-capped container 
containing 50 ml of nutrient broth and mixed well. Then, it was allowed to stand for 1 
hour and mixed well again. After one hour, the screw caps of the bottle was loosened and 
incubated at 37º for 18 to 24 hours. 
 
1.5.1.2. Primary Test 
  From the above prepared enrichment culture, 1.0 ml was taken and transferred 
aseptically into a tube containing 5 ml of Mac- Conkey broth. Inoculated tubes were 
incubated in a water-bath at 36º to 38º for 48 hours.  
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1.5.1.3. Secondary Test 
  From the primary test, 1.0 ml of the enrichment culture was taken and transferred 
aseptically in to 5 ml of peptone water. It was then incubated in a water-bath at 43.5º to 
44.5º C for 24 hours and observed the tubes for acid and gas. Then, the culture was 
subjected to biochemical tests of imvic and the results were observed and correlated.       
 
1.5.1.4. Alternative test  
  It was done by a loop full of enriched culture in the primary test was streaked on a 
sterile Mac-Conkey agar medium. Then, the plates were inverted and incubated at 37 º C 
for 24 hours. After incubation, the pink or brick red color colonies were examined and 
transfer them individually into the surface of Eosin Methylene Blue agar medium (EMB), 
on Petri dishes. Inoculated plates were inverted and incubated at 37 º C for 24 hours. 
After incubation, the colonies on medium were checked for their color appearance like 
green metallic sheen under reflected light. The colonies were subjected to confirmation 
by further suitable cultural and biochemical tests. 
 
1.5.1.5. Components of Eosin Methylene Blue Agar Media 
Pancreatic digest of gelatin   : 10.0 g 
Dibasic potassium phosphate   : 2.0 g 
Lactose      : 10.0 g 
Eosin Y      : 400 mg 
Methylene blue    : 65 mg 
Agar       : 15.0 g 
Distilled water     : 1000 ml 
 
1.5.2. Isolation & Identification of Salmonella sp.  
  One ml of the prepared sample was added in a sterile screw-capped container 
containing 100 ml of nutrient broth and mixed well. Then, it was allowed to stand for 1 
hour and mixed well again. After one hour, the screw caps of the bottle was loosened and 
incubated at 37º for 18 to 24 hours. 
 
1.5.2.1. Primary Test  
  From the above prepared enrichment culture, 1.0 ml was taken and transferred 
aseptically into a tube containing 10 ml of Selenite F broth. Inoculated tubes were 
incubated in a water-bath at 36º to 38º for 48 hours. After incubation, the culture was 
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subcultured on two of the agar media namely Bismuth sulphate agar and Deoxy cholate 
citrate agar and incubated the plates at 36º to 38º for 18 to 24 hours. After incubation, 
colonies were observed on the medium and confirmed the genus Salmonella based on 
guidelines. 
 
1.5.2.2. Secondary test 
  The suspected colonies of the primary test were subcultured on the slant of triple 
sugar-iron agar in test tube and in urea broth. Both media were incubated at 37ºC for 24 
hours. After incubation, the results were observed according to the development of color 
change and acid / gas in media.  The presence of Salmonella was confirmed by 
agglutination tests. 
 
1.5.2.3. Composition of Salmonella Shigella Agar Media 
Beef Extract     : 5.0 gm 
Enzymatic Digest of Casein   : 2.5 g 
Enzymatic Digest of Animal Tissue  : 2.5 gm 
Lactose     : 10 gm 
Bile salts     : 8.5 gm 
Sodium Citrate     : 8.5 gm 
Ferric Citrate     : 1.0 gm 
Brilliant Green    : 0.00033 gm 
Neutral Red     : 0.025 
Agar      : 13.5 gm 
Distilled water     : 1000 ml 
  
1.5.3. Isolation and Identification of Pseudomonas aeruginosa  
  From the above prepared enrichment culture, 1.0 ml was taken and transferred 
aseptically into 100 ml of fluid soyabean-casein digest medium and mixed well.  The 
inoculated tubes were incubated at 37º C for 24 hours. After incubation, the growth of 
bacteria was checked. From this, a loop full of culture was streaked on the surface of 
Cetrimide agar medium and Pseudomonas Isolation Agar medium and incubated at 
incubated at 37º C for 24 hours. After incubation, the colonies from the agar surface of 
these two media were checked for detection of fluorescein and pyocyanin. 
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1.5.3.1. Composition of Cetrimide Agar Media 
Pancreatic digest of gelatin   : 20.0 g 
Magnesium chloride    : 1.4 g 
Potassium sulphate    : 10.0 g 
Cetrimide     : 0.3 g 
Agar      : 13.6 g 
Glycerin     : 10.0 g 
Distilled Water t   : 1000 ml 
 
1.5.4. Isolation and Identification of Staphylococcus aureus 
  From the above prepared enrichment culture, a loop full of culture was taken and 
transferred aseptically on Mannitol salt agar and incubated at 37º C for 24 hours.. After 
incubation, the colonies were subjected to confirmation by hem agglutination test.  
 
1.5.4.1. Composition of Mannitol Salt Agar Media 
Pancreatic digest of gelatin   : 5.0 g 
Peptic digest of animal tissue  : 5.0 g 
Beef extract     : 1.0 g 
D-Mannitol     : 10.0 g 
Sodium chloride    : 75.0 g 
Agar      : 15.0 g 
Phenol red     : 25 mg 
Distilled Water    : 1000 ml 
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4.2.3. BIO CHEMICAL ANALYSIS 
PROCEDURE: 
  5gms of  the drug was wighted accurately and placed in a 250ml clean beaker. 
Then 50ml of distilled water is added and dissolved well. Then it is boilded well for about 
10 minutes. It is cooled and filtered in a 100ml volumetric flask and then it is make up to 
100ml with distilled water. This fluid is taken for analysis. 
 
QUALITATIVE ANALYSIS FOR BASIC RADICALS: 
Test for Calcium: 
 2ml of the above prepared extract is taken in a clean test tube. To this add 2ml of 
4% Ammonium oxalate solution. Formation of white precipitate indicates the presence of 
calcium. 
 
Test for Iron (Ferric): 
The extract is acidified with glacial acetic acid and potassium ferro 
cyanide.absence of blue colour indicates the absence of ferric iron. 
 
 
Test for Iron (Ferrous): 
 The extract is treated with concentrated Nitric acid and ammonium thio-cyanate 
solution. Formation of blood red colour indicates the presence of ferrous iron. 
 
Test for zinc: 
The extract is treated with potassium ferro-cyanide. Gives absence of white 
precipitate indicates the absence of zinc. 
 
QUALITATIVE ANALYSIS FOR ACIDIC RADICALS: 
Test for Sulphate: 
 2ml of extract is added to 5% barium chloride solution. Formation of white 
precipitate indicates the presence of sulphate. 
 
Test for Chloride: 
 The extract is treated with silver nitrate solution. Formation of white precipitate 
indicates the presence of chloride. 
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Test for Phosphate: 
 The extract is treated with ammonium molybdate and concentrated nitric acid. 
Formation of yellow precipitate indicates the presence of phosphate. 
 
Test for carbonate: 
On treating the extract with concentrated Hydrochloric acid giving absence of 
brisk effervescence indicates the absence of carbonate. 
 
Test for starch: 
 The extract is added with weak iodine solution. Formation of blue colour indicates 
the presence of starch. 
 
Test for albumin: 
The extract is treated with Esbach’s reagent. Gives absence of formation of yellow 
precipitate indicates the absence of albumin. 
 
Test for tannic acid: 
The extract is treated with ferric chloride.Gives absence of formation of bluish 
black precipitate indicates the absence of tannic acid. 
Test for unsaturation: 
 The extract is treated with potassium permanganate solution. The dis-
colourization of potassium permanganate indicates the presence of unsaturated 
compounds. 
 
Test for the reducing sugar: 
 5ml of Benedict`s qualitative solution is taken in a test tube and allowed to boil 
for 2 minutes and added 8-10 drops of the extract and again boil it for 2 minutes. Any 
colour change indicates the presence of reducing sugar. 
 
Test for amino acid: 
 One or two drops of the extract is placed on a filter paper and dried it well. After 
drying, 1% Ninhydrin is sprayed over the same and dried it well. Formation of violet 
colour indicates the presence of amino acid. 
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4.2.4. PHYTOCHEMICAL ANALYSIS OF KARPOORA SINTHAMANI  
MATHIRAI 
The siddha preparation KARPOORA SINTHAMANI  MATHIRAI was prepared and 
used for phytochemical analysis.  Preliminary test, on the siddha preparation KARPOORA 
SINTHAMANI  MATHIRAI was carried out for the presence of alkaloids, carbohydrates, 
glycosides, phytosterols, saponins, tannins, phenolic compounds, proteins and free amino 
acids, flavanoids, lignin, fixed oils and fats. The methods adopted for the estimation are 
as follows: 
Test for Alkaloids (Evans, 1997)  
A small segment of the siddha preparation KARPOORA SINTHAMANI  
MATHIRAI was mixed separately with a few drops of dilute hydrochloric acid and 
filtered. The filtrates were tested carefully with various alkaloidal reagents as follows:  
 
a) Mayer’s test (Evans, 1997):  
  To a few ml of filtrate, a drop of Mayer’s reagent is added by the side of the test 
tube. A white or creamy precipitate indicates that the test as positive.  
 
b) Hager’s test (Wagner et al., 1996):  
  To a few ml of filtrate, one to 2ml of Hager’s reagent is added. A prominent 
yellow precipitate indicates the test as positive.  
 
c) Dragendorff’s test (Waldi, 1965):  
  To a few ml of filtrate, one to 2ml of Dragendorff’s reagent is added. A prominent 
yellow precipitate indicates the test as positive.  
 
Test for Carbohydrates (Ramakrishnan et al., 1994)  
A small quantity of siddha preparation KARPOORA SINTHAMANI  MATHIRAI 
was dissolved separately in 5ml of distilled water and filtered. The filtrate was subjected 
to Molisch’s test to detect the presence of carbohydrates. Filtrate was treated with 2-3 
drops of 1% alcoholic alpha naphthol solution and 2ml of concentrated sulphuric acid was 
added along the sides of the test tube. Appearance of brown ring at the junction of 2 
layers shows the presence of carbohydrates. 
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Test for Glycosides  
The siddha preparation KARPOORA SINTHAMANI  MATHIRAI was hydrolyzed 
with hydrochloric acid for few h on a water bath and the hydrolysate was subjected to 
Legal’s and Borntrager’s test to detect the presence of different glycosides.  
 
(a) Legal’s Test:  
  To the hydrolysate, one ml of pyridine and few drops of sodium nitro prusside 
solution were added and then it was made alkaline with sodium hydroxide solution. 
Appearance of pink to red color shows the presence of glycosides and aglycones.  
 
(b) Borntrager’s Test: 
  Hydrolysate was treated with chloroform and the chloroform layer was separated. 
To this equal quantity of dilute ammonia solution was added. Ammoniacal layer acquires 
pink color, shows the presence of glycosides (Evans, 1997).  
 
Test for Phytosterols (Finar, 1986)  
(a) Liebermann Burchard Test:  
  Small amount of the siddha preparation KARPOORA SINTHAMANI  MATHIRAI 
was dissolved with 3ml of acetic anhydride, a few drops of glacial acetic acid and 
followed by the addition of few drops of concentrated sulphuric acid. Appearance of 
bluish green color shows the presence of phytosterols.  
 
(b) Salkowski Test:  
  Small quantities of the siddha preparation KARPOORA SINTHAMANI  
MATHIRAI were dissolved in chloroform separately. This chloroform solution was added 
with few drops of concentrated sulphuric acid. The appearance of bluish green color 
shows the presence of phytosterols.  
 
Test for Flavanoids  
(a) Shinoda’s Test:  
  Small quantity of siddha preparation KARPOORA SINTHAMANI  MATHIRAI  
was treated with alcohol to that a piece of magnesium was added followed by an addition 
of concentrated hydrochloric acid drop wise and heated. Appearance of magenta color 
shows the presence of flavanoids (Harborne, 1984).  
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(b) Florescence Test: Small quantity of KARPOORA SINTHAMANI  MATHIRAI  was 
dissolved separately in alcohol and a drop of that extract was placed on Whatman filter 
paper and observed under UV light. Florescence indicates the presence of flavanoids.  
 
Test for Tannins (Mace, 1963)  
Small quantities of siddha preparation KARPOORA SINTHAMANI  MATHIRAI 
was dissolved separately in water and tested for the presence of phenolic compound and 
tannins. In the process of testing and treating, the following observations were noted:  
a) Dilute ferric chloride solution (5%) gives a dark green color. 38  
b) 10% aqueous potassium dichromate solution gives yellowish brown precipitate.  
c) 10% lead acetate solution gives a white precipitate.  
 
Test for Proteins and Free Amino Acids (Fisher, 1968; Ruthmann, 1970)  
Small quantities of various siddha preparation KARPOORA SINTHAMANI  
MATHIRAI  was dissolved in few ml of water and the following reaction were carried out  
 
(a) Millon’s Test : To 2ml of filtrate, few drops of Millon’s reagent were added. A white 
precipitate indicates the presence of proteins (Rasch and Swift, 1960).  
 
(b) Ninhydrin Test: To 2ml of filtrate 2 drops of ninhydrin solution was added. A 
characteristic purple color indicates the presence of amino acids (Yasma and Ichikawa, 
1953).  
 
(c) Biuret Test: An aliquot of 2ml of filtrate was treated with a drop of 2% copper 
sulphate solution. To this, 1ml of ethanol (95%) was added, followed by excess of 
potassium hydroxide pellets, Pink color in the ethanol layer indicates the presence of 
protein (Gahan, 1984).  
 
Tests for Fixed oils and Fats  
(a) Spot Test:  
  A small quantity of siddha preparation KARPOORA SINTHAMANI  MATHIRAI  
was placed between 2 filter papers. Oil stains produced with any extract shows the 
presence of fats and fixed oils in the KARPOORA SINTHAMANI  MATHIRAI  (Harborne, 
1984).  
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 (b) Saponification Test:  
  A small quantity of siddha preparation KARPOORA SINTHAMANI  MATHIRAI  
was treated with few drops of 0.5N alcoholic potassium hydroxide along with 2 to 3 drops 
of phenolphthalein. Later the mixture is refluxed for about 2h. Soap formation indicates 
the presence of fats and fixed oils in the KARPOORA SINTHAMANI  MATHIRAI . 
 
Tests for Lignin  
Small quantities of KARPOORA SINTHAMANI  MATHIRAI  was dissolved 
separately in few ml of alcoholic solution of hydrochloric acid and phloroglucinol gives 
red color, which shows lignin is present.  
 
Test for Saponins (Kokate, 1999)  
Frothing Test:  
 The siddha preparation KARPOORA SINTHAMANI  MATHIRAI  was diluted 
separately with 20ml of distilled water and it was agitated on a graduated cylinder for 
15min. Absence of the foam formation shows the devoid of saponins.  
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4.2.5. INSTRUMENTAL ANALYSIS 
Fig. No. 1   SCANNING ELECTRON MICROSCOPE (SEM) 
 
  The microstructure of the powders was examined using a Hitachi S 3000H 
scanning electron microscope  
Introduction: 
  The scanning Electron Microscope is one of the most versatile instruments 
available for the examination and analysis of the micro structural characteristics of solid 
objects. The primary reason for the SEM’s usefulness is the high resolution which can be 
obtained when bulk objects are examined; values of the order of 5nm (50degreeA) are 
usually quoted for commercial instruments. Advanced research instruments have been 
described which have achieved resolutions of about 2.5nm (25 degree A). Any solid 
material can be studied. Sample size is limited to specimens less than about 10µm in 
diameter 
 
Principle:  
  The beam is then rastered over the specimen in synchronism with the beam of a 
cathode ray tube display screen. The eleastically scattered secondary electrons are emitted 
from the sample surface and collected by a scintillator, the signal from which is used to 
modulate the brightness of the cathode ray tube. In this way the secondary electron 
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emission from the sample is used to form an image on the CRT display screen. 
(Goldstein, et. al., 1992) 
 
SEM MECHANISM 
Procedure: 
  An electron beam passing through an evacuated column is focused by 
electromagnetic lenses onto the specimen surface. Since an electron is a charged particle, 
it has a strong interaction with the specimen (due to coulomb interaction).So when an 
electron beam images on a specimen, it is scattered by atomic layers near the surface of 
the specimen. As a result, the direction of electron motion changes and its energy is 
partially lost. Once an incident electron (primary electron) enters a substance, its direction 
of motion is influenced by various obstructions (multiple scattering), and follows a 
complicated trajectory which is far from a straight line. Also, when electrons with the 
same energy are incident on the specimen surface, a portion of electrons is reflected in the 
opposite direction (back scattered) and the remainder is absorbed by the specimen 
(exciting X- rays or other quanta in the process). If the specimen issufficiently thin, the 
electron can pass all the way through the specimen (transmitted electrons, scattered or 
non-scattered). 
 
  The depth at which various signals are generated due to electron beam – specimen 
interaction indicates the diffusion area of the signals in the specimen in addition to the 
local chemistry of the specimen. Secondary electrons mainly indicate information about 
the surface of a specimen. Since secondary electrons do not diffuse much inside the 
specimen, they are most suitable for observing the fine-structures of the specimen surface. 
That is to say, sharp scanning images with high resolution can be expected from 
secondary electrons, because of the smaller influence on resolution by their diffusion.  
 
  As the incident electron energy increases, the probability of incident electrons 
Colliding with elemental components of the specimen and releasing secondary electrons 
also increases. In other words, as the incident energy increases, the emission of electrons 
from the specimen also increases. However, as the energy increases beyond a certain 
level, the incident electrons penetrate deeper into the specimen with the result that the 
specimen derived electrons use up most of their energy to reach the specimen surface. 
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Consequently, the electron emission yield decreases. Therefore, the peak secondary 
electron emission yield occurs at a specific entry level of the incident electrons. 
 
  In order to verify the existence of a substance and recognize its shape, the image 
contrast must be well defined. In other words, even if a system boasts extremely high 
resolution, if image contrast is poor, it would be extremely difficult to determine the 
existence of a substance, let alone recognize its shape. Another important feature of the 
SEM is the three-dimensional appearance of the specimen image, which is a direct result 
of the large depth of field.  
 
Applications: 
  The SEM is capable of examining objects at very low magnification. This feature 
is useful in viewing particle size and shape of any composition at various stages of 
preparation in Siddha system as well as other fields.The large depth of field available in 
the SEM makes it possible to observe 3-dimensional objects in stereo. Today, a majority 
of SEM facilities are equipped with X-ray analytical capabilities. Thus topographic 
crystallographic and compositional information can be obtained rapidly, efficiently and 
simultaneously from the same area. 
 
  The author was chosen this analysis for detecting Particle size of the classical 
Siddha herbo-mineral drug KARPOORA SINTHAMANI  MATHIRAI. SEM results of 
KARPOORA SINTHAMANI  MATHIRAI were represented in results section. 
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Fig. No. 2 FOURIER TRANSFORM-INFRA RED SPECTROSCOPY       
(FT-IR) 
 
 
 
Introduction: 
  Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular structure .The spectral bands can be assigned to different vibrational modes of 
the molecule. The various functional groups present in the molecule can be assigned by a 
comparison of the spectra with characteristic functional group frequencies. As the 
positions of the bands are directly related to the strength of the chemical bond, a large 
number of investigations including intermolecular interactions, phase transitions and 
chemical kinetics can be carried out using this branch of spectroscopy. In IR 
spectroscopy, the resonance absorption is made possible by the change in dipole moment 
accompanying the vibrational transition. The Infrared spectrum originates from the 
vibrational motion of the molecule. The vibrational frequencies are a kind of fingerprint 
of the compounds. This property is used for characterization of organic, inorganic and 
biological compounds. The band intensities are proportional to the concentration of the 
compound and hence qualitative estimations are possible. The IR spectroscopy is carried 
out by using Fourier transform technique.  
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Principle: 
  Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation characteristic of 
the interacting system may be absorbed (or emitted). The experimental data consist of the 
nature (frequency of wave length) and the amount (intensity) of the characteristic 
radiation absorbed or emitted. These data are correlated with the molecular and electronic 
structure of the substance and with intra- and inter molecular interactions. 
Source   : Nernst Glower 
Beam splitter  :  It is made up of a transparent material. Thin  
films of  Silicondepositedon  Potassium bromide  
(KBr) Bromide (KBr) Detectors:  DeutratedTriGlycine Sulphate (DTGS). 
Scan Range  :  MIR 450to 4000 cm-1 
Resolution  :   4.0 cm-1 
Sample required : 50mg, solid or liquid 
Sampling Techniques: There are a variety of techniques for sample  
preparation physical form of the sample to be  
analyzed. 
Solid   : KBr or Nujol mull method. 
Liquid   : Csl / TIBr Cells 
Gas   : Gas cells 
 
Measurements Techniques: 
The procedure for recording the %T or %A is as follows: 
1. Air is first scanned for the reference and stored. The sample is then recorded 
and finally the ratio of the sample and reference data is computed to give 
required  % T  or % A at various frequencies. 
2. Study of substances with strong absorbance bands and weak absorbance bands 
aswell as possible. 
3. Small amount of samples are sufficient 
4. High resolution is obtained. 
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Procedure: 
  Typically,1.5 mg of protein, dissolved in the buffer used for its purification, were 
centrifuged in a 30 K Centric on micro concentrator (Amicon) at 3000_g at 4oC until a 
volume of approximately 40 Al. 
1. Then, 300 Al of 20 mM buffer, prepared in H20 or 2H20, pH or p2H 7.2, were 
added and the sample concentrated again. The p2H value corresponds to the pH 
meter reading + 0.4. The concentration and dilution procedure was repeated 
several times in order to completely replace the original buffer with the This 
buffer. 
2. The washings took 24 h, which is the time of contact of the protein with the 
2H20medium prior FT-IR analysis. In the last washing, the protein was 
concentrated to fine a volume of approximately 40 Al and used for the infrared 
measurements.The concentrated protein sample was placed in CaF2 windows and 
a 6 Am tin spacer or a 25 Am Teflon spacer for the experiments in H20 or 2H20, 
respectively. FT-IR spectra were recorded by means of a Perkin-Elmer -Spectrum-
1 FT-IR spectrometer using a deuteratedtriglycinesulfate detector. 
3. At least 24 h before, and during data acquisition, the spectrometer were 
continuously purged with dry air at a dew point of 40oC. Spectra of buffers and 
samples were acquired at 2 cm_1 resolution under the same scanning and 
temperature conditions. In the thermal denaturation experiments, the temperature 
was raised in 5oC steps from 20 to 95oC. 
4. Before spectrum acquisition, samples were maintained at the desired temperature 
for the time necessary for the stabilization of temperature inside the cell (6 
min).Spectra were collected and processed using the SPECTRUM software from 
Perkin-Elmer. Correct subtraction of H20 was judged to yield an approximately 
flat baseline at 1900-1400 cm_ 1, and subtraction of 2H20 was adjusted to the 
removal of the2H20 bending absorption close to 1220 cm_ 1 
 
KBr Method 
1. The sample is grounded using an agate mortar and pestle to give a very fine 
powder. 
2. The finely powder sample is then mixed with about 100mg dried KBr salt. 
3. The mixture is then pressed under hydraulic press using a die to yield a 
transparent disc and measure about 13mm diameter and 0.3mm in thickness. 
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Nujol Mull Method: 
1. The sample is ground using an agate mortar and pestle to give a very fine powder. 
2. A small amount is then mixed with nujol oil to give a paste and this paste is 
thenapplied between two sodium chloride plates. 
3. The plates are then placed in the instrument sample holder ready for scanning. 
 
Liquids: 
1. Viscous liquids can be smeared in the cell and directly measured. 
2. For dilute solutions, liquid cells and variable path length cells are employed. 
 
Applications: 
   Infrared spectrum is useful in identifying the functional groups like -OH, -CN, -
CO, -CH, -NH2, etc. Also quantitative estimation is possible in certain cases for 
chemicals, pharmaceuticals, petroleum products, etc. Resins from industries, water and 
rubber samples can be analyzed.  
 
 
 
Fig. No. 3 Mechanism of FTIR analyzer 
 
Analytical Capabilities: 
1. Identifies chemical bond functional groups by the absorption of infrared radiation 
which excites vibrational modes in the bond. 
2. Especially capable of identifying the chemical bonds of organic materials  
3. Detects and identifies organic contaminants. 
4. Identifies water, phosphates, sulphates, nitrates, nitrites, and ammonium ions  
5. Detection limits vary greatly, but are sometimes <1013 bonds/cm3 or sometimes 
sub monolayer .Useful with solids, liquids, or gases. 
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Fig. No. 4  INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY(ICP-OES): 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction: 
  Inductively coupled plasma optical emission spectrometry (ICP-OES) is an 
analytical technique used for the detection of trace metals. It is a type of emission 
spectroscopy that uses the inductively coupled plasma to produce excited atoms and ions 
that emit electromagnetic radiation at wavelengths characteristic of a particular element. 
The intensity of this emission is indicative of the concentration of the element within the 
sample. 
 
Mechanism: 
  The ICP-OES is composed of two parts:  ICP and the optical spectrometer. The 
ICP torch consists of 3 concentric quartz glass tubes. The output or “work” coil of the 
radiofrequency (RF) generator surrounds part of this quartz torch. Argon gas is typically 
used to create the plasma. 
  When the torch is turned on, an intense electromagnetic field is created within the 
coil by the high power radio frequency signal flowing in the coil. This RF signal is 
created by the RF generator which is, effectively, a high power radio transmitter driving 
the “workcoil” the same way a typical radio transmitter drives a transmitting antenna. The 
argon gas flowing through the torch is ignited with a Tesla unit that creates a brief 
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discharge are through the argon flow to initiate the ionization process. Once the plasma is 
“ignited”, the Tesla unit is turned off. 
  The argon gas is ionized in the intense electromagnetic field and flows in a 
particular rotationally symmetrical pattern towards the magnetic field of the RF coil. 
Stable, high temperature plasma of about 7000 K is then generated as the result of the 
inelastic collisions created between the neutral argon atoms and the charged particles.  A 
peristaltic pump delivers an aqueous or organic sample into a nebulizer where it is 
changed into mist and introduced directly inside the plasma flame. The sample 
immediately collides with the electrons and charged ions in the plasma and is itself 
broken down into charged ions. The various molecules break up into their respective 
atoms which then lose electrons and recombine repeatedly in the plasma, giving off 
radiation at the characteristic wavelengths of the elements involved. 
  Within the optical chamber(s), after the light is separated into its different 
wavelengths (colours), the light intensity is measured with a photomultiplier tube or tubes 
physically positioned to “view” the specific wavelength(s) for each element line involved, 
or, in more modern units, the separated colours fall upon an array of semiconductor photo 
detectors such as charge coupled devices (CCDs). In units using these detector arrays, the 
intensities of all wavelengths (within the system’s range) can be measured 
simultaneously, allowing the instrument to analyse for every element to which the unit is 
sensitive all at once. Thus, samples can be analysed very quickly. 
The intensity of each line is then compared to previously measured intensities ofknown 
concentrations of the elements and their concentrations are then computed by 
interpolation along the calibration lines. In addition, special software generally corrects 
for interferences caused by the presence of different elements within a given sample 
matrix.  
 
Applications : 
  ICP-OES is used in   the determination of metals, arsenic present in Traditional 
medicines, and trace elements bound to proteins. ICP-OES is widely used in minerals 
processing to provide the data on grades of various streams, for the construction of mass 
balances. 
  The author used it for elemental identification and quantitative compositional 
information of the KARPOORA SINTHAMANI  MATHIRAI. 
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X-RAY POWDER DIFFRACTION 
 (XRD) INSTRUMENTATION 
 X-ray diffractometers consist of three basic elements: an X-ray tube, a 
sample holder and an X-ray detector. 
 
 
Fig.No. 5 Bruker’s X-ray Diffraction D8-Discover instrument. 
 X-rays are generated in a cathode ray tube by heating a filament to produce 
electrons, accelerating the electrons towards a target by applying a voltage and 
bombarding the target material with electrons. When electrons have sufficient energy to 
dislodge inner shell electrons of the target material, characteristic X-ray spectra are 
produced. These spectra consist of several components, the most common being Kα and 
Kβ. Kα consists in part of Kα1 and Kα2. Kα1 has a slightly shorter wavelength and twice the 
intensity of Kα2. The specific wavelengths are characteristic of the target material (Cu, Fe, 
Mo, Cr). Filtering, by foils or crystal monochrometers, is required to produce 
monochromatic X-rays needed for diffraction. Kα1 and Kα2 are sufficiently close in 
wavelength such that a weighted average of the two is used. Copper is the most common 
target material for single-crystal diffraction, with CuKα radiation = 1.5148A0. These X-
rays are collimated and directed onto the sample. As the sample and detector are rotated, 
the intensity of the reflected X-rays is recorded. When the geometry of the incident X-
rays impinging the sample satisfies the Bragg Equation, constructive interference occurs 
and a peak in intensity occurs. A detector records and processes this X-ray signal and 
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converts the signal to a count rate which is then output to a device such as a printer or 
computer monitor. 
The geometry of an X-ray diffractometer is such that the sample rotates in the path 
of the collimated X-ray beam at an angle θ while the X-ray detector is mounted on an arm 
to collect the diffracted X-rays and rotates at an angle of 2θ. The instrument used to 
maintain the angle and rotate the sample is termed a goniometer. For typical powder 
patterns, data is collected at 2θ from -50 to 700, angles that are present in the X-ray scan. 
 
Applications: 
 X-ray powder diffraction is most widely used for the identification of unknown 
crystalline materials (e.g. minerals, inorganic compounds). Determination of unknown 
solids is critical to studies in geology, environmental science, material science, 
engineering and biology. 
 
Other applications include: 
1. Characterization of crystalline materials 
2. Identification of the fine-grained minerals such as clays and mixed layer clays that 
are difficult to determine optically. 
3. Determination of unit cell dimensions. 
4. Measurement of sample purity. 
 
With specialized techniques, XRD can be used to: 
1. Determine crystal structures using Rietveld refinement 
2. Determine of modal amounts of minerals (quantitative analysis) 
3. Make textural measurements such as the orientation of grains in a polycrystalline 
sample. 
 
Strengths and Limitations of X-ray Powder Diffraction: 
Strengths: 
1. Powerful and rapid (<20 min) technique for identification of an unknown 
minerals. 
2. In most cases, it provides an unambiguous mineral determination. 
3. Minimal sample preparation is required. 
4. XRD units are widely available. 
5. Data interpretation is relatively straight forward. 
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Limitations: 
1. Homogenous and single phase material is best for identification of an unknown 
2. Must have access to a standard reference file of inorganic compounds (d-spacings, 
hkls) 
3. Requires tenths of a gram of material which must be ground into a powder. 
4. Foe mixed materials, detection limit is -2% of sample. 
5. For unit cell determinations, indexing of patterns for non-isometric crystal 
systems is complicated. 
6. Peak overlay may occur and worsens for high angle ‘reflections’. 
 
User’s Guide-Sample Collection and Preparation: 
Determination of an unknown requires: the material, an instrument for grinding 
and a sample holder. 
1. Obtain a few tenths of a gram (or more) of the material, as pure as possible. 
2. Grind the sample to a fine powder, typically in a fluid to minimize inducing extra 
strain (surface energy) that can offset peak positions, and to randomize 
orientation. 
a. Powder less than -10 µm (or 200-mesh) in size is preferred. 
3. Place into a sample holder or onto the sample surface. 
a. Packing of the fine powder into a sample holder. Smear uniformly onto a 
glass slide, assuring a flat upper surface. 
4. Pack into a sample container 
5. Sprinkle on double sticky tape 
a. Typically the substance is amorphous to avoid interference 
6. Care must be taken to create a flat upper surface and to achieve a random 
distribution of lattice orientations unless creating an oriented smear. 
7. For unit cell determinations, a small amount of a standard with known peak 
positions (that do not interfere with the sample) can be added and used to correct 
peak positions. 
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Data Collection, Results and Presentation: 
Data collection: 
  The intensity of diffracted X-rays is continuously recorded as the sample and 
detector rotate through their respective angles. A peak in intensity occurs when the 
mineral contains lattice planes with d-spacings appropriate to diffract X-rays at that value 
of θ. Although each peak consists of two separate reflections (Kα1 and Kα2), at small 
values of 2θ the peak locations overlap with Kα2 appearing as a hump on the side of Kα1. 
Greater separation occurs at higher values of θ. Typically these combined peaks are 
treated as one. The 2λ position of the diffraction peak is typically measured as the center 
of the peak at 80% peak height. 
Data reduction: 
  Results are commonly presented as peak positions at 2θ and X-ray counts 
(intensity) in the form of a table or an x-y plot (shown above). Intensity (I) is either 
reported as peak height intensity, that intensity above background, or as integrated 
intensity, the area under the peak. The relative intensity is recorded as the ratio of the 
peak intensity to that of the most intense peak (relative intensity =I/I1 x 100). 
The d-spacing of each peak is then obtained by solution of the Bragg equation for 
the appropriate value of λ. Once all d-spacings have been determined, automated 
search/match routines compare the ds of the unknown to those of known materials. 
Because each mineral has a unique set of d-spacings, matching these d-spacings provides 
an identification of the unknown sample. A systematic procedure is used by ordering the 
d-spacings in terms of their intensity beginning with the most intense peak. Files of d-
spacings for hundreds of thousands of inorganic compounds are available from the 
International Centre for Diffraction Data as the Powder Diffraction File (PDF). Many 
other sites contain d-spacings of minerals such as the American Mineralogist Crystal 
Structure Database. Commonly this information is an integral portion of the software that 
comes with the instrumentation. 
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4.3. TOXICOLOGICAL STUDIES  
4.3.1. ACUTE TOXICITY STUDY IN FEMALE WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF KARPOORA SINTHAMANI  MATHIRAI  
OBJECTIVES 
  The aim of this Study is to evaluate the toxicity of the test substance Karpoora 
Sinthamani  Mathirai , when administered orally to Female Wister Rats with different 
doses, so as to provide a rational base for the evaluation of the toxicological risk to man 
and indicate potential target organs. 
 
Guidelines followed: 
  (a)  OECD Guidelines No. 423, 
 
Study Design and Controls: 
1) Female Wister Rats in controlled age and body weight were selected. 
2) Karpoora Sinthamani  Mathirai  was administered at 5 mg/kg, 50 mg/kg,  300 
mg/kg,1000  mg/kg, 2000  mg/kg,  body weight as  (Water) as suspension along 
with blank. 
3) The results were recorded on day 0, with single oral dosing period of 14 days.  
 
EXPERIMENTAL PROCEDURE 
1. ANIMALS  
Supply 
        A total of 15 Female Wister Rats with an approximate age of 6 weeks and purchased 
from Central Animal House, Arulmigu Kalasalingam college of pharmacy, krishnankoil. 
On their arrival a sample of animals was chosen at random and weighed to ensure 
compliance with the age requested. The mean weights of Female Wister Rats were 100-
150 g respectively.  The animals were housed in metabolic cages (55 x 32.7 x 19 cm), 
with sawdust litter, in such a way that each cage contained a maximum of 3 animals of 
the same sex. 
  All animals underwent a period of 20 days of observation and acclimatization 
between the date of arrival and the start of treatment. During the course of this period, the 
animals were inspected by a veterinary surgeon to ensure that they fulfilled the health 
requirements necessary for initiation of the Study. 
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Housing 
  The Female Wister Rats were housed in metabolic cages (55 x 32.7 x 19 cm), 
placed on racks. From the week before initiation of the treatment, each cage contained a 
maximum of 3 rats  of the same sex and treatment group. 
  Each cage was identified by a card, color coded according to the dose level. This 
card stated the cage number, number and sex of the animals it contained, Study number, 
test substance code, administration route, dose level and Study Director's name, date of 
the arrival of the animals and initiation of treatment. 
  The temperature and relative humidity were continuously monitored. Lighting was 
controlled to supply 12 hours of light (7:00 to 19:00 hours) and 12 hours of dark for each 
24-hour period. 
  The cages corresponding to each experimental group were distributed on racks in 
such a manner that external factors, such as environmental conditions, were balanced as 
far as possible. 
2. DIET 
     All the rats had free access to a pelleted rat diet. The diet was analyzed by the   
manufacturer to check its composition and to detect possible contaminants. 
Water 
  The water was offered ad libitum in bottles.  
 
3. ADMINISTRATION ROUTE AND PROCEDURE 
          The test substance was administered orally. The Female Wister Rats belonging to 
the control group were treated with the vehicle (Water) at the same administration volume 
as the rest of the treatment groups. 
Table – 2  Numbering and Identification 
  The animals were marked on body with picric acid solution prepared in water. The 
marking within the cage was as below. 
Table – 2  Numbering and Identification 
Group No Animal Marking 
1 Head 
2 Body 
3 Tail 
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 The group no., cage no., sex of the animal and animal no. were identified as 
indicated below using cage label and body marking on the animals 
 
Cage No Group No Animal Marking Sex 
1 I H,B,T Female 
2 II H,B,T Female 
3 III H,B,T Female 
4 IV H,B,T Female 
5 V H,B,T Female 
 
Doses 
  The doses for the study were selected based on literature search and range finding 
study. Following the period of fasting, the animals were weighed and then drug was 
administered orally as single dose using a needle fitted onto a disposable syringe of 
approximate size at the following different doses. 
 
GROUP DOSE 
Group-I 5  mg/kg 
Group-II 50  mg/kg 
Group-III 300 mg/kg 
Group-IV 1000  mg/kg 
Group-V 2000 mg/kg 
 
  The test item was administered as single dose. After single dose administration 
period, all animals were observed for day 14. 
 
Dose Preparation 
  Karpoora Sinthamani  Mathirai  was added in distilled water and completely 
dissolved to form oral for administration. The dose was prepared of a required 
concentration before dosing by dissolving, in distilled water. It was mixed well. The 
preparation for different doses was vary in concentrations to allow a constant dosage 
volume. 
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Administration 
  The test item was administered orally to each Female Wister rats as single dose 
using a needle fitted onto a disposable syringe of appropriate size at the following 
different doses. The concentration was adjusted according to its body weight. The volume 
was not exceeding 10 ml/kg bodyweight. Variability in test volume was minimized by 
adjusting the concentration to ensure a constant volume at all dose levels. 
 
Observation period 
  All animals were observed for any abnormal clinical signs and behavioral 
changes. The appearance, change and disappearance of these clinical signs, if any, were 
recorded for approximately 1.0, 3.0 and 4.0 hours post-dose on day of dosing and once 
daily thereafter for14 days. Animals in pain or showing severe signs of distress were 
humanely killed. The cageside observation was included changes in skin, fur, eyes and 
mucous membranes, occurrence of secretions and excretions. Autonomic activity like 
lacrimation,  piloerection, pupil size and unusual respiratory pattern, changes in gait, 
posture, response to handling, presence of clonic or tonic movements, stereotypes like 
excessive grooming and repetitive circling or bizarre behavior like self-mutilation, 
walking backwards etc were observed. At the 14th day, sensory reactivity to stimuli of 
different types (e.g. auditory, visual and proprioceptive stimuli) was conducted. Auditory 
stimuli responses were measured by clicker sound from approximately 30 cm to the rats; 
visual stimuli response were measured with the help of shining pen light in the eye of rats 
and placing a blunt object near to the eye of rats. Response to proprioceptive stimuli was 
measured by placing anterior/dorsal surface of animals paw to the table edge. The 
responses of reactions for these three exercises were normal in animals belonging to both 
the controls as well as drug treatment dose groups. 
 
Mortality and Morbidity 
  All animals were observed daily once for mortality and morbidity at 
approximately 1.0, 3.0 and 4.0 hours post dose on day of dosing and twice daily (morning 
and afternoon) thereafter for 14 days. 
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4.3.2. SUB-ACUTE TOXICITY STUDY IN WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF KARPOORA SINTHAMANI  MATHIRAI     
                              
Objective 
  The objective of this ‘Sub-Acute Toxicity Study of  Karpoora Sinthamani  
Mathirai on Wister Rats’ was to assess the toxicological profile of the test item when 
treated as a single dose. Animals should be observed for 28 days after the drug 
administration. This study provides information on the possible health hazards likely to 
arise from exposure over a relatively limited period of time.  
 
Test Guideline Followed 
      OECD 407 Method - Sub-Acute Toxic Class Method (Repeated Dose 28-Day Oral 
Toxicity Study in Rodents) 
 
Test Item Detail 
  Karpoora Sinthamani  Mathirai 
 
Test System Detail 
  The study was conducted on 5 male 5 female Wister rats. These   animals were 
selected because of the recommended rodent species for oral studies as per followed 
guideline and availability of Animals 8-12 weeks old male and female rats were selected 
after physical and behavioral examination. The body weight range was fallen within ± 
20% of the mean body weight at the time of Randomization and grouping. The rats were 
housed in standard laboratory condition in Polypropylene cages, provided with food and 
water adlibitum in the Animal at Central Animal House, Arulmigu Kalasalingam College 
of Pharmacy, Krishnankoil. The experimental protocol was approved by Institutional 
Animal Ethical Committee as per the guidance of Committee for the Purpose of Control 
and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment and 
Forest, government of India. 
 
Acclimatization 
   The animals were selected after veterinary examination by the veterinarian. All 
the selected animals were kept under acclimatization for a week. 
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Randomization & grouping 
  One day before the initiation of treatment (days 0- last day of acclimatization), the 
selected animals were randomly grouped into three different groups containing minimum 
5 male  and 5 female animals per group.  
 
The animals were marked on body with picric acid solution prepared in water. The 
marking within the cage was as below.   
Table – 3 Numbering and Identification 
  The group  no., cage no., sex of the animal and animal no. were identified  as 
indicated below  using cage  label and body marking on the animals: 
 
Case 
No 
Group No Animal Marking Sex 
1 CONTROL 
H,B,T,HB,NM 
H,B,T,HB, NM 
Male 
Female 
2 
Low dose of  KARPOORA 
SINTHAMANI  MATHIRAI 300mg/kg 
H,B,T,HB,NM 
H,B,T,HB, NM 
Male 
Female 
3 
Middle dose of KARPOORA 
SINTHAMANI  MATHIRAI 600mg/kg 
H,B,T,HB,NM                   
H,B,T,HB, NM 
Male 
Female 
4 
High dose of  KARPOORA 
SINTHAMANI  MATHIRAI 900 mg/kg 
H,B,T,HB,NM 
H,B,T,HB ,NM 
Male 
Female 
  
Case 
No 
Group No Animal Marking 
1 CONTROL 
H,B,T,HB,NM   (Male)               
H,B,T,HB, NM (Female 
2 
Low dose of  KARPOORA 
SINTHAMANI  MATHIRAI 300mg/kg 
H,B,T,HB,NM  (Male)                  
H,B,T,HB, NM (Female) 
3 
Middle dose of KARPOORA 
SINTHAMANI  MATHIRAI 600mg/kg 
H,B,T,HB,NM  (Male)                  
H,B,T,HB, NM (Female) 
4 
High dose of  KARPOORA 
SINTHAMANI  MATHIRAI 900 mg/kg 
H,B,T,HB,NM  (Male)           
H,B,T,HB ,NM (Female) 
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Husbandry 
Housing 
   The Wister rats were housed in standard polypropylene cages with stainless steel 
top grill. Paddy husk was used as bedding. The paddy husk was changed at least twice in 
a week. From the week before   initiation of the treatment, each cage contained a 
maximum of 5 rats of the same sex and treatment group. 
Environmental conditions 
  The animals were kept in a clean environment with 12 hour light and 12 hour dark 
cycles. The air was conditioned at 22±30C and the relative humidity was maintained 
between 30-70% with 100% exhaust facility. The cages corresponding to each 
experimental group were distributed on racks in such a manner that external factors, such 
as environmental conditions, were balanced as far as possible. 
Feed & feeding schedule 
  Feed was provided adlibitum throughout the study period, except over night 
fasting (18-20 hours) prior to dose administration. After the substance has been 
administered, food was with held for a further 3-4 hours. 
Water 
  The water was offered adlibitum in bottles. There was periodically analyzed to 
detect the presence of possible contaminants 
Doses 
  The doses for the study were selected based on literature search and range finding 
study. Following the period of fasting, the animals were weighed and then extract was 
administered orally as single dose using a needle fitted on to a disposable syringe of 
approximate size at the following different doses. 
 
Test Group 
Dose to Animals 
(mg/kg body –weight / day Number of Animals 
Group – I CONTROL 10 ( 5 Male  and 5 Female) 
Group – II Low dose of  KSM  300mg/kg 10 ( 5 Male  and 5 Female) 
Group – III Middle dose of KSM 600mg/kg 10 ( 5 Male  and 5 Female) 
Group - IV High dose of  KSM  900 mg/kg 10 ( 5 Male  and 5 Female) 
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  The test item was administered as single dose. After single dose administration 
period, all animals were observed for 28 days. 
 
Dose Preparation 
  Karpoora Sinthamani  Mathirai was added in distilled water and completely 
dissolved to for oral for administration. The dose was prepared of a required 
concentration before dosing by dissolving Karpoora Sinthamani  Mathirai in distilled 
water. It was mixed well. The preparation for different doses was vary in concentrations 
to allow a constant dosage volume. 
 
Administration 
  The test item was administered orally to each   rat as single dose using a needle 
fitted on to a disposable syringe of appropriate size at the following different doses. The 
concentration was adjusted according to its body weight. The volume was not exceeding 
10 ml/kg body weight. Variability in test volume was minimized by adjusting the 
concentration to ensure a constant volume at all dose levels. 
 
OBSERVATIONS  
  These observations were also performed on week-ends. The observations included   
but were not limited to changes in skin and fur, in the eyes and mucous membranes, in the 
respiratory, circulatory, central nervous and autonomous systems, somatomotor activity 
and behavior. 
 
Clinical signs of toxicity  
          All the rats were observed at least twice daily with the purpose of recording any 
symptoms of ill- health or behavioral changes. Clinical signs of toxicity daily for 28 days. 
 
Food intake  
  Prior to the beginning of treatment, and daily, the food intake of each cage was 
recorded for period of 28 days and the mean weekly intake per rats was calculated. 
 
Water intake 
  Water intake was checked by visual observation during the Study. In addition, the 
water consumption in each cage was measured daily for a period of 28 days. 
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Bodyweight: 
  The body weight of each rat was recorded one week before the start of treatment, 
and during the course of the treatment on the day of initial, 3rd, 7th, 10th, 14th, 17th, 
20th, 24th and 28th days (day of sacrifice). The mean weights for the different groups and 
sexes were calculated from the individual weights. 
 
Blood Collection  
  Blood was collected through retro-orbital sinus from all the animals of different 
groups on 28th day. The blood was collected in tubes containing Heparin/EDTA as an 
anticoagulant. Animals were fasted over night prior to the blood collection. 
 
LABORATORY STUDIES  
    During the 4th week of treatment, samples of blood were withdrawn from the 
orbital sinus of 10 rats from each group, under light ether anesthesia after fasting for 16 
hours. The blood samples are used to evaluate Hematological   parameters like RBC, 
WBC, and PLATELETS etc….. The collected blood samples also centrifuged 10000 rpm 
in 10 minutes to separate the serum. The separated serum used to evaluate biochemical 
parameters like SGOT, SGPT, ALP and BILIRUBIN etc……... 
 
Hematology  
The following hematological parameters were analysed using Autoanalyser  
Hb  :  Haemoglobin (g %)  
PCV   :  Packed Cell Volume 
WBC  :  White Blood Corpuscles (x103/cmm)  
RBC  :  Red Blood Corpuscles (x106/cmm)  
Blood Platelet count (x103/cmm)  
Differential WBC count:  
N  :  Neutrophils (%)  
L  :  Lymphocytes (%)  
M  :  Monocytes (%)  
E  :  Eosinophils (%)  
RDW  :  Red Cell Distribution Width. 
MPV  :  Mean Platelet Volume 
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Clinical Biochemistry:  
  The following clinical Bio parameters were analysed using Auto analyser  
Total serum protein (g/dl)  
ALT/SGPT  :  Alanine amino transferase (U/L)  
AST/SGOT  :  Aspartate amino transferase (U/L)  
ALP    :  Alkaline serum phosphatase (U/L)  
CHL    :  Cholesterol (mg/dL)  
HDL    :  High density lipoprotein 
TG    :  Triglyceride 
 
TERMINAL STUDIES  
Sacrifice and macroscopic examination 
  On completion of the 4 weeks of treatment, 18 Wister rats were sacrificed by ether 
inhalation. A full autopsy was performed on all animals which included examination of 
the external surface of the body, all orifices, cranial, thoracic and abdominal cavities and 
their contents both in situ and after evisceration. As the number of animals exceeded the 
number that could be sacrificed in one day, the autopsies were carried out over three 
consecutive days at the end of the treatment period.  
 
Organ weights: 
            After the macroscopic examination the following organs were weighed after 
separating the superficial fat: Brain, Heart, Spleen Kidneys, Testes, Liver, Lungs, 
pancreas and stomach.   
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4.4. PHARMACOLOGICAL STUDY 
4.4.1. ANTI-INFLAMMATORY ACTIVITY OF SIDDHA PREPARATION  
KARPOORA SINTHAMANI MATHIRAI  ON  
CARRAGEENAN INDUCED HIND PAW OEDEMA IN RATS 
 
                The anti-inflammatory activities of siddha preparation Karpoora Sinthamani 
Mathirai  at a dose of  100 mg/kg and 200 mg/kg were evaluated using carrageenan-
induced paw edema method. The inflammation was readily produced in the form of 
edema with the help of irritant such as carrageenan. Carrageenan is a sulphated 
polysaccharide obtained from sea weed (Rhodophyceae) and when injected cause the 
release of prostaglandins by the way it produces inflammation and edema. 
 
REQUIREMENTS: 
Animal                                :  Albino rat (180-200 g) 
Drugs and chemicals          :  Carrageenan (1%w/v),  
Diclofenac sodium (standard), 
Carboxy methyl cellulose (1%w/v), 
Digital plethysmo meter. U G O Basile (Italy) 
Test compounds                :    Siddha preparation Karpoora Sinthamani Mathirai  
 
PROCEDURE: 
  Anti-inflammatory study of  Karpoora Sinthamani Mathirai  was studied in 
healthy albino rats. 
  Six rats were selected for each group and divided into IV groups. To the first 
group distilled water was given and kept as control. The second group was given the 
standard drug diclofenac a dose of 5 mg/kg body weight. The third and fourth group was 
treat with the test drug extermelly. Before the application of the drug the Hind paw 
volume of all rats was measure .This was done by dipping the Hind paw upto the tibio 
dorsal junction in a mercury plethysmography. Subcutaneous injection of 0.1 ml of 
1%w/v carrageenin in water was made in to planter surface of the left hind paw of each 
rat. Three hours after injection the Hind paw volume was measured once again. The 
difference between the initial and final volume would show the amount of inflammation. 
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  Taking the volume in the control group as 100% of inflammation the 
inflammatory or anti-inflammatory effect of the test group is calculated, injection of 0.1 
ml of 1%w/v of carrageenin in water was made into planter surface of both the hind paw 
if each rat. 
  Three hours after carrageenin injection, the hind paw volume was measured once 
again. Difference between the initial and final value were noted and compared. 
  The method is more suitable for studying anti-inflammatory activity on acute 
inflammation. 
  The result of the drug is compared with the standard as well as control group. 
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4.4.2. ANALGESIC ACTIVITY OF KARPOORA SINTHAMANI MATHIRAI BY 
HOT PLATE METHOD 
  Analgesic activity of siddha preparation  Karpoora Sinthamani Mathirai  was 
evaluated by Hot plate method.  
REQUIREMENTS 
  Animal  : Wistar Albino Rat (4 – 5 weeks) 
 Drugs and chemicals : 1% Tween-80 solution in water, 10ml/kg, p.o.  
Diclofenac sodium 10 mg/kg, p.o. and the test  
siddha preparation Karpoora Sinthamani Mathirai  
drug of 100 mg/kg, p.o. & 200 mg/kg, p.o. 
respectively 
METHOD: 
Hot plate method: 
Animals  
  Young wister albino rats of either sex aged 4-5 weeks, average weight 100-150 
gm were used for the experiment. The rat were purchased from the animal TANVASU . 
They were kept in standard environmental condition (at 24.0±0°C temperature & 55-65% 
relative humidity and 12 hour light/12 hour dark cycle) for one week for acclimation after 
their purchase and fed ICDDRB formulated rodent food and water ad libitum. The set of 
rules followed for animal experiment were approved by the institutional animal ethical 
committee (Zimmermann, 1983). 
  Experimental animals of either sex were randomly selected and divided into four 
groups designated as group-I, group-II, group-III and group-IV consisting of five Rats in 
each group for control, positive control and test sample group respectively. Each group 
received a particular treatment i.e. control (1% Tween-80 solution in water, 10ml/kg, 
p.o.), positive control (Diclofenac sodium 10 mg/kg, p.o.) and the test sample (drug of 
100 mg/kg, p.o. & 200 mg/kg, p.o. respectively). The animals were positioned on Eddy’s 
hot plate kept at a temperature of 55±0.5 0C. A cut off period of 15 s (Franzotti et al., 
2000) was observed to avoid damage to the paw. Reaction time was recorded when 
animals licked their fore or hind paws, or jumped prior to and 0, 30, 60 and 90 min after 
oral administration of the samples (Eddy et al., 1953; Kulkarni, 1999; Toma et al., 2003). 
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4.4.3. IN-VITRO ANTI-SPASMODIC ACTIVITY OF KARPOORA 
SINTHAMANI MATHIRAI  ON EXCISED GUINEA PIG ILEUM 
 
ISOLATION OF GUINEA PIG ILEUM: 
 Guinea pig were anesthetized and sacrificed by cervical displacement followed by 
exsanguinations.  The ileum was dissected out, immersed in tyrode’s solution and cleaned 
off the mesentery.  Respective segments of 2-3 cm long were mounted in a 25ml tissue 
organ bath, filled with a mixture of 95% O2 and 5% Co2 and maintained at 37°C.  The 
composition of Tyrode’s solution (in mm for 1 lit) was 9 mg KCl, 0.1mg NaCl, 0.1mg 
NaHCo3, 0.42mg NaH2PO4, 0.6 mg Glucose and pH value was 7.4. 
 
ANTI-SPASMODIC ACTIVITY ASSAY PROCEDURE: 
1. Firstly concentration dependent responses of acetylcholine awere recorded (with 
dose of 0.1ml, 0.2ml, 0.4ml, 0.8ml, 1.6ml, 3.2ml) using Sherrington’s recording 
drum with a frontal writing level.  Contact time of 60 sec, and base line of 30 sec 
time cycle were opted for proper recording of the responses in presence of plane 
Tyrode’s solution as stock – I solution. 
2. Then same concentration dependent responses of acetylcholine (Ach) using same 
procedure for a mixture of Tyrode’s solution+ KSM extract (with a concentration 
of 1mg/ml) as a stock-II solution were recorded. 
3. Lastly the same concentration dependent responses of Ach for a mixture of 
Tyrode’s solution+ Atropine (as a standard antispasmodic agent) as a stock-III 
solution were recorded. 
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4.4.4. LAXATIVE  ACTIVITY OF KARPOORA SINTHAMANI MATHIRAI  
Requirements: 
Animal   : Rat (180 – 220gm) 
Drugs and Chemicals  : Sodium Picosulphate, Siddha preparation  
      Karpoora Sinthamani Mathirai  
Method: 
  Rats fasted for 12 h before the experiment were placed individually in cages lined 
with clean filter paper. Rats were divided in five groups with the I group acting as the 
control and administered saline (5 ml/kg, p.o.) that acted as the negative control. The II 
group received sodium picosulfate (5 mg/kg, p.o.), this served as the positive control. The 
III, IV and V groups received 100, 200 and 300 mg/kg per os of the KSM. The 
administration was done using metal oropharyngeal cannula. The faeces production (total 
number of normal as well as wet faeces) in all five groups was monitored for 16 h7. 
 
 Statistical Analysis 
  Results were expressed as mean ± SEM. The data were analyzed by using one 
way analysis of variance (ANOVA) followed by Newmann keul’s  multiple range tests. P 
values < 0.05 were considered as significant. 
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5. MICROBIOLOGICAL ANALYSIS 
ANTI - MICROBIAL STUDIES 
Aim 
   To study the Anti-microbial action of “Karpoora Sinthamani  Mathirai” done by 
“Agar well diffusion method” – Kirby – bauyermethod. 
 
Components of Muller Hinton agar medium 
         Beef extract   -  300gms/lit 
         Agar    -  17 gms/lit 
         Starch    -  1.5 gms/lit 
         Casein Hydrolysate  -  17.5 gms/lit 
         Distilled water  -  1000 ml 
         PH   -  7.6 
 
Procedure: 
  The method of antibacterial activity study is UPS Diffusion Method. Antibiotic 
discs are prepared with known concentration of antibiotic are placed on agar plates that 
has been inoculated with the known pathogenic micro organism. The antibiotic diffuses 
through the agar producing an antibiotic concentration, gradient antimicrobial 
susceptibility is proportional to the diameter of the inhibitory zone around the disc. If the 
microorganism which grows up to the edge of the disc are resistant to the antimicrobial 
agent. The recommended medium in this method is Muller Hinton Agar, its PH should be 
between 7.2-7.6 and should be poured to uniform thickness of 4mm in the petri plate 
(25ml). 
 
Methodology: 
  Muller Hinton Agar plates are prepared and Pseudomonas, Staphylococcus 
aureus,  Escherichia coli, is inoculated separately. 
  The prepared disc of Karpoora Sinthamani  Mathirai are placed over the 
incubated plate using sterile forceps and incubated for 24 hours at 37 degree celcius. The 
plates after 24 hours incubation are observed for the zone of inhibition. 
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6. RESULTS AND DISCUSSION 
6.1. STANDARDISATION OF KARPOORA SINTHAMANI MATHIRAI   
  The test drug Karpoora Sinthamani Mathirai  had been subjected to various 
studies to establish the works of Siddhar`s to be true. Literary collections, physico-
chemical and elemental analysis, pharmacological study, toxicological study and 
antimicrobial study are done to prove the activity of Karpoora Sinthamani Mathirai  as 
an anti-inflammatory, analgesic, anti-spasmodic and laxative activities. 
Table – 4  Physico Chemical Standardisation. 
SL. NO. PARA METER RESULTS 
1. Organo leptic characters  
a. Color 
b. Odour 
c. taste 
d. Sense of touch 
e. Appearance 
 
Brown 
Pleasant odour 
Salt, bitter 
Hard 
Round 
1. Physico chemical standard 
a. Loss on drying at 70°C 
b. Ash  
i. Total ash 
ii. Acid insoluble ash 
iii. Water soluble  
c. Extractive value 
i. Ethanol soluble extractive 
ii. Water soluble extractive 
d. pH value (1% solution) 
             
 
7.40 % 
 
7.96% 
0.90 % 
7.85 % 
 
8.10 % 
9.30 % 
7.140 
 
Interpretation: 
  The physical parameters like colour, odour touch, appearance revealed that 
Karpoora Sinthamani Mathirai  is a Brown,  Pleasant odour, hard to touch and  having 
the  PH 7.140 slightly alkaline Ph, Round in appearance. 
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Determination of loss on drying normal: 
  The loss on drying test is designed to measure the amount of volatile matters in a 
sample when the sample is dried under specified conditions moisture is one of the major 
factors.  Responsible for the deterioration of the drugs and formulations low moisture 
content is always desirable for higher  stability of days. 
  The percentage of loss on drying was (7.40%) within acceptable range to thus 
implying that the formulation can be stored for a long period and would not easily be 
attacked by microbes. 
 
Total Ash: 
  Ash values are helpful in determining the quality and purity of crude drugs.  in 
this trial drug KARPOORA SINTHAMANI MATHIRAI  (The minerals that present in the 
trial drug are calcium, chloride, sulphate). The salts, Ca+, Cl-, Sulphate are not harmful 
one. In this trial drug KARPOORA SINTHAMANI MATHIRAI  is used as a condensation  
from water extraction .    So only water soluble trace elements present here in a very few 
trace levels. The total ash value was 7.96%. 
 
Acid insoluble Ash: 
  Acid insoluble ash values represents detecting the presence of silica and oxalate in 
a drugs. In my drug the silica and oxalate that is the acid insoluble ash is very low on 0.90 
± 0.011. So the drug has high quality. 
 
Water soluble ash: 
  Water soluble ash also indicate the purity of the drug water soluble ash higher 
than acid insoluble ash represents good quality of the drug which is KARPOORA 
SINTHAMANI MATHIRAI  is 7.85 %. So water soluble ash is higher than acid insoluble 
ash. 
 
b)Water soluble extractive 
               Proceed as directed for the determination of Alcohol-soluble extractive , using 
chloroform water instead of ethanol water soluble extractive Karpoora Sinthamani 
Mathirai  is 9.30 %. 
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c)Alcohol soluble extractive 
                Macerate 5g of the air dried drug, coarsely powdered, with 100ml of alcohol of 
the specified strength in a closed flask for 24 hrs, shaking frequently during six hours and 
allowing to stand for eighteen hours. Filter rapidly, taking precautions against loss of 
solvent, evaporate 25 ml of the filtrate to dryness in a tared flat bottomed shallow dish, 
and dry at 105o,to constant weight and weigh. Calculate the percentage of alcohol-soluble 
extractive with reference to the air-dried drug. Alcohol soluble extractive Karpoora 
Sinthamani Mathirai  is 8.10 %. 
 
d)Determination of pH  
  5 gms of Karpoora Sithamani Mathirai was weighted accurately and placed in 
clear 100ml beaker. Then 50ml of distilled water was added to it and dissolved well. after 
30 minutes it was then applied into pH meter at standard buffer solution of  4.0,  7.0 and  
9.0. Repeat the test 4 times and average was recorded. The pH of Karpoora Sinthamani 
Mathirai  is 7.140. 
 
Microbial Limit Tests 
Table 1: Results of Microbial Contamination Test 
S.No. Test Particulars Colony Counts (CFU/ g) 
Limits Value 
(CFU/g) 
1. Total  Viable Aerobic Bacterial Count 4 x 102 1 x 105 
2. Total  Viable Fungal Count 3.5 x 102 1 x 103 
 
Results of Specific Pathogens Test 
S.No. Test for Specified Pathogens Colony Counts (CFU/ g) 
Limits Value 
(CFU/g) 
1. Salmonella sp.  No growth - 
2. Staphylococcus aureus No growth - 
3. Escherichia coli No growth - 
4. 
 
Pseudomonas aeruginosa No growth 
- 
Interpretation : 
  The total bacterial count and the total fungal count of the drug were found to be 
within the WHO prescribed limits which indicate that the drug is free from microbial 
contamination. The other pathogens like Escherichia coli, Salmonella sps, Pseudomonas 
aeruginosa and Staphylococcus aureus were found to be completely absent in the drugs 
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Disintegration: 
  The disintegration of test sample under the  specifications not more than 15 
minutes. In the present analysis the KARPOORA SINTHAMANI MATHIRAI   
disintegration on only 10m 50 sec. 
 
BIO CHEMICAL ANALYSIS 
Table – 5  Results of Preliminary test for basic and acidic radicals 
S.NO EXPERIMENT INFERENCE 
1. Test for Calcium  Present 
2. Test for Sulphate Present 
3. Test for Chloride Present 
4. Test for Carbonate Absent 
5. Test for Starch Present 
6. Test for Ferric Iron Absent 
7. Test for Ferrous Iron Present 
8. Test for Phosphate Absent 
9. Test for Albumin Absent 
10. Test for Tannic Acid Absent 
11. Test for Unsaturated Compounds Present 
12. Test for Reducing Sugar Absent 
13. Test for Amino Acid Present 
14. Test for Zinc Absent 
 
INTERPRETATION: 
   The biochemical analysis  of Karpoora Sinthamani Mathirai  contains the 
following chemical constituents, Sulphate, Chloride, Starch, Ferrous iron,  Unsaturated 
compound and Amino acid. 
 
CALCIUM: 
 Maintenance of plasma calcium level within normal range is of vital 
importance because neuro-muscular excitability is dependent on plasma 
calcium level. 
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 99% of calcium is used to keep our bones and teeth strong, thereby supporting 
skeletal structure and function. The rest of the calcium in our body plays a 
major role in muscle contraction, nerve function and blood clotting. 
 Proper levels of calcium in body over a lifetime can prevent osteoporosis.  
 
SULPHATE: 
 It significantly improves the joint function. It helps in reduce the pain and 
inflammation. 
 Sulphate’s primary biological role in halting or reversing joint degeneration. 
 Nutritionally essential element 
 Functional in the form of sulphur containing amino acids.  
 
STARCH: 
 Starches functions much like dietary fibre. They provide nutrition for the 
beneficial bacteria in the colon, keeping them thriving and health.  Dietary fibre in 
starch reduces effects of haemorrhoids, diverticulosis & controls blood pressure. 
 
FERROUS IRON : 
 Iron help to preserve many vital functions in the body, including general energy 
and focus, gastrointestinal processes, the immune system and regulation of body 
temperature. 
 
CHLORIDE: 
 Calcium- activated chloride channels (Ca-Cl) are thought to regulate neuronal 
excitability and recently chloride regulation in DRG (Dorsal root ganglion) 
neurons has attracted much attention in pain research. 
 Chloride forms the chief anion of the extracellular fluid and exists along with 
sodium mostly. 
 Regulates acid base balance. 
 Formation of HCl in gastric juice 
 Help to preserve normal neuromuscular irritability by maintaining a state of 
equilibrium, on account of their relative proportion in ECF and ICF.  
 
                                                                                                                             
 
   110 PRE CLINICAL  STUDY OF  KARPOORA  SINTHAMANI  MATHIRAI 
 
UNSATURATED COMPOUND: 
 A free phenolic hydroxyl group is essential for scavenging oxygen free-radicals 
and is also essential for inhibiting leukocyte chemotaxis, 
 That inhibition of leukocyte chemotaxis may be involved in the anti-inflammatory 
action of phenolic compounds, and that one of the anti-inflammatory actions of 
phenolic compounds is the prevention of the production of oxygen free-radicals 
by leukocytes. 
 
AMINO ACID: 
 Amino acids are involved in protein synthesis. 
 Amino acid nourishes smooth muscles  of GIT 
 The body can also use aminoacid for energy when lack of carbohydrates and fats  
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PHYTOCHEMICAL STUDY OF KARPOORA SINTHAMANI MATHIRAI   
The Karpoora Sinthamani Mathirai  was subjected to qualitative chemical investigation 
Details of the various tests performed for the presence of phytoconstituents is shown in 
Table 7.  
Table – 6  Phytochemical tests for Karpoora Sinthamani Mathirai   
 
Tests 
 
Karpoora 
Sinthamani 
Mathirai   
Alkaloids  
Mayer’s test  +ve  
Dragendroff’s test  +ve 
Hager’s test  +ve  
Carbohydrates and glycosides  
Molisch test  +ve  
Legal’s test  -ve  
Borntrager’s test for anthraquinones  -ve  
Phytosterols  
Liebermann-Burchard test  -ve  
Salkowski test  -ve  
Flavanoids  
Shinoda test  
Magnesium turnings and hydrochloric acid  
(Presence of red color)  
-ve  
Fluorescence test  -ve  
Tannins  
Ferric chloride test  -ve  
Potassium dichromate test  -ve  
Lead acetate test  +ve  
Proteins  
Millon’s test  -ve  
Biuret test  -ve  
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Ninhydrin test  -ve  
Fixed oils and fats  
Spot test  -ve  
Saponification test  +ve  
Lignin  
Phloroglucinol test  -ve  
Saponins  
Frothing test  -ve  
(+ve) indicates the presence of phytochemical, (-ve) indicates the absence of 
phytochemical. 
 
INTERPRETATION: 
Alkaloids-decreased gastric acid secretion and inhibit the gastric motility 
Tannins-Tannins react with tissue promote tissue proteins. 
This study revealed the presence of active phytochemicals in Karpoora Sinthamani 
Mathirai  such as alkaloids, carbohydrates, glycosides, tannins, lignins, fixed oils and fats. 
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INSTRUMENTAL ANALYSIS 
SCANNING ELECTRON MICROSCOPE (SEM) 
 
SEM -30000 Magnification 
 
SEM -20000 Magnification 
Figure - 6 Showing SEM Results of Trial Drug                                                              
(KARPOORA SINTHAMANI MATHIRAI  ) 
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INTERPRETATION : 
 
  The morphology of the Karpoora Sinthamani Mathirai  samples can be 
determined by Environmental SEM (FEI Quanta). A representative portion of each 
sample must be  sprinkled onto a double side carbon tape and mounted on aluminium 
stubs, in order to get a higher quality secondary electron image for SEM examination. 
The SEM photographs revealed that particles were spherical in shapes and sizes were in 
the range from 1µm to 5µm.Although the particle sizes of different batches showed 
similarity, it seems that these particles were aggregates of much smaller particles.  
  When dispersed in an aqueous medium, these preparations form a negatively 
charged hydrophobic particle suspension. This hydrophobicity gave these particles a 
tendency to aggregate together to form larger particles. Karpoora Sinthamani Mathirai  
exhibited larger sizes and agglomeration of the particles. Therefore, the comparatively 
larger size may be due to the agglomeration of the particles by repeated cycles of 
calcinations involved in preparation. SEM analysis of the Karpoora Sinthamani 
Mathirai  shows most of the particles present in the sample are nano size, average particle 
size is  2 - 1µm. 
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FOURIER TRANSFORM-INFRARED SPECTROSCOPY( FTIR) 
 
  Fourier Transform Infra-Red Spectroscopy (FTIR) analysis results in absorption 
spectra that provide information about the functional group and molecular structure of a 
material IR relates with the sample and the bonds among atoms in the molecule stretch 
and bend, absorbing infrared energy and creating the infrared spectrum. It is of two kinds 
of bending and stretching. 
 
  FT-IR is a very useful tool in the recognition of the functional groups of bio 
molecules, thus aiding in their structural elucidation, so confirming the presence of active 
molecules responsible for the therapeutic activity of Siddha drugs. The results of Table 
no: 7 and Fig no:7 shows the presence of functional group and inorganic compounds of 
Karpoora Sinthamani Mathirai   
 
 
            Figure -7  Showing FTIR Image of KARPOORA SINTHAMANI MATHIRAI   
 
KSM 
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Table – 7  Interpretation of FTIR Spectrum 
S.No Frequency Bond Functional Group 
1. 3779 - Unknown compound 
2. 3465 O-H Stretch Hydrogen Bonded -  
Alcohol Phenol 
3. 2556 O-H Stretch Carboxylic acid 
4. 2426 - Unknown compound 
5. 2065 - Unknown compound 
6. 1634 N-H Bend Primary amines 
7. 1585 -NO2 Aliphatic nitro group 
8. 1488 C-C-Stretch Aromatics 
9. 1470 C-H Bend Alkanes 
10. 1430 C-H Bend Alkanes 
11. 1384 NO2 Symmetrical stretch Aliphatic nitro 
compounds 
12. 1220 C-O Stretch Alcohols, ether, 
carboxylic acid, ester 
13. 1184 C-O Stretch Alcohols, ether, 
carboxylic acid, ester 
14. 1044 C-N Stretch Aliphatic amines 
15. 967 =C-H Bend Alkenes 
16. 928 O-H Bend Carboxylic acid 
17. 848 C-H Bend Phenyl ring substitution 
bands 
18. 781 C-Cl Stretch Alkyl halides 
19. 712 C-H Bend Aromatics 
20. 602 Actylenic C-H Bend Alkynes 
 
INTERPRETATION: 
1. FTIR instrumental analysis was done. The test drug was identified to have 20 
peaks. They are the functional groups present in the trial drug Karpoora 
Sinthamani Mathirai .  
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2. It confirms that Karpoora Sinthamani Mathirai  constitutes Alcohol, Phenol, 
Carboxylic acid, Primary amine, Aliphatic Nitro groups, Aromatics, Alkanes, 
Aliphatic Nitro compounds, ether, Aliphatic amine, Alkenes, Phenyl ring, Alkyl 
halides, Alkynes as functional  groups.  
 
Ether:  
• Ether is a class of organic compound characterized by an oxygen atom bonded to 
two alkyl or aryl group.  
• Diethyl ether inhibits alcohol dehydrogenase and thus slows the metabolism of 
ethanol. It depresses the myocardium and increases tracheobronchial secretion.  
• Codine a potent pain relieving drug is the methyl ether of morphine.  
 
Carboxylic acid : 
 It is a classical organic compounds that are characterised by the presence of 
carboxyl groups (-COOH) in them. They make up series fatty acids which are extremely 
good for human health.The omega3 and the omega 6 are the essential fatty acids which 
are not produced by the body. They help in maintaining the cell membrane and control 
nutrient use along with metabolism.  
Phenols: 
Phenol is active  against a wide range of micro organisms. .It is a powerful Anti-
septic, Antiferment and disinfectant.Prevents the decomposition of albuminous fluids by 
bacteria.It is a neurolytic agent, applied in order to relieve spasms and chronic pains. 
Amines: 
Acts as a neuro transmitter.Involved in protein synthesis.Amines play an important 
role in reducing abdominal pain,bloating. 
Alkanes: 
They protect against bacteria and fungal infections. 
Alcohols  
It has anti microbial action.Acts as a antiseptic agent. 
Aldehydes: 
Aldehydes normally have Anti-microbial activities.They are readily absorbed  by the  
Gastro intestinal tract. 
Aromatics:  
Aromatics are good pain relievers.It has Anti-pyretic, Anti-inflammatory, Auto-
immune activities.  
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ICP-OES of KARPOORA SINTHAMANI MATHIRAI   
 
Karpoora Sinthamani Mathirai   (wt:0.41210g) 
 
Elements Wavelength 
(nm) 
Concentration 
Al 396.152 BDL 
As 188.979 BDL 
Ca 315.807 121.100 mg/l 
Cd 228.802 BDL 
Cu 327.393 BDL 
Fe 238.204 21.354 mg/l 
Hg 253.652 BDL 
K 766.491 03.071 mg/l 
Mg 285.213 01.104 mg/l 
Na 589.592 04.180 mg/l 
Ni 231.604 BDL 
Pb 220.353 BDL 
P 213.617 86.307 mg/l 
S 180.731 41.204 mg/l 
Zn 206.200 3.256 mg/l 
 
BDL: Below Detectable Limit(Normal-1ppm) 
     1%  = 10000ppm, 
     1ppm = 1/1000000 or 0.0001% 
Toxic metals and the permissible limits 
 
Heavy metals WHO & FDA limits 
Arsenic(As) 10ppm 
Mercury(Hg) 1ppm 
Lead (pb) 10ppm 
Cadmium (Cd) 0.3ppm 
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INTERPRETATION 
This result indicates the presence of Calcium, Iron, Potassium, Sodium, 
Magnesium, Phosporus, Sulphur, Zinc 
 Calcium is essential for maintaining the necessary level of bone mass. The 
body is constantly using calcium for the muscles and nerves. Maintenance of 
plasma calcium level within normal range is of vital importance because 
neuro-muscular excitability is dependent on plasma calcium level.  
 Phosphorous, it decreases urine calcium, reduces demineralization of bone 
and increases calcium balance. It is an important constituent of phosphate 
buffers in the blood and urine. It is required for the formation of certain 
physiologically important phosphorus containing compounds like 
phospholipids, coenzymes and enzymes of intermediary metabolism. 
Contributes formation of ATP, ADP and creatine phosphate.
 [24] 
 Sodium and Potassium: In the presence of Sodium and Potassium regulate 
the acid-base balance of the body fluids . They help to preserve the 
neuromuscular irritability by maintaining a state of equilibrium on account of 
their relative proportion in the ECF and ICF.  
   Magnesium is a cofactor that regulates diverse biochemical reactions in the 
body, including protein synthesis, muscle, nerve function, blood glucose 
control and blood pressure regulation  
 Zinc may be regarded as an antioxidant, protects the body against free radical 
damage and cell damage. Zinc is important for a healthy immune system. It 
enhances absorbtion of iron.It can produce healthy veins and arteries that 
enhance the blood circulation 
 Sulphate may prevent the occurrence of any  infection, sulphate is potent anti 
oxidant activity in human body. 
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XRD (X-Ray Diffraction): 
   X-Ray powder diffraction is a rapid analytical technique primarily used for 
phase identification of a crystalline material and can provide information on unit cell 
dimensions.  
Fig. No. 8 XRD –Results of  KSM 
 
This XRD finger print shows both the similarities and differences of the sample 
successfully and is a valuable primary tool for checking the quality control of Herbo-
mineral formulations. The different peaks show the presence of minerals in the samples. 
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TOXICITY STUDIES 
EVALUATION OF ACUTE TOXICITY STUDY OF KARPOORA 
SINTHAMANI MATHIRAI  
8. Effect of Acute Toxicity Study (14 Days) of KARPOORA SINTHAMANI 
MATHIRAI  
Table no –8.1   Physical and behavioral examinations. 
Group 
no. 
Dose(mg/kg) Observation sign No. of animal affected. 
Group-I 5mg/kg Normal 0 of 3 
Group- II 50mg/kg Normal 0 of 3 
Group-III 300mg/kg Normal 0 of 3 
Group-IV 1000mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
Table no-8.2   Home cage activity 
Functional 
and 
Behavioural 
observation 
Observation 
5mg/kg 
Group 
(G-I) 
50mg/kg 
(G-II) 
300mg/kg 
(G-III) 
 
1000mg/kg 
(G-IV) 
2000mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body 
position Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Tonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Palpebral 
closure Normal 3 3 3 3 3 
Approach 
response Normal 3 3 3 3 3 
Touch 
response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch 
response Normal 3 3 3 3 3 
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Table no-8.3  Hand  held  observation 
Functional 
and 
Behavioral 
observation 
Observat
ion 
Cont
rol 
5 
mg/ 
kg 
(G-I) 
50 
mg/k
g 
(G-
II) 
300mg/
kg 
(G-III) 
1000mg
/kg 
(G-IV) 
2000mg
/kg 
(G-V) 
Fema
le 
n=3 
Fem
ale 
n=3 
Fem
ale 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 3 
Lacrimation Normal 3 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 3 
Piloerection Normal 3 3 3 3 3 3 
Pupillary 
reflex 
Normal 3 3 3 3 3 3 
Abdominal 
tone 
Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
 
Table no-8.4   Mortality 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
RESULT: 
 From acute toxicity study it was observed that the administration of 
KARPOORA SINTHAMANI MATHIRAI at a dose of 2000 mg/kg to the rats do not 
produce drug-related toxicity and mortality. So No-Observed-Adverse-Effect- Level 
(NOAEL) of KARPOORA SINTHAMANI MATHIRAI is 2000 mg/kg. 
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DISCUSSION 
 KARPOORA SINTHAMANI MATHIRAI was administered single time at 
the dose of 5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and 
observed for consecutive 14 days after administration. Doses were selected based on 
the pilot study and literature review. All animals were observed daily once for any 
abnormal clinical signs. Weekly body weight and food consumption were recorded. No 
mortality was observed during the entire period of the study. Data obtained in this 
study indicated no significance physical and behavioural signs of any toxicity due to 
administration ofKARPOORA SINTHAMANI MATHIRAI  at the doses of 
5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats.  
 At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, hand held 
activity were observed. Home cage activities like Body position, Respiration, Clonic 
involuntary movement, Tonic involuntary movement, Palpebral closure, Approach 
response, Touch response, Pinna reflex, Sound responses, Tail pinch response were 
observed. Handheld activities like Reactivity, Handling, Palpebral closure, 
Lacrimation, Salivation, Piloercetion, Papillary reflex, abdominal tone, Limb tone were 
observed. Functional and behavioral examination was normal in all treated groups.  
Food consumption of all treated animals was found normal as compared to normal 
group. 
 Body weight at weekly interval was measured to find out the effect of 
KARPOORA SINTHAMANI MATHIRAI  on the growth rate. Body weight 
change in drug treated animals was found normal. 
 
INTERPRETATION: 
 
 KARPOORA SINTHAMANI MATHIRAI was administered single time at 
the dose of 5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and 
observed for consecutive 14 days after administration. Doses were selected based on 
the pilot study and literature review. All animals were observed daily once for any 
abnormal clinical signs. Weekly body weight and food consumption were recorded. No 
mortality was observed during the entire period of the study. Data obtained in this 
study indicated no significance physical and behavioural signs of any toxicity due to 
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administration of KARPOORA SINTHAMANI MATHIRAI at the doses of 5mg/kg, 
50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats.  
At the 14th day, all animals were observed for functional and behavioral examination. 
In functional and behavioral examination, home cage activity, hand held activity were 
observed. Home cage activities like Body position, Respiration, Clonic involuntary 
movement, Tonic involuntary movement, Palpebral closure, Approach response, 
Touch response, Pinna reflex, Sound responses, Tail pinch response were observed. 
Handheld activities like Reactivity, Handling, Palpebral closure, Lacrimation, 
Salivation, Piloercetion, Papillary reflex, abdominal tone, Limb tone were observed. 
Functional and behavioral examination was normal in all treated groups.Food 
consumption of all treated animals was found normal as compared to normal group. 
Body weight at weekly interval was measured to find out the effect of KARPOORA 
SINTHAMANI MATHIRAI on the growth rate. Body weight change in drug 
treated animals was found normal. 
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SUB-ACUTE TOXICITY STUDY IN WISTAR RATS TO EVALUATE 
TOXICITY PROFILE OF KARPOORA SINTHAMANI MATHIRAI  
 
Table 9.1.EFFECT OF SUB- ACUTE DOSE (28 DAYS)OF KARPOORA SINTHAMANI 
MATHIRAI  ON  BODY WEIGHT IN GRAM 
GROUP CONTROL LOW MID HIGH 
1st day 120.3±1.03 123±1.543 122.3±2.231 124.3±2.23 
7th day 130.3±1.03 129.3±1.343 129±2.113 135±2.11 
14th day 132.1±1.004 100.3±1.12 100.4±2.012 101.4±2.012 
21st day 101.3±2.120 108.2±1.501 102±1.131 103±1.13 
28th day 111.3±1.041 110.3±1.202 141±2.0405 144±2.040 
 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group. 
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EFFECT OF SUBACUTE DOSE (28 DAYS) OF KARPOORA SINTHAMANI 
MATHIRAI  
Table : 9.2. KARPOORA SINTHAMANI MATHIRAI ON ORGAN WEIGHT 
(PHYSICAL PARAMETER) IN GRAM 
GROUP CONTROL LOW  MID HIGH 
HEART 0.23±0.02 0.09±0.04 0.90±0.11 0.21±0.02 
LIVER 2.11± 0.23 2.13±0.23 2.09±0.01 2.03± 0.23 
LUNGS .61±0.10 0.59±0.14 0.30±0.24 0.63±0.10 
KIDNEY L 0.53±0.02 0.52±0.03 0.63±0.02 0.71±0.02 
 R 0.71±0.024 0.59±0.02 0.51±0.024 0.52±0.024 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group.  
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EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF KARPOORA SINTHAMANI 
MATHIRAI ON HAEMATOLOGICAL PARAMETERS 
Table no 9.3 
GROUP CONTROL KSM 200mg/kg 
KSM 
400mg/kg 
KSM 
600mg/kg 
RBC (X106/µL) 6.01±0.40 5.27±0.20 5.13±0.21 6.06±0.21 
WBC (X103/µL) 5232.41±23.32 4314.04±23.22 4828.25±32.35 7468.25±32.35 
HB (g/dl) 12.40±0.45 12.20±0.43 12.11±1.03 14.11±1.03 
Neutrophils(%) 29.27±1.20 23.54±1.41 28.32±2.22 26.32±2.22 
Eosinophils(%) 1.33±0.11 1.90±0.14 1.24±0.12 1.30±0.12 
Monocyte(%) 2.89±0.15 3.09±0.30 3.44±0.40 3.57±0.40 
Lymphocyte(%) 67.46±3.32 66.27±3.51 66.93±3.32 64.69±3.32 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group.  
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Table :9.4 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF KARPOORA 
SINTHAMANI MATHIRAI ON BIOCHEMICAL PARAMETERS 
 
Drug 
Treatment 
SGPT 
(IU/L) 
SGOT(IU/L) ALP(IU/L) Urea 
(mg/dl) 
Creatinine(mg/dl) 
Control 40.14±3.02 40.24±4.31 241.12±11.32 33.35±3.00 0.54±0.03 
LOW 40.13±3.22 39.23±4.01 249.11±12.42 38.53±2.42 0.60±0.04 
MID 38.21±4.44 42.31±2.21 243.45±4.14 37.12±2.22 0.45±0.04 
HIGH 40.21±4.44 38.31±2.21 232.45±4.14 38.12±2.22 0.56±0.04 
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EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF KARPOORA SINTHAMANI 
MATHIRAI BIOCHEMICAL PARAMETERS 
 
GROUP CONTROL 
KSM 
(200mg/kg) 
KSM 
(400mg/kg) 
KSM 
(600mg/kg) 
TOTAL 
BILIRUBIN 
(mg/dl) 
0.508±0.2457 0.858±0.2827 0.819±0.3376 0.904±0.199 
  
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group.  
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Table: 9.5. EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF ON FOOD 
INTAKE IN GRAM 
GROUP CONTROL L M H 
1st DAY 17.33±13.6110 18.1672±15.3 11.10±22.71 16.5±8.62 
7th DAY 14.5±12. 9.863±13.67 15.73±10.853 10.17±15.41 
14th DAY 17.83±8.72 9.83±15.28 9±14.96 18.72±9.981 
21st DAY 10.87±13.4 14±8.466 14.88±10.43 18.17±9.02 
28th DAY 11.10±11.38 17.38±11.50 9±8.90 9±7.57 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group 
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Table: 9.6. Effect of Sub- Acute Dose (28 Days) Of KARPOORA SINTHAMANI 
MATHIRAI On Water Intake in ml 
GROUP CONTROL KSM 
(200mg/kg) 
KSM 
(400mg/kg) 
KSM 
(600mg/kg) 
1st DAY 98.±13.10 89.72±14.3 102.10±21.79 67.5±7.623 
7th DAY 85.5±11.78 100.863±12.60 76.66±9.85 81.617±14.41 
14th DAY 58.3383±8.717 90.8363±14.28 80±13.92 89.162±881 
21st DAY 91.6687±12.49 85±8.2 65.88±9.50 89.17±8.72 
28th DAY 82.10±11.30 88.38±114 80±0.861 70±7.5 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group. 
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Table: 9.7  EFFECT OF SUB ACUTE DOSES (28 DAY) OF KARPOORA 
SINTHAMANI MATHIRAI ON ELECTROLYTES: - 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-way 
ANOVA followed by Dunnett’s(n=6); NS- non-significant, *p<0.05, **p<0.01, 
***p<0.001 calculated by comparing treated groups with control group. 
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GROUP CONTROL 
KSM 
(200mg/kg) 
KSM (400mg/kg) KSM (600mg/kg) 
Sodium (mg/dl) 147.10±055 147.30±0.672 148±0.71 151.80±0.70 
Calcium(mg/dl) 5.80±0.137889 9.20±0.13*** 7.7±0.129** 7.180±0.19611*** 
Phosphorus 
(U/L) 
5.78±0.023017 6.0410±0.21 6.30±0.035491ns 5.037±0.32502* 
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RESULTS: 
CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the dosing   period 
of 28 days. 
 Mortality: 
All animals in control and in all the treated dose groups survived throughout the dosing 
period of 28 days. 
 Body weight: 
Results of body weight determination of animals from control and different dose 
groups exhibited comparable body weight gain throughout the dosing period of 28 
days. 
Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food consumed by 
animals from different dose groups was found to be comparable with that by control 
animals. 
Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in Table No.9.2 
Comparison of organ weights of treated animals with respective control animals on day 
29 was found to be comparable similarly. 
Hematological investigations: 
The results of hematological investigations conducted on day 29 revealed following 
significant changes in the values of different parameters investigated when compared 
with those of respective controls; however, the increase or decrease in the values 
obtained was within normal biological and laboratory limits or the effect was not dose 
dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on the day 29th and recorded in Table 
no 9.4 revealed the following significant changes in the values of hepatic serum 
enzymes studied. When compared with those of respective control. However, the 
increase or decrease in the values obtained was within normal biological and laboratory 
limits. 
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INTERPRETATION: 
1)  All the animals from control and all the treated dose groups up to 15ml/kg survived 
throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during the 
dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain 
with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
5)   Haematological analysis conducted at the end of the dosing period on day 29th, 
revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29th, no 
abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was found to 
be comparable with that of respective controls. 
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PHARMACOLOGICAL RESULTS 
ANTI-INFLAMMATORY ACTIVITY OF SIDDHA PREPARATION  
KARPOORA SINTHAMANI MATHIRAI  ON  
CARRAGEENAN INDUCED HIND PAW OEDEMA IN RATS 
 
Table : 10   Study of Acute –Inflammatory By Hind Paw Method 
Serial 
no 
Name of 
drugs/groups 
Dose/100 
gram 
body 
weight 
Initial 
reading 
average 
final 
reading 
average 
Mean 
difference 
Percentage 
inflammation 
Percentage 
inhibition 
1 Water 2 ml 0.9 1.2  100 - 
2 Diclofenac 5 mg/kg 0.9 0.8 0.2 11.1 88.9 
3 KSM  100mg/kg 0.8 1.1 0.30 37.5 62.5 
4 KSM 200mg/kg 0.8 0.7 0.1 16.4 74.6 
 
Figure : 10 Study of Acute –Inflammatory By Hind Paw Method 
 
INTERPRETATION: 
  The Anti-inflammatory activity of siddha formulation Karpoora Sinthamani 
Mathirai  at 100 mg/kg & 200 mg/kg were tested for their Anti-inflammatory activity by 
using carrageenan induced Hind paw method and the result are tabulated in Table. No.10   
The results revals that both  100 mg/kg & 200 mg/kg dose of siddha preparation  of 
Karpoora Sinthamani Mathirai  possesses signification  Anti-inflammatory activity when 
compared to control group. 
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ANALGESIC ACTIVITY  OF KARPOORA SINTHAMANI MATHIRAI BY 
HOTPLATE METHOD 
Table :11  Analgesic activity  of karpoora sinthamani mathirai 
 
GROUP DOSE 
Mean latency before and after drug 
administration % inhibition 
0 min 30 min 60  min  90 min 30mi
n 
60mi
n 
90mi
n 
Group I Vehicle 3.96±0.20 4.35±0.26 3.86±0.198 4.28±0.267 - - - 
Group II 10 4.04±0.88 7.32±0.65 7.67±0.645 5.37±1.008 68% 98% 20% 
GROUP 
III 100 3.91±0.04 5.97±0.25 6.89±0.776 6.87±0.617 37% 78% 60% 
Group IV 200 3.77±0.08 5.27±0.82 6.04±0.514 7.63±0.465 21% 56% 78% 
 
Figure : 10 Study of Analgesic Activity  
 
 
Statistical analysis  
  The results of statistical analysis for animal experiment were expressed as mean ± 
SEM and were evaluated by ANOVA followed by Dunnet’s multiple comparisons. The 
results obtained were compared with the vehicle control group. The p<0.05, 0.001 were 
considered to be statistically significant 
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Result  
  Results of hotplate test are presented in Table  for drug Karpoora Sinthamani 
Mathirai  respectively. The drug  were found to exhibit a dose dependent increase in 
latency time when compared with control. At 90 minutes, the percent inhibition of two 
different doses of Karpoora Sinthamani Mathirai  (100 and 200 mg/kg body weight) was 
60% & 78% respectively. The results were found to be statistically significant (p<0.001)  
INTERPRETATION: 
  Karpoora Sinthamani Mathirai possess significant analgesic and anti-
inflammatory potential as evidenced from the present preclinical study. These findings 
support the use of Karpoora Sinthamani Mathirai   in traditional system of medicine for 
the management of pain and inflammatory conditions. Further studies are needed to be 
carried out in other animal models of pain and inflammatory to validate its efficacy and to 
identify the active phytoconstituents in the formulation and their targets in pain and 
inflammatory pathways. 
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ANTI-SPASMODIC ACTIVITY (SMOOTH MUSCLE RELAXANT) OF 
KARPOORA SINTHAMANI MATHIRAI  
Table No: 12 
Dose Response Relationship Observations of Acetylcholine 
Sl.No Concentration/dose Acetylcholine Response (cm) 
1 0.1 ml 3.8 cm 
2 0.2 ml 4.0 cm 
3 0.4 ml 4.2 cm 
4 0.8 ml 5.0 cm 
5 1.6 ml 5.0 cm 
 
Table No: 13 
Dose Response Relationship Observations of Atropine 
Sl.No Concentration/dose atropine Response (cm) 
1 0.1 ml - 
2 0.2 ml - 
3 0.4 ml - 
4 0.8 ml - 
5 1.6 ml - 
 
Table No: 14 
Dose Response Relationship Observations of Acetylcholine and KARPOORA 
SINTHAMANI MATHIRAI  
Sl.No Concentration/dose Acetylcholine + KSM Response (cm) 
1 0.1 ml +0.1 ml 2.6 cm 
2 0.2 ml +0.2 ml 3.0 cm 
3 0.4 ml +0.4 ml 5.6 cm 
4 0.8 ml +0.8 ml 5.8 cm 
5 1.6 ml + 1.6 ml 623 cm 
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Comparative Dose Response of Acetylcholine followed by KARPOORA 
SINTHAMANI MATHIRAI  
Table No:15 
Sl. No Treatment Dose(ml) response 
1 
 
Acetylcholine 
0.1 ml 3.8 cm 
2 0.2 ml 4.0 cm 
3 0.4 ml 4.2 cm 
4 0.8 ml 5.0 cm 
5 1.6 ml 5.0 cm 
6 
 
Acetylcholine  +KARPOORA 
SINTHAMANI MATHIRAI  
0.1 ml+0.1 ml 2.6 cm 
7 0.2 ml+0.2 ml 3.0 cm 
8 0.4 ml+0.4 ml 5.6 cm 
9 0.8 ml+0.8 ml 5.8 cm 
10 1.6 ml+1.6 ml 6.23cm 
 
 
Figure 11: Comparative dose response relationship of Acetylcholine and KARPOORA 
SINTHAMANI MATHIRAI  on excised rat ileum. 
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RESULTS:-  
 Effect of Acetylcholine on excised rat ileum reflected an increase in spasmodic 
activity (response) with an increase in dose. 
 
INTERPRETATION: 
             From the present study results it was observed that acetylcholine (Ach) alone 
causes contraction of excised rat ileum but when acetylcholine was given in presence of 
KARPOORA SINTHAMANI MATHIRAI there was a marked decrease in contraction of 
ileum was observed. This revealed that KARPOORA SINTHAMANI MATHIRAI 
possess a high degree of anti-spasmodic (smooth muscle relaxant)  activity by blocking 
cholinergic receptors. 
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LAXATIVE ACTIVITY OF KARPOORA SINTHAMANI MATHIRAI  
Table 16: Laxative Activity of KSM in Rats 
 
Group (Treatment) Dose (mg/kg) 
Faeces output (g) 
0 - 8 hr 8 - 16 hr 
Control (Saline) 5 ml/kg 0.82 ± 0.04 0.87 ± 0.2 
Sodium picosulfate 5 mg/kg 4.56 ± 0.01 4.73 ± 35 
KSM 100 mg/kg 3.1 ± 0.12 3.3 ± 0.1 
KSM 200 mg/kg 4.25 ± 0.30 4.8 ± 0.79 
KSM 300 mg/kg 3.01 ± 0.01 3.2 ± 0.01 
 
Figure 12. : Laxative Activity of drug in Rats 
 
 
 
DISCUSSION 
  The siddha formulation Karpoora Sinthamani Mathirai was studied for its laxative 
activity in Wistar Albino rats. The laxative activity was assessed by measuring the wet 
faeces in all test drugs 
  Administered groups: The siddha formulation Karpoora Sinthamani Mathirai 
showed significant (P<0.01) dose dependent laxative activity as compare to normal 
control animals. The laxative activity produced by the siddha formulation Karpoora 
Sinthamani Mathirai was similar to that of the reference control sodium picosulfate. The 
laxative activity of siddha formulation Karpoora Sinthamani Mathirai was studied in rats.  
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The results showed that an oral administration of the siddha formulation Karpoora 
Sinthamani Mathirai produced significant and dose dependant increase in faeces output of 
rats. Sodium picosulfate is a member of the poly phenolic group of stimulant laxatives. 
Following oral administration, it is converted in the colon to an active form through the 
action of bacterial enzymes. As a result, its effects are directed the colon, where it 
stimulates peristalsis and, in common with other laxatives, reduces water reabsorption 
leading to the softening of stools. The results suggest that the siddha formulation 
Karpoora Sinthamani Mathirai might also be produced its laxative activity by reducing 
the water reabsorption in the colon which might soften the stool. 
 
INTERPRETATION 
  From the result it could be concluded that oral administration of siddha 
formulation Karpoora Sinthamani Mathirai shows significant laxative activity in rats. 
Further phyto-chemical studies are required to isolate the active compounds responsible 
for laxative activity which could be a major contribution to prove the claims in Indian 
systems of medicine. 
  
 
  
                                                                                                                             
 
   147 PRE CLINICAL  STUDY OF  KARPOORA  SINTHAMANI  MATHIRAI 
 
ANTIMICROBIAL ACTIVITIES  
Table 17: Antimicrobial Activities of Drug by Agar Well Diffusion Method 
S.No. Test Pathogens 
 
Result  Zone of Inhibition (mm) at 30µl 
Positive Control 
(Gentamycin) Size of Inhibition 
1. Escherichia coli Sensitive  20 mm 12 mm 
2 Klebsiella pneumoniae Sensitive 22 mm 14 mm 
3 Staphylococcus aureus Sensitive  21 mm 10 mm 
4 Pseudomonas aeruginosa Sensitive 22 mm 9 mm 
5. Salmonella typhi Sensitive 19 mm 14 mm  
 
FIGURE : 13   ANTI-MICROBIAL ACTIVITY RESULT 
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INTERPRETATION  
  Both Gram positive and Gram negative bacteria E.coli, Klebsiella pneumoniae 
and Staphylococcus aureus, Pseudomonas aeruginosa and Salmonella typhi were found 
to be sensitive  when compared to the standard drug Gentamycin (Broad spectrum) (Table 
17). The herbal drug Karpoora Sinthamani Mathirai   exhibited broad spectrum activity 
against bacterial pathogens at 100mg / ml concentration of the drug.  
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7. SUMMARY 
  In this dissertation work, I have selected  “KARPOORA SINTHAMANI 
MATHIRAI ” from the Siddha literature Anuboga Vaithiya  Navaneetham, Part – IV, 
authored by Abdhula Sayubu PM,  Thamarai Noolagam, Chennai ( 2006) 106 for the 
evaluation of safety, efficacy and therapeutic potency in  “KEEL VAYU” for its anti –
inflammatory, analgesic, anti-spasmodic and laxative activities. 
  “Karpoora Sinthamani Mathirai ”  is a herbo-mineral preparation. it is very 
effective and traditionally used in the treatment of  “Keel Vayu” (Arthritis). 
  Collection of literature reviews regarding the trial medicine carried out in siddha 
aspect, geochemical aspect and pharmaceutical review. 
  All the ingredients of the test drug  “Karpoora Sinthamani Mathirai ” were 
collected from Nagercoil, Traditional drug store. Each ingredient are verified and 
authenticated by the Gunapadam exeperts from Department of Gunapadam of 
Government Siddha Medical College, Palayamkottai. The test drug was prepared as per 
the procedure given in the literature. 
  As per siddha literature “Keel Vayu” is a disease caused due to domination 
vatham to neutralize deranged vatha kutram. The drug “Karpoora Sinthamani Mathirai ” 
has hot )ouh<hl<* in potency it is essential to neutralize vatha kutram. 
  Physiochemical analysis of  “Karpoora Sinthamani Mathirai ” shows brown in 
colour, sense of touch is hard, pleasan odour, round in appearance with salt, pungent, 
bitter, astringent taste. the loss on drying  (LOD) is  7.40% which shows low moisture 
content present in the prepared medicine. Increased moisture content is the issue for 
instability of drug and lesser shelf-life of a drug. Since, Karpoora Sinthamani Mathirai 
has been well prepared it could get maximum stability and better shelf-life. Longer shelf-
life for mathirai mentioned in siddha literature is thus justified from the above 
observation. 
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The acid-insoluble ash limit test is designed to measure the amount of ash 
insoluble to diluted hydrochloric acid. Acid-insoluble ash value of the prepared 
formulation (0.90%) shows that a very small amount of the inorganic component is 
insoluble in acid. It indicates that adulteration of raw ingredients by substances, such as 
silica and husk, is very less, and a low acid-insoluble ash value may also affect the 
amount of the component absorbed in the gastro-intestinal canal when taken orally. 
The test drug Karpoora Sinthamani Mathirai  having, lower the acid insoluble 
value better will be the drug quality.  
 Total viable aerobic counts within the normal level. (Normal- 4x102CFU/g.) 
 Total Enterobacteriaceae counts is Nil 
 Total fungal count within the normal level. (Normal-3.5x102 CFU/g.) 
 Specific pathogens Salmonella sp., Staphylococcus aureus, E. coli, Pseudomonas 
aeruginosa are Nil. 
 So it can be stored for a long period and would not easily be attacked by microbes. 
It is hygienically good for taking as internal medicine. 
 Water soluble extract shows, water is a better solvent of extraction for the 
formulation.  
 The alkaline (7.140) nature of the drug is very useful in gastric juice.  
 Physio chemical and bio-chemical analysis of Karpoora Sinthamani Mathirai  
shows the presence of  calcium, sulphate, ferrous iron, chloride, starch, 
Unsaturated compounds, amino acids and all the above minerals might be 
responsible for the effectiveness of the drug.  
 The Pharmacological review were done to establish the different methodologies 
adopted in the preclinical evaluation of the test drug 
 FTIR reveals the presence of alcohols,phenols,carboxylic acids,amines, aliphatic 
nitro groups, alkanes, aromatics, alkyl halides groups which has anti- 
inflammatory activity.  
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 ICP-OES analysis of these drug shows heavy metals Like Arsenic, cadmium, 
Nickel, copper and lead are found in below detecting level. The toxic metals 
are found in BDL. It reveals the drug in safer for long term use. The elements 
like magnesium are also found in below detecting level. The phosphorus is 
involved in tissue repair, Sodium chloride regulates acid-base balance. 
calcium has got potent anti- inflammatory activity.  
 SEM analysis result shows most of the particles present in the sample is micro 
size, average particle size is 2 to 1  microns. So very minimal quantity of the 
medicine is enough to treat the disease.  
 Anti-microbial study of the test drug carried out by Agar well-diffusion 
method.  It is observed that “Karpoora Sinthamani Mathirai”  is sensitive to 
Escherichia coli, klebsiella pneumoniae, staphylococcus aureus, pseudomonas 
aeruginosa, salmonella typhi.  The Karpoora Sinthamani Mathirai  has 
significant anti-bacterial activity. 
 Pharmacological analysis of  Karpoora Sinthamani Mathirai  shows that the 
drug has got significant anti-inflammatory activity and excellent analgesic 
activity and good anti-spasmodic activity and laxative activity. 
 According to siddha aspect, Keel Vayu is a disease caused by derangement of 
vadha humors chiefly and kabha  humour the drug has salt, bitter taste. Salt 
taste neutralize vadha humour and bitter taste normalise  kabha humour. In 
this case vadha and kabha humours are gradually normalised by administration 
of Karpoora Sinthamani Mathirai . Neutralization of affected humours by 
giving Viresanam (purgative) vatha kuttram is neutralize the drug Karpoora 
Sinthamani Mathirai  having ingredients with laxative and purgating action 
such as  (Pooram, Nervalam and Kattrazhai) because of this actions vatha 
kutram is neutralized by administration of Karpoora Sinthamani Mathirai .  
 Acute oral toxicity of Karpoora Sinthamani Mathirai  observed no toxicity. 
Acute and sub acute toxicity study of Karpoora Sinthamani Mathirai  
represents non toxic and safe drug in Wistar albino rats.  
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8.  CONCLUSION 
   
  From the literature review, Physico-chemical, Bio-chemical, Instrumental 
analysis, Microbiological, Toxicological, Pharmacological studies, it has been concluded 
that The trial drug is a Karpoora Sinthamani Mathirai in herbo mineral form, selected 
from the text book of “Anuboga vaithiya navaneetham Part IV” authored by 
Hakeem.P.M.Abdulla saheeb and the results supported the study has got a good Anti-
inflammatory, Analgesic, Anti-spasmodic activity, laxative activity and hence effective 
for Keel Vayu. 
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9.  FUTURE SCOPE 
  Preclinical evaluation of the test drug Karpoora Sinthamani Mathirai  has been 
done by bio-chemical, physio-chemical, instrumenta, pharmacologica, toxicological and 
microbial standard presecribed procedures. In future the drug has to validated by 
extensive  clinical trials as per WHO guidelines. This Karpoora Sinthamani Mathirai  
is to be used very much to treating all types of arthritis. 
  Having made up of nano particles, Karpoora Sinthamani Mathirai  holds extra 
ordinary promise for the presentation and treatment Keel Vayu. Thus  the ancient wisdom 
siddhars will remains as one important source of future medicine and therapeutics. 
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